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Abstract 
The twin-arginine translocase (Tat) is a highly specialised protein transport system, present in 
prokaryotes and plant chloroplasts. This translocase functions to transport proteins across the 
cytoplasmic membrane in a fully folded state. Substrates of the Tat system are targeted to the 
system by N-terminal signal peptides, which bear the consensus motif (S/T)RRxFLK. These 
proteins often require redox centres for function that must be incorporated prior to transport, 
with many utilising the molybdenum cofactor Mo-bis-MGD for enzymatic activity during 
anaerobic respiration. Cofactor loading and protein maturation of these substrates is often 
coordinated by a ‘Tat proofreading’ process, involving the binding of cytoplasmic chaperone 
proteins to the substrate signal peptide to prevent premature translocation before maturation 
is complete. A large group of these proteins form the TorD family of chaperone proteins, of 
which two examples are DmsD and TorD. DmsD is known to aid maturation of three Tat 
substrates in Salmonella enterica subsp. enterica serovar Typhimurium; YnfE - the catalytic 
subunit of selenate reductase, YnfF, and DmsA - the catalytic subunit of dimethyl sulphoxide 
(DMSO) reductase. TorD assists in the assembly of the catalytic subunit of trimethylamine N-
oxide (TMAO) reductase, TorA. 
 Work presented in this thesis has demonstrated that the interaction between S. Typhimurium 
DmsD and YnfE requires a hydrophobic stretch of residues on the N-terminal signal peptide of 
YnfE, the sequence of which is highly conserved amongst signal peptide sequences of all three 
DmsD target proteins. Genetic and biochemical analysis also revealed residues of importance 
on the DmsD protein, with a proposed binding mechanism being discussed involving a 
hydrophobic cleft on the protein surface. The possibility that DmsD is involved in activities 
other than signal peptide binding was also touched upon. TorA/TorD binding interactions of 
Escherichia coli were also investigated, and again highlighted the prospect of dual functionality 
of these chaperone proteins, with TorD amino acid residues being implicated in TorA signal 
peptide interactions and TMAO reductase activity. High resolution microscopy was employed 
to enable imaging of TorD within the cellular environment, and super resolution microscopy 
was utilized to elucidate the interplay between Tat substrates and the Tat translocase. Finally, 
broad metabolic phenotype screening technology was used to gain an understanding of the 
broader function of dmsD and other genes in bacterial cell metabolism. 
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1 Introduction  
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1.1 Protein translocation in Gram-negative organisms  
1.1.1 Escherichia coli and Salmonella enterica subsp. enterica serovar 
Typhimurium 
Escherichia coli K-12 is a typical member of the gut microflora and is normally harmless to the 
host. However, certain strains do exist that can cause disease, including enterohaemorrhagic E. 
coli (EHEC) and enteropathogenic E. coli (EPEC). These virulent strains have arisen through the 
acquisition of virulence genes such as those encoding Shiga toxin, and are well known for their 
ability to cause diarrhoeal disease and other serious illnesses (Johnson & Nolan, 2009). Due to 
its genetic tractability and relatively simple growth requirements under laboratory conditions 
E. coli K-12 has become a model bacterium for biochemical and cellular studies. 
The Salmonella genus contains over 2000 serovars, with some causing systemic infections such 
as meningitis and others affecting the GI tract causing localised alimentary infections. The 
bacterium Salmonella enterica subsp. enterica serovar Typhimurium is a facultative 
intracellular pathogen and a major cause of human gastroenteritis. S. Typhimurium strain LT2 
was first isolated in the 1940s and is now a standard laboratory research strain, with the entire 
chromosome having been sequenced (McClelland et al., 2001).  
 
1.1.2 Structure of the Gram-negative bacterial cell membranes 
E. coli and S. Typhimurium are both Gram-negative bacteria. Gram-negative bacteria can be 
characterised by the presence of a double layered cell envelope; the inner membrane 
enclosing the cytoplasm and the outer membrane surrounding this inner membrane (Figure 
1.1). The ‘space’ between the two membranes is known as the periplasm and is an aqueous 
and highly viscous environment that contains the peptidoglycan cell wall. The contents of the 
periplasm are able to act as a buffer against the extracellular environment, and this 
environment is highly reactive with many proteins being present involved in a great many 
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cellular processes. These include cell wall biogenesis and division, nutrient uptake, motor 
protein assembly and anaerobic respiration (Hall et al., 1997, Kojima et al., 2009, Richardson, 
2000, Tarry et al., 2009a, Tsui et al., 1994). 
 
 
Figure 1.1: The Gram-negative cell envelope. 
The cell envelope enclosing the cytoplasm of Gram-negative organisms comprises two layers, the inner cytoplasmic 
membrane (IM) and the outer membrane (OM). The inner membrane consists of a phospholipid bilayer with two 
types of protein: integral inner membrane proteins (IMPs) that span the membrane bilayer through α-helical 
transmembrane domains, and inner membrane lipoproteins that are anchored to the membrane by a lipid moiety. 
Soluble proteins and the peptidoglycan layer reside in the aqueous periplasm. The asymmetric outer membrane is 
composed of a phospholipid inner layer and a lipopolysaccharide (LPS) outer layer. Outer membrane proteins 
(OMPs) and OM lipoproteins reside within this layer. Figure based on (Ruiz et al., 2009) 
 
The cytoplasmic and outer cell membranes are significantly different in their compositions due 
to the differing requirements of their roles. The cytoplasmic membrane separates the 
cytoplasm from the periplasm. It consists of a phospholipid bilayer studded with integral 
membrane proteins, and functions as a permeability barrier. The phospholipid composition of 
the bilayer is generally 70-80 % phosphatidylethanolamine (PE), 20-25 % phosphatidylglycerol 
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(PG) and up to 5 % cardiolipin (CL) (Dowhan, 1997). CL levels have been shown to rise with a 
related decrease in PG upon entry to the stationary phase (Hiraoka et al., 1993). The 
hydrophobic nature of the internal portion of the cytoplasmic membrane causes it to be 
impermeable to ions, thereby enabling the establishment of a charge separation and 
electrochemical gradient across the cis (cytoplasmic) and trans (periplasmic) sides of the 
membrane. This transmembrane electrochemical gradient is utilised by the bacterial cell for a 
large number of cellular functions, for example protein translocation (Driessen, 1992), flagellar 
rotation (Berry, 1993), active solute transport (Ramos et al., 1976) and ATP synthesis (Maloney 
et al., 1974). 
The outer membrane of the Gram-negative cell also consists of a phospholipid bilayer and 
proteins, however in addition to these components are polysaccharides, which in combination 
with lipids form lipopolysaccharides (LPS). LPS is arranged on the extracellular face of the outer 
membrane, and can be structurally described in three components: the hydrophobic lipid A 
portion, the core polysaccharide and the O-specific polysaccharide (or O-antigen).  The lipid A 
region of LPS is associated with causing toxicity to animals, whilst the O-antigen is involved in 
bacterial resistance to antibiotics and is a key target of the complement pathway of the 
immune system (Raetz & Whitfield, 2002). 
 
1.1.3 Protein translocation in Gram-negative bacteria 
Transport of proteins across the cytoplasmic membrane is an essential capability of bacteria, 
with approximately 20% of synthesised proteins requiring translocation partially or entirely 
across the cytoplasmic membrane (Pugsley, 1993). The cytoplasmic membrane plays an 
important role in energy production by bacteria, allowing the generation of proton-motive 
force required in respiratory and photosynthetic electron transfer chains (Berks et al., 2000). A 
number of redox proteins require an extracellular location for this proton motive force 
generation to occur (Berks et al., 2000). The cell envelope presents a physical barrier which all 
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enzymes requiring extra-cytoplasmic localisation must cross. There is also the issue of the 
differing environments created by this compartmentalisation that proteins must be able to 
overcome in order to assemble correctly for function.  
In order to address these challenges, specialised transport systems have developed to target 
proteins from their site of synthesis in the cytoplasm to their site of function. These systems 
are able to distinguish between proteins requiring translocation and those that must remain 
cytoplasmic, and have mechanisms by which proteins are targeted to their cognate transport 
system to ensure correct and efficient transport.  This transport may be termed export or 
secretion, depending upon the end location of the protein. Whilst protein export involves the 
transport of proteins from the cytoplasm across the cytoplasmic membrane to the periplasm, 
protein secretion defines the translocation of proteins through both cytoplasmic and outer 
membranes to the extracellular environment or into another target cell. A wide range of 
translocation systems have evolved to conduct these roles and by working alone or in 
cooperation enable translocation of proteins to every cellular compartment and extracellularly 
(Dalbey & Kuhn, 2012). 
 
1.1.4  The general secretory (Sec) pathway 
1.1.4.1 Overview of Sec translocation 
In Gram-negative bacteria such as Escherichia coli many proteins undergo transport across the 
cytoplasmic membrane into the periplasm via the general secretory (Sec) pathway (Rusch & 
Kendall, 2007). The Sec pathway is the only protein translocation pathway known to be 
universally conserved across all domains, and is the route by which the majority of proteins 
reach the periplasm  (Pohlschröder et al., 2005).  During early studies of the Sec system in E. 
coli, the Sec components were identified through genetic screening. In this work, a number of 
genetic mutants were isolated; either general secretion (sec) mutants that displayed general 
secretion defects, or protein localisation dominant suppressor (prl) mutations that were able 
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to restore the export of precursor proteins with altered signal peptides (Bieker & Silhavy, 1990, 
Danese & Silhavy, 1998, Trun et al., 1988). Through the use of these mutants, two Sec protein 
complexes were generated (Bieker-Brady & Silhavy, 1992) and this led to the reconstitution in 
vitro of the Sec translocase and further characterisation of the translocase (Natale et al., 2008). 
The Sec translocase exports proteins in an unfolded state, either co- or post-translocationally 
(Pohlschröder et al., 2005). 
Proteins destined for export by Sec are synthesized as precursor proteins with N-terminal 
signal peptides that target them to this translocase. Whilst these signal peptides do not share 
specific sequence homology, they do have a general organization with clearly definable 
features (Figure 1.2). Normally between 18 and 26 amino acid residues in length, the peptides 
consist of an n-region with one or more positively charged residues, a core h-region of 
hydrophobic residues, and a c-region with a signal peptidase cleavage site (commonly AxA), 
the only conserved motif amongst these signal peptides (Cristóbal et al., 1999a, Izard & 
Kendall, 1994, Stanley et al., 2000). Efficient transport is dependent upon conservation of 
these general features of Sec signal peptides, for example the positive charge of the n-region, 
although not dependent on amino acid-type, must be present for translocation to occur (Izard 
& Kendall, 1994). Increasing the positive charge through amino acid substitutions can in fact 
increase efficiency of Sec transport (Sasaki et al., 1990). Mutations in the AxA motif inhibited 
cell growth and protein processing, thereby preventing maturation of Sec substrates (Barkocy-
Gallagher & Bassfor Jr., 1992). 
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Figure 1.2: General structural features of Sec signal peptides. 
Signal peptides of the Sec translocase range in length from 18 to 26 amino acids. They have a conserved tripartite 
structure with a positive n-region, a hydrophobic h-region and a c-region that contains the AxA signal peptidase 
cleavage site. 
 
1.1.4.2 Components of the Sec translocon 
The heterotrimeric protein conducting channel of Sec consists of two universally conserved 
transmembrane proteins, named SecE and SecY in prokaryotes, and also a third protein 
subunit that varies between domains. In bacteria this third subunit is named SecG (Natale et 
al., 2008, Pohlschröder et al., 2005, Pugsley, 1993). Whilst SecE and SecY are highly conserved 
and essential for protein export, and it has been shown that these protein components are 
sufficient for transport, SecG is  not necessary for function and only makes limited contact with 
SecEY (Berg et al., 2004, Brundage et al., 1990, Natale et al., 2008), but may play a role in 
translocation with its presence appearing to improve efficiency, for example at low 
temperature (Nishiyama et al., 1994). The crystal structure of the SecYEG complex from the 
Archaea Methanococcus jannaschii was solved by van den Berg and colleagues in 2004 (Figure 
1.3), and suggests that a single heterotrimer can serve as a translocation unit. SecY appears to 
consist of two halves (TM1-5 and TM6-10) linked by a flexible loop, with SecE acting to clamp 
these two domains together. The two halves of SecY create an hourglass shaped pore through 
their arrangement of an inverted two-fold rotation pseudo-symmetry. The pore is thought to 
exist in a closed inactive state with the distorted short helix TM22 of SecY acting as a plug (van 
den Berg et al., 2004). The pore has been predicted to open via the ‘lateral gate’ region 
between TM2 and TM7 upon binding of a substrate signal peptide (du Plessis et al., 2011).  
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Figure 1.3: 3D crystal structure of the SecYEG complex from Methanococcus jonnaschii. 
Images taken from (van den Berg et al., 2004). A – View from the cytoplasm. SecA helices 1-10 are coloured blue to 
red, with SecE in magenta and SecG in pink. B – View from the back of the SecYEG pore.  
 
Peripherally associated with the SecYEG pore is cytoplasmic protein SecA, an ATPase involved 
in coupling ATP hydrolysis to protein translocation, thereby energizing export (Lill et al., 1989, 
Pohlschröder et al., 2005). In addition to interacting with the Sec pore, SecA appears to bind to 
the Sec signal peptide, with both n- and h-regions being important for interactions, and also 
demonstrates reversible interactions with the cytoplasmic membrane (Cunningham & 
Wickner, 1989, Lill et al., 1989). Whilst SecA is required for energy production for 
translocation, the transmembrane proton motive force also appears to play a role in Sec 
transport, possibly in prevention of reverse translocation (Arkowitz et al., 1993, Driessen, 
1992). 
 
1.1.5 Co- and post-translational protein targeting 
There are two distinct targeting routes by which signal peptide-bearing precursor proteins 
(‘preproteins’) arrive at the Sec translocon – post-translational and co-translational (Figure 
1.4). The route a preprotein follows is determined immediately upon emergence from the 
ribosome, and appears to be related to signal peptide hydrophobicity with the signal 
9 
 
recognition particle (SRP) involved in co-translational export tending to recognise more 
hydrophobic signal peptides than SecA (De Gier et al., 1997, Kebir & Kendall, 2002). 
 
 
Figure 1.4: Post- and co-translational export through the Sec pathway. 
Post-translational export (left) is mediated by the SecB chaperone (light blue), that binds the unfolded Sec substrate 
as it exits the ribosome. SecB then shuttles the substrate to the Sec machinery where the SecA ATPase (green) 
drives export through the SecYEG pore. Co-translational export occurs with the signal recognition particle (SRP – 
red) binding to the signal sequence of the Sec substrate (orange). The ribosome/substrate complex is then taken to 
the Sec machinery and translocation can occur as the protein is synthesised. Folding of the substrate then takes 
place in the periplasm.  
 
The majority of proteins are exported post-translationally, and this route involves primary 
interactions with the molecular chaperone protein SecB (Figure 1.4). SecB is a small 
cytoplasmic protein of 12 kDa that exists as a tetramer (Dekker et al., 2003, Xu et al., 2000), 
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and does not appear to be essential for export (Hartl et al., 1990, Trun et al., 1988), however it 
is thought to be involved in shuttling preproteins to SecA as well as maintaining proteins in an 
unfolded state to promote Sec export (Natale et al., 2008). Indeed SecB recognition of 
preproteins appears to be dependent upon them being in a non-native conformation (Hardy & 
Randall, 1991), and it is thought to interact with multiple hydrophobic regions of the 
preprotein via hydrophobic grooves (Dekker et al., 2003, Randall et al., 1998a, Randall et al., 
1998b, Xu et al., 2000). SecB interacts with SecA at its extreme carboxyl region (Crane et al., 
2005), causing a conformational change enabling passing of the preprotein to SecA from SecB 
in coordination with SecB release (Fekkes et al., 1997, Joly & Wickner, 1993). It is thought that 
binding of a preprotein peptide to SecA causes conformational changes that repress the 
ATPase DEAD/DEXH ATPase motor in the C domain. As the preprotein is passed to the SecYEG 
pore through an interaction with SecY, the DEAD motor becomes active and ATPase activity is 
initiated, which aids insertion of the preprotein into the SecYEG pore. This is thought to be a 
type of safety mechanism, ensuring ATPase activity does not occur when SecA is not 
associated with the SecYEG pore (Baud et al., 2002, Papanikou et al., 2005). SecA subsequently 
penetrates SecYEG, and preprotein is threaded through the SecYEG pore (Economou et al., 
1995, Economou & Wickner, 1994). The signal peptide is cleaved as translocation is completed 
and the mature protein then folds in the periplasm. 
Co-translational export, facilitated by the SRP, is the route of choice for the majority of 
membrane proteins (Figure 1.4). The SRP of E. coli consists of two components, a 4.5S RNA and 
the 48 kDa GTPase called Ffh for “fifty four homolog” (Valent et al., 1998). The SRP recognises 
highly hydrophobic stretches such as those found on Sec signal peptides, whilst proteins with 
less hydrophobic signal sequences are unable to stably bind and so are instead dependent 
upon SecB (Valent et al., 1998, Zhou et al., 2014). Newly synthesised polypeptides emerge 
from the ribosome and are immediately picked up by SRP via their signal peptide, with less 
hydrophobic signal peptides thought to be prevented through competition with another 
ribosome-bound protein Trigger Factor (TF) (Ullers et al., 2003). Ribosome-bound SRP is 
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recognised by the cytoplasmic membrane SRP receptor, another GTPase (Zhang et al., 2008, 
Zhang et al., 2009). Upon interactions with FtsY, the ribosome binds to the SecYEG complex in 
a high affinity interaction with the large ribosomal subunit (Prinz et al., 2000). Interactions of 
the FtsY-SRP complex with the membrane and SecYEG are thought to induce conformational 
changes activating GTP hydrolysis of both FtsY and Ffh, leading to the unloading of the 
preprotein from the SRP. The release of preproteins from the SRP and their association with 
SecYEG are interlinked processes (Valent et al., 1998). GTP is eventually hydrolysed once the 
preprotein is successfully transferred to SecYEG, and appears to drive disassembly of the 
SRP/FtsY complex for a new cycle of targeting to begin (Connolly & Gilmore, 1989). Preproteins 
are threaded through the Sec pore in a precursory unfolded state, with folding occurring in the 
periplasm once translocation is complete (Berks et al., 2000, Bogsch et al., 1998). 
 
1.1.6 YidC 
A large number of proteins are required to be inserted in the cytoplasmic membrane for 
function. The Sec translocase is able to insert a number of proteins, however YidC is also 
thought to be important in inserting proteins into the cytoplasmic membrane, both 
independently and in conjunction with the Sec translocase (Scotti et al., 2000, van der Laan et 
al., 2005). The YidC mechanism of membrane insertion is highly important for the maintenance 
of the proton-motive force, with many membrane proteins involved in energy transduction 
being inserted by YidC (van der Laan et al., 2003). 
YidC is predicted to consist of six transmembrane regions plus a large periplasmic domain 
between regions 1 and 2. The crystal structure of the periplasmic part of YidC has been 
determined and forms a β-sandwich motif of 18 β-strands and three α-helices (Oliver & 
Paetzel, 2008). The structure of the entire YidC protein has been predicted using modelling and 
appears to induce membrane ‘thinning’, which may be relevant to the membrane insertion of 
proteins (Wickles et al., 2014). 
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When inserting proteins with the Sec pathway, YidC interacts with the lateral gate of SecY 
involved in membrane insertion, perhaps involved in the coordination of lateral gate 
movement (Sachelaru et al., 2013). SecF and SecD of the accessory complex SecDFyajC have 
also been observed in interactions with YidC, perhaps important as a scaffold aiding to hold 
YidC with SecY (Nouwen & Driessen, 2002). 
When inserting membrane proteins independently of the Sec system, YidC appears to 
recognise a small number specific preproteins such as the phage Pf3 coat protein, the 
mechanosensitive MscL protein and other small membrane proteins (Chen et al., 2002, Facey 
et al., 2007). Some of these proteins also require SRP for insertion (Wang & Dalbey, 2011). 
 
1.1.7  The twin-arginine translocation (Tat) pathway 
1.1.7.1 Overview of Tat translocation 
Many proteins functioning in the periplasm require cofactors that are synthesised in the cell 
cytoplasm. In order to secure such cofactors the protein must fold, however this then renders 
them incompatible with the Sec translocase (Berks et al., 2000). In some cases the protein and 
cofactors are transported separately into the periplasm where cofactor insertion and protein 
maturation then occurs (Berks et al., 2000). The more common mechanism, however, involves 
protein maturation in the cytoplasm with the fully folded, cofactor-containing protein then 
being transported out of the cytoplasm and into the periplasm. This Sec-independent pathway 
found in many bacteria and archaea, as well as being present in the thylakoid membranes of 
plant chloroplasts (Pohlschröder et al., 2005), and is named the Tat (twin-arginine 
translocation) pathway due to the consensus twin-arginine amino acid sequence motif that is 
apparent in signal peptides targeting proteins to this pathway (Berks et al., 2000). The Tat 
pathway differs from the Sec system in that it transports a very small subset of proteins in 
their fully folded form across the cytoplasmic membrane, with many of these proteins playing 
roles in many important cellular functions including energy metabolism, cell division and 
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motility, resistance to heavy metals and antimicrobials, and virulence (Palmer & Berks, 2012). 
Since its discovery in the late 1990’s, the Tat system has been studied intensely and has 
revealed an intriguing and unique mechanism of protein export. 
 
1.1.7.2 Components of the Tat translocon 
In E. coli the fully assembled Tat translocase consists of a 600 kDa complex of four related 
membrane proteins named TatA, TatB, TatC and TatE (Bogsch et al., 1998, Sargent et al., 1998, 
Weiner et al., 1998). The tatABCD operon encodes for TatA, TatB and TatC proteins, as well as 
for TatD; a cytoplasmic protein with no apparent function in protein translocation, thought 
instead to have DNase activity (Figure 1.5) (Bolhuis et al., 2001, Sargent et al., 1998, Wexler et 
al., 2000). The fourth Tat component is TatE, found as a completely separate monocistronic 
gene tatE (Figure 1.5) (Bolhuis et al., 2001) and is said to be a gene duplication encoding a 
functional homologue of TatA (Sargent et al., 1998). 
 
 
Figure 1.5: Organisation of tat genes in E. coli. 
Genes encoding for components of the Tat system are indicated in green. Nearby genes are shown in white. Base 
numbers on the E. coli MG1655 genome are indicated above the illustrated genes. A – The essential genes of the Tat 
system are found in a single operon alongside tatD, a gene that is cotranscribed but not involved with protein 
translocation (Wexler et al., 2000). B - Gene tatE, a duplication of the tatA gene found as a monocistronic gene in 
another region of the genome (Chanal et al., 1998). 
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Expression studies have shown that tatABC and tatE are expressed constitutively, therefore 
indicating the importance of the translocase system in both aerobic and anaerobic growth 
conditions (Jack et al., 2001). It appears that tatE is expressed at significantly lower levels than 
tatA, with the cellular molar ratio of the main Tat components having been determined as 
TatA:B:C 40:2:1 (Jack et al., 2001, Sargent et al., 1998). The TatA and TatB proteins are similar 
in structure, whilst TatC belongs to a separate family. 
 
1.1.7.3 TatA family proteins 
The TatA family encompasses proteins TatA, TatB and TatE. These proteins have been shown 
to be membrane spanning proteins consisting of one transmembrane α-helix at the N-
terminus connected to a C-terminal amphipathic helix via a short hinge region (Hu et al., 2010). 
Whilst both TatA and TatB are required for Tat transport in E. coli, suggesting distinct roles for 
each protein, some bacteria such as Gram-positives have minimal Tat systems consisting of 
just TatA and TatC (Freudl, 2013, Robinson et al., 2011). It has been shown that TatA from 
Bacillus subtilis is able to complement both tatA and tatB deletions in E. coli (Barnett et al., 
2008). It appears that early gene duplication led to the emergence of TatA and TatB proteins, 
with the TatB proteins then diverging in sequence from TatA leading them to take on differing 
roles in the Tat translocase (Yen et al., 2002). 
Encoded at minute 14 of the E. coli genome, TatA is the smallest of the main Tat components, 
being just 9.6 kDa protein 89 amino acids in length (Sargent et al., 1998). The structure and 
membrane alignment of monomeric TatA has been studied using both solid state and solution 
NMR, and is shown to display an L-shaped structure composed of a membrane-bound helix 
and an amphipathic helix with a long unstructured C-region linked by a highly conserved hinge 
region (Figure 1.6). This hinge region contains the only amino acid residue absolutely 
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conserved in both TatA and TatB, Gly-21, and this amino acid in TatA is essential for Tat 
translocation (Hicks et al., 2003).  
 
 
Figure 1.6: Solution NMR structures of monomeric TatA. 
A - Cartoon representation of a single TatAd molecule from Bacillus subtilis, solved by Hu et al. (2010). B – Cartoon 
representation of a TatA monomer from E. coli, solved by Rodriguez et al. (2013). The grey rectangles represent the 
cytoplasmic membrane in order to give an indication of protein orientation. TMH – transmembrane helix. APH – 
amphipathic helix. 
 
In addition Phe-20 is also strictly conserved, and it is likely that these two residues are 
important for the formation of this hinge region, particularly due to the flexibility conferred by 
Gly-21 (Hicks et al., 2003). The amphipathic helix appears to lie on a steep tilt along the face of 
the cytoplasmic membrane, causing it to be partially buried in the membrane (Chan et al., 
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2011, Hu et al., 2010, Walther et al., 2010, Zhang et al., 2014a). Numerous studies over several 
years have been undertaken to determine the exact orientation of TatA within the membrane. 
A number of years ago it was suggested that TatA adopted an ‘N-in, C-out’ topology in the 
membrane (Chan et al., 2007). However more recently it has been categorically shown that 
TatA does in fact adopt an ‘N-out, C-in’ topology (Koch et al., 2012). 
The 7 kDa protein TatE shares 53 % sequence identity with TatA and is thought to play a similar 
role in Tat translocation. In-frame deletion mutants of tatA or tatE are not sufficient to 
completely abolish Tat export of proteins, only with the deletion of both genes was transport 
completely disrupted. This indicates that TatE and TatA have overlapping functions (Sargent et 
al., 1998, Sargent et al., 1999). However, whilst TatE has been shown to play a role in 
translocation it is thought to be to a lesser extent, due to the 50 to 100-fold lower expression 
levels of TatE and also the lack of severe transport defects induced by a tatE gene deletion 
compared to that of tatA (Jack et al., 2004, Jack et al., 2001, Sargent et al., 1998). 
TatB is a specialist member of the wider TatA family and is a slightly larger protein than TatA at 
18.4 kDa, containing 181 amino acids with 20 % shared sequence identify to TatA. TatB is also 
structurally similar to TatA although it has been shown to have a number of structural 
differences, in particular in its C-region which has been shown to be much longer than that of 
TatA (Sargent et al., 1999). A new structure for E. coli TatB has recently been published, 
showing an extended L-shape conformation with four α-helices: a single transmembrane helix, 
plus three helices in the extended C-region comprising an amphipathic helix and a two helices 
that are hydrophilic in nature (Figure 1.7) (Zhang et al., 2014b). Truncation analysis has shown 
that TatB can still show significant transport with even 70 amino acids of the C-terminal 
domain missing, whilst interactions of TatB with TatC can still occur when the entire C-region 
truncated, and it is suggested that the C-terminal tail region is not essential for protein 
function (Lee et al., 2002, Lee et al., 2006a, Maldonado et al., 2011). The hinge region of TatB 
contains the conserved Gly-21, whilst amino acids around this essential residue have been 
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shown to differ to those in TatA (Hicks et al., 2003). In E. coli TatB is known to be functionally 
different to TatA and TatE, with complementation experiments with plasmids expressing tatA 
and tatE genes unable to resume translocation in a tatB deletion mutant. Only upon the re-
introduction of tatB on a plasmid was the block on Tat export corrected (Sargent et al., 1999). 
 
 
Figure 1.7: Solution NMR structure of E. coli TatB. 
Cartoon representation of a TatB monomer from E. coli. Comprises four helices; a single transmembrane helix 
(TMH), an amphipathic helix (APH) plus two hydrophilic helices (Zhang et al., 2014b). 
 
1.1.7.4 TatC proteins 
TatC proteins are the most highly conserved of the Tat protein subunits (Yen et al., 2002). In E. 
coli TatC is composed of 258 amino acids and are 28.9 kDa in molecular weight. This protein 
has been shown to be an essential component for Tat translocation (Bogsch et al., 1998). 
Structural studies show that TatC consists of six transmembrane helices, whilst both N- and C-
termini of the protein are located in the cytoplasm (Behrendt et al., 2004, Punginelli et al., 
2007). Recently the structure of TatC from Aquifex aeolicus, a hyperthermophile, was solved to 
a resolution of 3.5 Å (Figure 1.8) (Rollauer et al., 2012). This TatC protein shares 40 % sequence 
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identity with E. coli TatC, allowing previous data from E. coli TatC to be accurately mapped 
onto this new structure. 
 
 
Figure 1.8: Three dimensional crystal structure of TatC from A. aeolicus. 
A – Cartoon representation of TatC structure, with helices coloured from blue (N-terminus) to red (C-terminus). 
Helix numbers are labelled in corresponding colour. B – Surface representation of TatC molecule. Left and right 
hand views in A and B are in the same orientation. Structure solved by Rollauer et al. (2012).  
 
Using molecular dynamics (MD) simulations Aquifex TatC was shown to have a number of 
helices spanning the membrane at a steep angle with relation to the membrane plane, thereby 
preventing any large amount of protrusion from the membrane and limiting solvent exposure 
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(Figure 1.8). Transmembrane helix 1 has a severe kink towards the periplasmic face forming an 
interfacial helix. These characteristics, plus the presence of helices 5 and 6 that are extremely 
short and unable to fully span the membrane, cause the membrane bilayer to become 
distorted (Rollauer et al., 2012). It is thought that the protruding periplasmic loops of TatC may 
help to stabilise helix positions within the membrane, potentially important for TatC function. 
Indeed, this corresponds with the tendency of amino acid mutations in these loop regions to 
lead to inactivation of Tat transport (Kneuper et al., 2012). 
 
1.1.7.5 Formation of the Tat translocase 
The major conundrum with the ability of the Tat translocase to transport folded substrates 
with such a large range of sizes is how the system is able to maintain ionic stability throughout 
the translocation process. Whilst most other transport systems translocate unfolded proteins 
of similar diameters and so are able to keep a permanent channel across the membrane, Tat 
substrates vary hugely in size from 20 – 70 Å in diameter and so it is not possible to follow a 
similar mechanism (Richter et al., 2007). This issue may explain the lack of homology between 
Tat components and those of other transport systems. In order to produce a translocon 
system able to perform to these requirements, it appears that the Tat system forms from two 
functional complexes, the TatA complex and the TatBC complex (Oates et al., 2005, Orriss et 
al., 2007).  
Electron microscopy of TatA purified protein complexes has revealed ring-like structures of 
varying size, with an apparent pore in the centre with a lid-like structure on the cytoplasmic 
face. Diameters of the pore ranged between approximately 30 and 70 Å, which would 
accommodate the entire size range of Tat substrates (Gohlke et al., 2005). Using blue native 
PAGE it has been shown that purified TatA complexes exist in varying sizes from below 100 kDa 
to over 600 kDa, increasing in size in a stepwise fashion with estimated increments of 40 kDa 
(Oates et al., 2005). Similar observations were made in vivo and at native expression levels 
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(Leake et al., 2008). In addition, purified TatA monomers were able to self-assemble into 
complexes and again display this ladder of complexes on blue native PAGE  (Oates et al., 2005). 
Higher oligomers of TatA were also present in the absence of TatB and TatC (De Leeuw et al., 
2001), although the size of these complexes considerably increase in the presence of the other 
component proteins (Leake et al., 2008). This suggests the functional TatA units are tetrameric 
protomers that interact and oligomerise to form larger complexes depending on the substrate 
requiring transport. This idea is supported by studies into the homologous transport system in 
plants, where it has been shown that oligomerisation of Tha4 – the TatA homologue found in 
the thylakoid membranes of chloroplasts – can be influenced by the presence of substrates 
(Dabney-Smith et al., 2006). 
The amphipathic helix of TatA has been shown to be essential for Tat function, with amino acid 
substitutions on the hydrophobic face of this helix inactivating transport (Greene et al., 2007). 
A number of these residues have also been highlighted in the TatA dimeric crystal structure as 
being involved in the dimeric interface that may come into play at higher oligomeric numbers 
(Zhang et al., 2014a). It appears that these amphipathic helices form a lid on the cytoplasmic 
side of the TatA channel that may work as a gating mechanism to maintain the ionic seal across 
the membrane (Gohlke et al., 2005). Using solution NMR, and utilising the knowledge that by 
adjusting the detergent levels the amount of TatA oligomerisation can be controlled, a high-
resolution structure of the TatA oligomeric complex was obtained (Figure 1.9). This shows the 
pore is created through interactions of the transmembrane helices (Figure 1.9D), whilst 
amphipathic helices extend out and away from the pore. This would leave them accessible by 
the TatBC/substrate complex during translocation. Modelling has indicated that such a pore 
would lead to extreme distortions of the cytoplasmic membrane, an effect that would create a 
thinned membrane and likely aid creation of a translocation pathway through eventual and 
transient rupture of the membrane (Rodriguez et al., 2013). 
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Figure 1.9: Modelling the TatA oligomeric pore. 
A – Structural models of TatA oligomeric complex containing 16 or 25 subunits. B – Structural diagrams of 
oligomeric TatA, both from the cytoplasmic face (left) and side-on from within the membrane (right). C – Surface 
plot of TatA oligomer as seen from the cytoplasmic side (left) and periplasmic side (right) of membrane. Atoms are 
coloured according to residue type: Lys (blue), Asp or Glu (red), Phe or Trp (pink), Ser or Thr (cyan), Gly (light 
orange), Pro (green), Gln (magenta), and Leu, Ile, Val, Ala, or Met (light grey). For clarity, residues 1-3 are omitted 
due to their flexibility. D – A comprehensive view of the packing interface between residues 4-21 of transmembrane 
helices. E – Surface plot of interior of TatA pore. Atoms are coloured according to type: nitrogen (blue), oxygen 
(red), sulphur (yellow), and carbon (light grey). The carboxamide of Gln8 plus aliphatic side-chains of the pore-lining 
Ile11, Ile15, and Leu19 are indicated. From (Rodriguez et al., 2013). 
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There have been numerous studies highlighting the ability of TatB and TatC to interact with 
high affinity, and these proteins are known to form a complex in vivo (Bolhuis et al., 2001). A 
number of studies have suggested TatC in fact depends upon the presence of TatB for its 
stability, becoming undetectable in the cell when expressed alone in a complete tat deletion 
strain, perhaps highlighting the necessity of TatB for translocase formation (De Leeuw et al., 
2001, Sargent et al., 1999). However, recent work has shown it is possible to purify TatB and 
TatC oligomers in the absence of all other Tat proteins (Orriss et al., 2007). TatBC complexes 
have been purified by various techniques, with complexes showing molecular masses of 
varying size depending upon the purification technique (Bolhuis et al., 2001, Oates et al., 2005, 
Tarry et al., 2009b). These complexes have a 1:1 TatB:TatC stoichiometry with an estimated 7 
copies of each protein per complex (Bolhuis et al., 2001, Tarry et al., 2009b). This is in 
agreement with data from the homologous plant thylakoid Tat system, where it has been 
demonstrated that TatB and TatC homologues form a signal peptide-binding complex 
independent of TatA (Cline & Mori, 2001). 
 
1.1.7.6 The Tat signal peptide 
Substrates of the Tat translocase are similar to substrates of the Sec pathways, with signal 
peptides present at the N-terminal end of the precursor protein used for targeting for 
translocation (Berks, 1996, Sargent, 2007a). Tat signal peptides have been identified to belong 
to two classes according to whether or not they have a role in biosynthesis in addition to 
targeting. Those encompassing the dual roles of Tat targeting and chaperone binding belong to 
class 1 or A-class whilst those with a single function in targeting belong to class 2 or B-class 
(Sargent et al., 2006). It is also likely that a third class of signal peptides may exist involved in 
chaperone binding only, the putative C-class (Sargent, 2007b).  
Tat signal peptides have a similar organisation to signal peptides of the Sec pathway with both 
composing a tripartite structure. This structure has an amino (n-) region, a hydrophobic (h-) 
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central region and a carboxyl (c-) region in both Sec and Tat signal peptides (Figure 1.10) 
(Berks, 1996, Rusch & Kendall, 2007). Tat signal peptides are in general somewhat longer than 
Sec signal peptides due to a slightly longer n-region of variable length (Cristóbal et al., 1999a).  
Tat signal peptides have a consensus sequence (S/T)RRxFLK, where the two arginine residues 
are almost completely invariant (Berks, 1996). This twin arginine motif, for which the Tat 
translocase is named, is thought to be essential for Tat transport with substitutions of either or 
both arginines inhibiting translocation. However in some cases there has been some evidence 
of translocation still occurring with a single conservative arginine to lysine amino acid 
substitution (Hinsley et al., 2001, Stanley et al., 2000). All other amino acid residues of the 
twin-arginine motif are conserved approximately 10-50 % of the time (Bendtsen et al., 2005, 
Berks, 1996, Stanley et al., 2000). 
 
 
Figure 1.10: General features of the Tat signal peptide. 
The N-terminal Tat signal peptide is split in a tripartite fashion into the basic n-region (blue), the central 
hydrophobic h-region (grey) and the polar c-region (turquoise). The highly conserved twin-arginine motif is found 
on the border between the n- and h-regions, whilst the signal peptidase cleavage site AxA is located at the C-
terminus. 
 
Tat signal peptides contain more glycine and less leucine residues in their h-regions than Sec 
signal peptides, thereby reducing the hydrophobicity of their h-region in comparison. The 
overall hydrophobicity of Tat signal peptides appears to play an important role in Sec 
avoidance, as by increasing the hydrophobicity of the signal peptide h-region it was shown to 
be able to be redirected through the Sec system (Cristóbal et al., 1999a). Secondary structure 
predictions, and other studies, of the signal peptide suggest that the h-region is likely to have a 
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helical organisation, with the helix starting close by the end of the twin-arginine motif (San 
Miguel et al., 2003). 
The c-region of Tat signal peptides contains the site of signal peptidase cleavage, usually an 
AxA motif. There is also thought to be a ‘Sec avoidance signal’ at the C-terminal region through 
the presence of a high number of basic residues. This feature in addition to the presence twin 
arginine motif appears to enable effective targeting to Tat and avoidance of Sec transport 
(Blaudeck et al., 2003, Bogsch et al., 1997). In both Sec and Tat translocase systems, the signal 
peptide travels through in a hairpin conformation. In this way, the c-region is actually the first 
part of the protein to enter the Tat pore, explaining the importance of this region for 
preventing incorrect translocation through Sec. 
 
1.1.7.7 Substrates of Tat 
There are currently 27 experimentally confirmed twin-arginine signal peptide-bearing 
substrates in E. coli, making up approximately 6 % of the E. coli exportome (Berks et al., 2005, 
Lee et al., 2006b, Palmer & Berks, 2012, Palmer et al., 2005). Evaluation of the current list of 
substrates (Table 1.1) reveals that the Tat system is utilised for transport of many proteins 
containing metal cofactors unavailable in the periplasm. In addition this specialised system 
enables transport of hetero-oligomeric protein complexes and helps proteins avoid metal ions 
that may be in higher abundance and so compete with required cofactors for insertion into 
their active site during maturation (Tottey et al., 2008).  
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Table 1.1: The thirty seven known and predicted Tat substrates of E. coli K-12. 
In some cases a Tat substrate does not have its own signal peptide, instead being exported as a complex with a signal peptide-containing partner. The signal peptide each substrate uses for 
export is listed, along with the signal peptide sequence. Assembly chaperones often aid insertion of bound cofactors, and for each substrate for which this is the case these are also shown 
below. (Bendtsen et al., 2005, Berks et al., 2005, Thomas et al., 1999, Tullman-Ercek et al., 2007). 
The thirty seven known or predicted Tat substrates in E. coli K-12. 
Protein Description Signal peptide 
used for export 
Bound 
cofactors(s) 
Potential Tat 
assembly 
chaperone(s) 
Signal peptide sequence 
Proteins with complex multiatom cofactors 
DmsA DMSO reductase α-
subunit 
DmsA MGD, [4Fe-4S] DmsD MKTKIPDAVLAAEVSRRGLVKTTAIGGLAMASSALTLPFSRIAHA 
DmsB DMSO reductase β-
subunit 
DmsA 4 x [4Fe-4S] DmsD MKTKIPDAVLAAEVSRRGLVKTTAIGGLAMASSALTLPFSRIAHA 
FdnG Nitrate-inducible formate 
dehydrogenase subunit 
FdnG MGD, [4Fe-4S] FdhE MDVSRRQFFKICAGGMAGTTVAALGFAPKQALAQA 
FdnH Nitrate-inducible formate 
dehydrogenase subunit 
FdnG 4 x [4Fe-4S] FdhE MDVSRRQFFKICAGGMAGTTVAALGFAPKQALAQA 
FdoG Formate dehydrogenase-
O α-subunit 
FdoG MGD, [4Fe-4S] FdhE MQVSRRQFFKICAGGMAGTTAAALGFAPSVALA 
FdoH Formate dehydrogenase-
O β-subunit 
FdoG 4 x [4Fe-4S] FdhE MQVSRRQFFKICAGGMAGTTAAALGFAPSVALA 
HyaA Hydrogenase-1 small 
subunit 
HyaA 2 x [4Fe-4S],  
[3Fe-4S] 
HyaE, HyaF MNNEETFYQAMRRQGVTRRSFLKYCSLAATSLGLGAGMAPKIAWA 
HyaB Hydrogenase-1 large 
subunit 
HyaA [Ni-
Fe(CN)2CO] 
HyaE, HyaF MNNEETFYQAMRRQGVTRRSFLKYCSLAATSLGLGAGMAPKIAWA 
HybA Electron transfer to 
hydrogenase-2 
HybA 4 x [4Fe-4S] - MNRRNFIKAASCGALLTGALPSVSHAAA 
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HybC Hydrogenase-2 large 
subunit 
HybO [Ni-
Fe(CN)2CO] 
HybE MTGDNTLIHSHGINRRDFMKLCAALAATMGLSSKAAA 
HybO Hydrogenase-2 small 
subunit 
HybO 2 x [4Fe-4S],  
[3Fe-4S] 
HybE MTGDNTLIHSHGINRRDFMKLCAALAATMGLSSKAAA 
NapA Periplasmic nitrate 
reductase 
NapA MGD,  [4Fe-
4S] 
NapD MKLSRRSFMKANAVAAAAAAAGLSVPGVARAVVGQQ 
NapG Electron transfer to 
periplasmic nitrate 
reductase 
NapG 4 x [4Fe-4S] - MSRSAKPQNGRRRFLRDVVRTAGGLAAVGVALGLQQQTARA 
NrfC Electron transfer to 
periplasmic nitrite 
reductase 
NrfC 4 x [4Fe-4S] - MTWSRRQFLTGVGVLAAVSGTAGRVVA 
TorA TMAO reductase TorA MGD TorD MNNNDLFQASRRRFLAQLGGLTVAGMLGPSLLTPRRATA 
TorZ TorA homologue TorZ MGD TorD/YcdY MTLTRREFIKHSGIAAGALVVTSAAPLPAWA 
YagR Xanthine dehydrogenase 
family domain homologue 
YagT MCD? YagQ MSNQGEYPEDNRVGKHEPHDLSLTRRDLIKVSAATAATA 
YagS Xanthine dehydrogenase 
family domain homologue 
YagT FAD YagQ MSNQGEYPEDNRVGKHEPHDLSLTRRDLIKVSAATAATA 
YagT Xanthine dehydrogenase 
family domain homologue 
YagT 2 x [2Fe-2S] YagQ MSNQGEYPEDNRVGKHEPHDLSLTRRDLIKVSAATAATA 
YdhX Iron-sulfur protein YdhX 4 x [4Fe-4S] - MSFTRRKFVLGMGTVIFFTGSASSLLA 
YedY Sulfite oxidase family 
homologue 
YedY Molybdopterin - MKKNQFLKESDVTAESVFFMKRRQVLKALGISATALSLPHAAHA 
YnfE Selenate reductase YnfE MGD,  [4Fe-
4S] 
DmsD MSKNERMVGISRRTLVKSTAIGSLALAAGGFSLPFTLRNAAA 
YnfF Selenate reductase YnfF MGD,  [4Fe-
4S] 
DmsD MMKIHTTEALMKAEISRRSLMKTSALGSLALASSAFTLPFSQMVRA 
YnfG DmsB homologue 
 
YnfE/YnfF 4 x [4Fe-4S] DmsD MSKNERMVGISRRTLVKSTAIGSLALAAGGFSLPFTLRNAAA 
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Proteins that appear to lack complex multiatom cofactors 
AmiA N-acetylmuramoyl-l-
alanine amidase 
AmiA Metal ions? - MSTFKPLKTLTSRRQVLKAGLAALTLSGMSQAIA 
AmiC N-acetylmuramoyl-l-
alanine amidase 
AmiC Metal ions? - MSGSNTAISRRRLLQGAGAMWLLSVSQVSLA 
CueO Multicopper oxidase 
linked to copper 
resistance 
CueO Cu ions - MQRRDFLKYSVALGVASALPLWSRAVFA 
FhuD Ferrichrome-binding 
protein 
FhuD Fe(III) 
hydroxamates 
- MSGLPLISRRRLLTAMALSPLLWQMNTAHAAA 
MdoD 
(OpgD) 
Periplasmic glucan 
biosynthesis 
MdoD ? - MDRRRFIKGSMAMAAVCGTSGIASLFSQAAFA 
SufI Multicopy suppressor of 
an ftsI mutation 
SufI None? - MSLSRRQFIQASGIALCAGAVPLKASA 
YaeI Probable metallo-
phosphoesterase 
YaeI Metal ions? - MISRRRFLQATAATIATSSGFGYMHYCEPGWFELIRH 
RLAFFKDNAAPFKILFLADLHYSRFVPLSLISDAIA 
 
YahJ Probable metallo-
hydrolase 
YahJ Metal ions? - MKESNSRREFLSQSGKMVTAAALFGTSVPLAHA 
YcbK Unknown YcbK ? - MDKFDANRRKLLALGGVALGAAILPTPAFA 
YcdB Unknown; structural gene 
overlaps that of YcdO 
YcdB ? - MQYKDENGVNEPSRRRLLKVIGALALAGSCPVAHA 
YcdO Unknown; structural gene 
overlaps that of YcdB 
YcdO ? - MTINFRRNALQLSVAALFSSAFMANA 
WcaM Coded in colonic acid 
biosynthetic gene cluster; 
possible lyase 
WcaM ? - MPFKKLSRRTFLTASSALAFLHTPFARA 
YfhG Unknown YfhG ? - MRHIFQRLLPRRLWLAGLPCLALLG 
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There are also a number of cofactor-less Tat substrates, requiring transport via Tat rather than 
Sec perhaps due to folding taking place too fast after leaving the ribosome to allow transport 
by Sec, or for those whose activity depends upon folding in the cytoplasm to be biologically 
active, such as has been observed with TorA signal peptide-GFP fusion protein (Feilmeier et al., 
2000, Santini et al., 2001, Thomas et al., 2001). The majority of Tat substrates have non-
covalently bound metal cofactors, and by inserting these prior to transport the need for 
additional mechanisms to transport cofactors and additional accessory proteins required for 
cofactor insertion is removed. 
One interesting way by which proteins can be translocated through the Tat system without 
requiring a signal peptide of their own is through a mechanism term ‘hitchhiking’ (Rodrigue et 
al., 1999). This involves complex formation of the signal peptide-less substrate with a partner 
protein that does have a Tat signal peptide to direct the complex to the Tat translocase. 
Processing and transport of these proteins relies upon them being folded and able to form a 
complex, and therefore for these proteins folding in the cytoplasm is essential. 
Another challenge some bacteria may use the Tat system to overcome is the environmental 
conditions in which they live. For example, halophilic archaea have a greatly increased number 
of Tat substrates when compared to E. coli. This is likely because of the high extracellular salt 
conditions in which they exist creating difficulties in protein folding outside of the cytoplasm 
without the presence of additional chaperone proteins. Because of these hostile conditions it 
appears that these species have adapted and transport a much larger proportion of proteins 
that include lipoproteins and other non-redox proteins through Tat than bacteria living in more 
accommodating environments (Dilks et al., 2003, Rose et al., 2002, Storf et al., 2010). 
Of the 27 Tat substrates in E. coli, 16 contain metal cofactors, most commonly Fe-S clusters 
and the molybdenum based cofactor molybdopterin guanine dinucleotide, also termed 
guanylyl molybdenum cofactor (MGD) (Table 1.1). These substrates play an important role in 
metabolism of the cell, specifically catalysing redox reactions during anaerobic respiration. For 
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example, the DMSO reductase family are involved in transferring electrons from quinols to 
terminal electron acceptors, whilst hydrogenases couple hydrogen oxidation with quinone 
reduction and transfer electrons to the quinone pool. Other substrates of Tat are known to be 
involved in completely different roles, in cellular process such as formation of biofilms, cell 
wall metabolism and iron acquisition (Ize et al., 2004, Ize et al., 2003, Stanley et al., 2001). 
A number of Tat substrates have been exploited as reporters of Tat functionality. For example, 
the cell wall amidases AmiA and AmiC were identified after characterization of a defective 
outer membrane phenotype displayed by E. coli tat mutants. Mutant cells were shown to be 
defective in cell separation following division (the cells form long chains) and also displayed 
leaky or permeable envelopes, rendering them sensitive to growth in the presence of SDS (Ize 
et al., 2003). The Tat-dependent cell wall amidase proteins are involved in cleavage of amide 
bonds from the stem peptide in peptidoglycan, and therefore play an important role in cell 
separation after cell division (Vollmer et al., 2008b). SDS sensitivity is now commonly used as a 
reporter of Tat function.  
 
1.1.7.8 The translocation cycle 
 
When inactive, the Tat translocase is unassembled and found as two complexes in the 
membrane. These are TatA, thought to exist under resting conditions as a tetramer, and the 
TatBC complex, comprising approximately 7 copies of each protein. During Tat system 
operation, up to four steps have been defined: (1) Tat signal-peptide recognition; (2) protein 
transport; (3) proton anti-transport; and (4) Tat signal peptide cleavage (Figure 1.11). 
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Figure 1.11: The cycle of protein translocation through Tat. 
The Tat translocase is made up of three main proteins, TatA, TatB and TatC. Initiation of the translocation cycle 
occurs upon interaction of the signal peptide of a fully folded Tat substrate with the TatBC complex. 1. Signal 
peptide recognition by the TatBC complex. 2. Upon substrate binding to TatBC, TatA polymerisation occurs, forming 
a pore across the cytoplasmic membrane of the cell. 3. The substrate is then able to cross the membrane through 
the TatA channel. 4. After translocation, the signal peptide is cleaved by a signal peptidase to leave the substrate 
free in the periplasm. TatA subunits then dissociate from TatBC and depolymerize back to free protomers. 
 
Dynamic changes in the topology of the Tat machinery have been observed, thought to have a 
role in the translocation of proteins across the cytoplasmic membrane (Gouffi et al., 2004). It 
has been hypothesized that protein translocation via the Tat pathway occurs by a cyclical 
mechanism, with initiation of transport involving primary sequence recognition of the 
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substrate protein by TatC and TatB (Figure 1.12 & Figure 1.11) (Alami et al., 2003, Berks et al., 
2014, Cline & Mori, 2001, Gérard & Cline, 2006, Xiong et al., 2007). 
 
 
Figure 1.12: Proposed interaction sites on TatC. 
Surface representation of TatC from Aquifex aeolicus as solved by Rollauer et al. (2012). Shown in red are two areas 
of highly conserved surface residues. The conserved residue patch on the cytoplasmic face of the protein is 
predicted to be the binding site for Tat substrate signal peptides, interacting with their n-regions. The other 
conserved region near the periplasmic side of the membrane is proposed to be involved in interactions with the 
transmembrane helix of TatB. The position of this helix upon interactions with TatC is indicated by the semi-
transparent cylinder. Figure taken from Berks et al. (2014). 
 
The TatC component of the complex is essential and sufficient for initial signal peptide binding, 
whilst TatB becomes involved later during transfer of the substrate from the TatBC complex to 
the TatA pore. Interestingly, TatB and TatC proteins appear to interact with signal peptides in 
different ways, with TatC being involved in a specific interaction localised to the area of the RR 
motif whilst TatB is capable of recognising a much longer stretch of the peptide encompassing 
the RR motif and hydrophobic region (Alami et al., 2003). It is possible that TatB acts as an 
intermediate between initial signal peptide binding and translocation, aiding in movement of 
the substrate to the translocation pore. It has been suggested that TatB helps to prevent 
premature signal peptide cleavage during translocation (Fröbel et al., 2012). There is no 
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requirement for TatA during this step in translocation, as binding of substrates to the TatBC 
complex in the absence of TatA has been observed in both bacterial and plant Tat systems 
(Cline & Mori, 2001, Tarry et al., 2009b). Three dimensional maps for TatBC-substrate 
complexes show that only one or occasionally two substrates are bound per TatBC complex. It 
was also noticed that on the event of two substrates binding, they would bind to TatBC 
subunits adjacent to one another, consistent with the idea that one subunit of the TatBC 
complex is in a high affinity state compared to all others within the complex. Indeed, the 
binding of one substrate induces structural changes in the complex that do not change further 
upon the addition of a second substrate (Tarry et al., 2009b). This suggests that secondary 
substrate binding to TatBC is not mechanistically relevant, and that the structural modification 
may be involved in substrate affinity. 
Once the substrate is bound to the TatBC complex, TatA then interacts with this TatBC-
substrate complex, stabilizing TatB and leading to the formation of an active translocon (Figure 
1.11) (Mangels et al., 2005). This is a transient interaction that is dependent upon the 
transmembrane electrochemical gradient across the cytoplasmic membrane; whilst this 
gradient is maintained translocation of substrates is allowed to occur (Alami et al., 2003, 
Bogsch et al., 1998, Dabney-Smith et al., 2006, Mori & Cline, 2001, Yahr & Wickner, 2001). 
TatA polymerisation has been visualised using TatA-YFP fusion proteins, a process that has 
been shown to require TatB and TatC (Leake et al., 2008). Interactions of the substrate with 
TatA are thought to occur in a membrane potential-dependent manner, with experiments 
using inside-out cytoplasmic membrane vesicles showing that removal of this H+ gradient 
appeared to eradicate any detectable substrate-TatA interactions (Alami et al., 2003). It has 
been suggested that translocation is able to occur through the creation of membrane 
distortions, caused by a combination of the TatA pore itself and also TatC, that aid to weaken 
the membrane and eventually allow for temporary membrane rupture (Rodriguez et al., 2013, 
Rollauer et al., 2012). As the substrate crosses the membrane pore the signal peptide remains 
bound to the TatBC complex (Panahandeh et al., 2008). It is unknown whether this part of the 
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translocation cycle requires the proton motive force. Following translocation the signal 
peptide is cleaved at the AxA site within the C-region by the enzyme signal peptidase LepB 
(Lüke et al., 2009), with the Tat components then going on to dissociate. Dissociation of TatA 
protomers may be induced simultaneously with the substrate passing through the TatA pore 
due to the predicted membrane rupturing involved in translocation (Rodriguez et al., 2013). 
The entire translocation process can be completed in a matter of minutes, and it is thought 
that there are at least two steps within this cycle that require the electrical potential (Δψ) of 
the proton motive force (PMF), although the exact nature of the energetic driving force for this 
system remains to be determined (Bageshwar & Musser, 2007, Whitaker et al., 2012). 
The Tat translocase is a highly specialised system, highly selective in that it only exports fully 
folded proteins across the membrane. Therefore, it is of great importance that bacterial cells 
should have control over proteins leaving the cytoplasm through Tat so as to prevent wasteful 
translocation of immature proteins, as well as avoidance of competition between fully folded 
and immature proteins at the Tat complex (Jack et al., 2004). The Tat system has two 
mechanisms by which such events are prevented, namely ‘quality control’ and ‘Tat 
proofreading’ (Figure 1.13).  
 
1.1.7.9 Tat quality control 
The Tat ‘quality control’ mechanism is suggested to be an inherent property of the TatABCE 
components within the membrane. Proteins that are incorrectly folded or unable to bind 
cofactors are thought to remain in the cell cytoplasm and become degraded (Figure 1.13) 
(DeLisa et al., 2003, Matos et al., 2008). An initial study by (DeLisa et al., 2003) used Tat signal 
peptide fusions to the enzyme alkaline phosphatase (PhoA), an enzyme dependent upon 
disulphide bond formation under oxidising conditions for activity, in conjunction with bacteria 
manipulated to have an oxidising cytoplasm to investigate Tat transport of folded and 
unfolded proteins. It was found that PhoA was only active and exported in the strain 
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engineered to have an oxidising cytoplasm whilst in strains with a reducing cytoplasm (and 
therefore unfolded PhoA) the inactive PhoA fusions were found localised to the cytoplasm. 
From this it was concluded that the Tat translocase must be capable of detecting the folded 
state of the substrate prior to transport. This work was followed up by investigations using a 
clever reporter system using export of a family of proteins displaying various levels of protein 
folding ranging from unfolded and molten globules to well-ordered stable proteins (Rocco et 
al., 2012). It was noted that whilst those proteins exhibiting unfolded and molten globule 
states remained in the cytoplasm of cells, those displaying native-like stable structures were 
transported to the periplasm in a Tat-dependent manner. This result fits in with the previous 
hypothesis that the Tat translocase is involved in structural proofreading.  
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Figure 1.13: The control mechanisms of Tat in place to prevent premature translocation. 
1. Cytoplasmic chaperone proteins bind to their substrate partners via the Tat signal peptide and occasionally on a 
region of the apoprotein itself. 2. Cofactor insertion occurs. 3. Completion of cofactor insertion triggers the release 
of the substrate. 4a. The substrate goes on to interact with the Tat system or 4b. the substrate is subjected to 
quality control. 
 
Using this reporter system a number of TatABC mutants were identified that supress this 
apparent proofreading function and were able to transport these unfolded proteins that 
before remained in the cytoplasm, as well as the aforementioned PhoA. Remarkably, a number 
of these mutants were identified as clustering in TatB and TatC proteins, suggesting a 
secondary role of the signal peptide recognition complex. A role of the TatBC complex in 
folded state sensing has also been suggested in other work (Panahandeh et al., 2008) 
However, it must also be mentioned that whilst amino acid substitutions such as TatC F94, P97 
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and E103 imparted a gain of function phenotype in this study, they have previously been 
identified as disrupting export (Buchanan et al., 2002). It has been suggested that contact of 
TatBC with exposed hydrophobic patches on unfolded proteins causes termination of Tat 
transport (Richter et al., 2007). Conflicting evidence has implied that turnover of malformed 
proteins by quality control is thought to be a function of TatA and TatE specifically, as a double 
knockout mutant of these Tat constituents in E. coli resulted in a lack of degradation ability 
(Matos et al., 2008). Recent stochastic modelling studies published have suggested that 
specific ‘quality control’ does not exist, with an alternative passive model being proposed 
where substrate-dependent association and disassociation rates instead play a role in 
translocation (Chitra et al., 2014). 
 
1.1.7.10 Tat proofreading 
In addition to quality control, it is apparent that a large proportion of Tat substrates are 
subjected to control by cytoplasmic chaperone proteins during maturation (Figure 1.13), 
thereby undergoing a two-tier system of transport regulation. This second mechanism by 
which premature translocation is prevented is known as ‘Tat proofreading’. This exists earlier 
in the protein biosynthesis pathway, and involves cytoplasmic substrate-specific chaperone 
proteins, acting to prevent targeting to the Tat complex before the substrate is fully matured 
(Dubini & Sargent, 2003b, Jack et al., 2004, Sargent, 2007a). These chaperone proteins are 
substrate specific and play a number of important roles in substrate maturation, including 
binding and masking of the signal peptide, cofactor(s) insertion, protection from protease 
degradation (Turner et al., 2004),  and oligomer assembly (Berks et al., 2005, Santini et al., 
1998, Sargent, 2007a). Cofactor-containing proteins are often monitored by this control 
mechanism. For example, the maturation of the Tat-dependent periplasmic redox enzyme 
trimethylamine N-oxide reductase (TorA), a molybdenum binding protein, is monitored by its 
chaperone protein TorD (Hatzixanthis et al., 2005, Jack et al., 2004, Matos et al., 2008). It has 
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been suggested that these chaperones escort their partner substrate proteins to the Tat 
translocase, with interactions of these chaperones with Tat thought to have been observed 
(Papish et al., 2003, Turner et al., 2004), although the requirements of chaperones for Tat 
interactions has been disputed (Ray et al., 2003). 
These chaperone proteins have become well-studied proteins, with a large number having 
been identified either through experimental data displaying interactions with known Tat 
substrates or prediction through sequence analysis and homology (Pommier et al., 1998, 
Redelberger et al., 2011) . These chaperone proteins are highly important in the biogenesis of 
their substrates. 
 
1.1.7.11 The TorD family of chaperone proteins 
As already mentioned, a considerable number of Tat substrates contain molybdenum as a key 
catalytic cofactor at the active site. Most of these enzymes contain the common form of 
molybdenum cofactor (MoCo) known as the bis-molybdopterin guanine dinucleotide (Mo-
bisMGD). The coordination of these molybdoenzyme active sites, alongside phylogenetic 
studies, has led to the classification of these bis-MGD-containing enzymes into three types: 
Type I, Type II and Type III. Type I bis-MGD enzymes normally have a cysteine or selenocysteine 
sidechain as a direct ligand to molybdenum, and comprises enzymes such as E. coli FdnG and 
NapA (periplasmic nitrate reductase) (Jormakka et al., 2004, McDevitt et al., 2002, Sargent, 
2007a), and Salmonella TtrA (tetrathionate reductase) (Hensel et al., 1999). Type II bis-MGD-
containing enzymes have an aspartate molybdenum ligand, and include E. coli NarG plus its 
many homologues (Jormakka et al., 2004), Rhodovulum sulfidophilum DdhA (the catalytic 
subunit of dimethyl sulphide dehydrogenase) (McDevitt et al., 2002) and Thauera selenatis 
SerA (selenate reductase) (Dridge et al., 2007). The Type III bis-MGD group display a serine 
ligand to molybdenum, including E. coli TMAO reductases TorA and TorZ and DmsA (DMSO 
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reductase), plus TMAO and DMSO reductases of Rhodobacter sp. and BisC (biotin sulfoxide 
reductase) (McDevitt et al., 2002, Sargent, 2007a). 
A great number of Type II and Type III molybdoenzymes interact with cytoplasmic chaperone 
proteins during their maturation. These important chaperone proteins all display the same 
general structure, and comprise a large protein family named the TorD family. This protein 
family can be split into three clades: the TorD, the DmsD/YcdY clade and the NarJ clade (Figure 
1.14) (Turner et al., 2004). Although structurally these proteins are very similar, they are all 
highly specific to their substrates (Ilbert et al., 2004). 
 
 
Figure 1.14: The TorD family of cytoplasmic chaperone proteins. 
Phylogenetic tree of the TorD family of chaperones, reproduced from (Turner et al., 2004). This family is separated 
into three clades, namely the NarJ, TorD and YcdY and DmsD clades. 
 
In E. coli there have been five TorD-like chaperones identified to date: TorD, responsible for 
TorA assembly (Ilbert et al., 2003, Pommier et al., 1998); DmsD, unusual in that it is involved in 
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maturation of three Tat substrates DmsA, YnfE and YnfF (Guymer et al., 2009, Oresnik et al., 
2001); NarJ and NarW, homologous proteins required for maturation of the nitrate reductases 
NarG and NarZ respectively; and most recently identified YcdY, predicted to be involved in 
maturation of YcdX, a zinc-containing protein with a putative involvement in bacterial cell 
swarming (Redelberger et al., 2011). A number of specific signature sequence motifs have 
been identified amongst these proteins, with most appearing to be confined to a specific 
clade. The existence of a highly conserved ‘E(Q)PxDH’ motif across all sub-domains of the TorD 
family was also identified (Turner et al., 2004). 
 
1.1.7.12 The role of TorD chaperones 
The chaperone DmsD was discovered to bind tightly to DmsA in affinity chromatography 
experiments, and from this work was deemed to be a signal peptide binding chaperone protein 
(Oresnik et al., 2001). DmsA is a Tat-targeted protein forming the active subunit of the 
heterotrimeric molybdoenzyme DMSO reductase (Bilous & Weiner, 1988). DMSO reductase is 
encoded by the dmsABC operon, where DmsA contains the MGD cofactor and DmsB has four 
[4Fe-4S] clusters (Rothery et al., 1995, Sambasivarao et al., 1990, Sambasivarao & Weiner, 
1991). It has been shown that, although essential for DMSO reductase activity and despite 
interactions with the signal peptide being observed (Oresnik et al., 2001), DmsD is not required 
for correct targeting of the DmsA signal peptide to the Tat translocase and therefore must be 
involved instead in enzyme biogenesis (Ray et al., 2003). Specific interactions of DmsD with the 
hydrophobic region of the DmsA signal peptide have been observed (Winstone et al., 2013a, 
Winstone et al., 2006). It may be that DmsD exerts a transport blocking effect during binding 
as well as being involved in enzyme maturation. More recently it has been found that in 
addition to DmsA proofreading, DmsD is also involved in interactions with an enzyme 
responsible for selenate reduction in both E. coli and S. Typhimurium encoded by the operon 
ynfFEGHI; interestingly DmsD is in fact encoded by the gene ynfI in this operon (Guymer et al., 
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2009, Lubitz & Weiner, 2003, Oresnik et al., 2001). YnfE, the catalytic subunit of selenate 
reductase, is similar to DmsA in that it contains an MGD cofactor, and this enzyme is described 
in further detail in Section 2.1. 
It was the identification of DmsD as a cytoplasmic chaperone that led to the suggestion of, and 
investigations into, the possibility of TorD belonging to the same family of chaperone proteins. 
TorD shares sequence homology with DmsD and both chaperone proteins have been found to 
contain (Y/F/W)xxLF and E(PX or XP)D(H/Y) motifs common to members of the DmsD family 
clade (Turner et al., 2004). This chaperone protein has been identified as playing a role in the 
assembly of TorA, the active subunit of the molybdoenzyme TMAO reductase (Ilbert et al., 
2003, Jack et al., 2004, Pommier et al., 1998). Recent studies into TorD interactions with TorA 
have clearly identified two binding sites for TorD, one on the signal peptide and another on the 
‘mature’ region of the TorA apoprotein (Dow et al., 2013, Jack et al., 2004). Although not 
essential for TorA export, TorD is thought to interact prior to cofactor loading and aid this 
maturation process by maintaining apo-TorA in the ideal conformation for insertion (Ilbert et 
al., 2003, Pommier et al., 1998). Remarkably, using TorA signal peptide fusions to the 
hydrogenase 2 subunit HybO (ssTorA::HybO) it was shown that interactions with TorD were 
maintained, with TorD appearing to restore correct targeting of HybO and its partner protein 
HybC, suggesting that TorD was able to perform Tat proofreading functions on a non-native 
substrate (hydrogenase 2) closely enough to rescue assembly of a “non-molybdo” enzyme 
(Jack et al., 2004). This result suggests TorD function is divorced, at least in part, from cofactor 
loading since hydrogenase 2 does not have the same cofactor as TorA. TorD also appears to 
bind GTP, with binding increasing when in the presence of the TorA signal peptide leading to 
suggestions that it may bind TorA in a GTP-dependent manner (Hatzixanthis et al., 2005). Later 
evidence to support this idea was provided by the findings of (Guymer et al., 2010) that TorD 
in its dimeric form was indeed able to hydrolyse GTP, albeit at a very low level. 
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In vitro characterisation of the ssTorA-TorD interaction was performed using isothermal 
titration calorimetry. Interactions of TorD to a ssTorA peptide encompassing residues 10-36 
generated negative enthalpy values and a sigmoidal binding curve that reached a clear 
saturation point, giving an initial reported apparent dissociation constant (Kd) of around 1 µM. 
Binding to a shorter peptide of ssTorA2-22 resulted in a considerably weaker Kd of 192 µM. This 
is likely due to the requirement of secondary structural features  of the signal peptide that 
would not be present in an aqueous environment for the correct interactions with TorD to 
occur (Hatzixanthis et al., 2005, Sargent, 2007a). Subsequent work with maltose binding 
protein fusions suggested an apparent Kd of 59 nM for the ssTorA-TorD interaction (Buchanan 
et al., 2008). It is thought that Tat signal peptides adopt a helical structure from the twin-
arginine motif onwards that would be relevant for chaperone protein binding (San Miguel et 
al., 2003), and this theory has been further confirmed by NMR analysis of signal peptides from 
E. coli NarJ and the phosphodiesterase PhoA of Bacillus subtilis, where results of both studies 
suggested the formation of helical structures (Klein et al., 2012, Zakian et al., 2010). 
As well as binding the signal peptide of their substrate partners TorD family chaperones have 
also been shown to interact with the ‘mature’ region of the apoprotein, for example a 
truncated version of NarG missing its first 40 residues is still able to interact with NarJ in 
bacterial two-hybrid studies (Vergnes et al., 2006). This work complements previous data using 
the TorA/TorD pair, where TorD is shown to still interact with mature TorA protein (therefore 
lacking its signal peptide) forced to unfold by heat treatment (Pommier et al., 1998). 
An interesting fact to be mentioned is that not all chaperone proteins in the TorD family aid 
maturation of proteins that go on to be transported out of the cytoplasm by the Tat system. In 
fact, the previously mentioned NarG, chaperoned by NarJ, is part of the multi-subunit nitrate 
reductase that functions in the cytoplasm (Blasco et al., 1998). In experiments using NarG and 
chaperone NarJ it has been shown that NarJ maintains NarG in a soluble state for cofactor 
insertion (Vergnes et al., 2006), and it is thought that proteins such as this have remnant signal 
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peptides that are still capable of being recognised by their chaperone proteins. Sequence 
analysis suggests that they do have an N-terminal signal sequence related to the twin-arginine 
motif, with the major difference being that the second arginine has been replaced by an 
aromatic residue. This hints at the possibility that these enzymes were once periplasmic, a 
theory that has been suggested in the past (Turner et al., 2004). Substitutions of certain key 
residues in these remnant signal peptides has been shown to ‘reactivate’ them, once again 
leading to their redirection to and transport via the Tat system (Ize et al., 2009b). In addition, 
the first 15 amino acids of NarG adopts an α-helical conformation in solution, as is the case for 
genuine signal peptides (Zakian et al., 2010). 
 
1.1.7.13 TorD chaperone structures 
The 3D structures of a number of TorD family proteins have been solved so far, and all appear 
to show high structural homology despite relatively low levels of similarity on a sequence level 
of around 20 % for most proteins (Figure 1.15) (Ilbert et al., 2004). Initially through structure 
prediction it was thought that these proteins displayed a high level of α-helixes, and this was 
later confirmed for a number of chaperones using circular dichroism spectroscopy (Genest et 
al., 2008, Ilbert et al., 2004, Sarfo et al., 2004, Tranier et al., 2002). 3D crystal structures of 
several TorD chaperone proteins have been solved to date: DmsD from E. coli and Salmonella 
Typhimurium, TorD from Shewanella massilia, and NarJ and TtrD, both from Archeoglobus 
fulgidus (Coulthurst et al., 2012, Kirillova et al., 2007, Ramasamy & Clemons Jr, 2009, Tranier et 
al., 2003). These proteins all share an all α-helical structure. 
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Figure 1.15: 3D crystal structures of TorD family proteins show conserved α-helical structure. 
A – S. massilia TorD dimer (1N1C). B – E. coli DmsD (3CW0). C – S. Typhimurium DmsD (1S9U). D – A. fulgidus NarJ 
(2o9x). E – A. fulgidus TtrD (2XOL). 
 
Whilst TorD family proteins are primarily monomeric, dimers and higher oligomeric forms have 
also been identified. For example purified DmsD has been observed as a number of folding 
forms when analysed by Western blot (Sarfo et al., 2004). In addition TorD has been found in 
various oligomeric forms that are variable depending upon the acidity of the environment 
(Tranier et al., 2002); indeed the crystal structure of TorD from S. massilia was solved as a 
dimer displaying a unique structure with extreme domain swapping (Tranier et al., 2003). TorD 
has been shown to have chaperone capabilities as both a monomer and a dimer (Tranier et al., 
2002), however due to the lack of other TorD family chaperone 3D crystal structures in dimeric 
form doubts have been raised over the relevance of this protein dimer. 
 
1.1.7.14 Other Tat proofreading chaperones 
Whilst the TorD family of chaperones cover assembly of type II and type III molybdoenzymes, 
additional chaperones must be involved in similar processes with type I molybdoenzymes as 
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well as FeS cluster proteins. These chaperones are important in the maturation of Tat 
substrates such as NapA (nitrate reductase), Hyd-1 and Hyd-2 (hydrogenases), and FdnG and 
FdoG (formate dehydrogenases) (Sargent, 2007a). 
E. coli periplasmic nitrate reductase, the catalytic subunit of which is Tat substrate NapA, is 
encoded in the operon napFDAGHBC. NapA contains a Mo-bis-MGD cofactor plus a [4e-4S] 
cluster (Jepson et al., 2007, Potter & Cole, 1999), and has been shown to reach its functional 
location in the periplasm through the Tat system due to the presence of an N-terminal signal 
peptide (Berks et al., 2005, Berks et al., 1995). NapD, one of the essential protein products of 
this operon predicted to be cytoplasmic in its localisation, was shown to be required for the 
production of active NapA hinting at a role in post-translational modifications (Berks et al., 
1995, Potter & Cole, 1999). Later work identified that NapD was able to interact with the signal 
peptide of NapA in vivo and also in vitro with a NapA fusion to MalE (Maillard et al., 2007), 
with the signal peptide binding epitope appearing to localise within the n-region of the 
sequence (Grahl et al., 2012). Through the use of high-resolution heteronuclear NMR the 
solution structure of NapD has been determined, and showed that the protein consists of two 
α-helices and four β-strands, adopting a β-α-β-β-α-β ferredoxin like fold where the β-strands 
form one face as an antiparallel β-sheet and the α-helices form the opposite face (Figure 1.16) 
(Maillard et al., 2007). This structure is indeed dissimilar from the TorD family all α-helical 
structure, highlighting differences between these families of chaperone proteins. 
 
45 
 
 
Figure 1.16: Solution NMR structure of E. coli NapD. 
NapD (2JSX) has a ferredoxin fold, with two α-helices and four β-strands forming opposite faces of the molecule 
(Maillard et al., 2007).   
 
In E. coli, the membrane bound formate dehydrogenase isoenzymes formate dehydrogenase-N 
and formate dehydrogenase-O, consist of FdnGHI and FdoGHI, respectively. These enzymes 
require a functional Tat system for transport, and are exported as heterodimers using the Tat 
hitchhiker mechanism where only one subunit contains a signal peptide (Berks et al., 2005, 
Sargent, 2007a, Stanley et al., 2002). FdnG and FdoG each contain the Mo-bis-MGD cofactor 
and a single [4Fe-4S] cluster as well as the Tat signal peptide for the complex, and associate 
with their respective FdnH and FdoH partners, containing 4[4Fe-4S] clusters, prior to transport.  
The chaperone protein FdhE is essential for activity of both enzymes, and interactions have 
been shown between this chaperone and FdnG and FdoG (Lüke et al., 2008, Mandrand-
Berthelot et al., 1988 ). Differing from TorD-like chaperone proteins, there is no evidence for 
FdhE binding to either formate dehydrogenase signal peptide, and therefore it is likely that 
these chaperones participate in a different mechanism of proofreading (Lüke et al., 2008). 
 
1.1.8 General chaperones involved with Tat substrates 
In addition to the many specific Tat chaperones involved in the Tat pathway, it is also known 
that a number of general chaperone proteins also appear to be involved in Tat substrate 
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assembly. Originally it was in the homologous Tat system in plant thylakoids that general 
chaperone proteins were identified as playing a role. Here chaperones Cpn60 and Hsp70 were 
identified in complex with the Rieske protein prior to transport, with the suggestion that they 
helped prevention of formation of assembly incompetent forms of the Rieske protein 
(Madueño et al., 1993, Molik et al., 2001). 
Evidence for a similar role of general chaperones in bacteria is perhaps less robust (Fisher & 
DeLisa, 2004). For example, the trigger factor (TF) protein has been shown to interact with Tat 
substrates TorA and SufI via their signal peptides. However the deletion or overexpression of 
TF did not alter Tat export of these substrates (Jong et al., 2004). GroEL appears to influence 
hydrogenase-1 assembly but not that of hydrogenase-2 (Rodrigue et al., 1996), whilst general 
chaperones including DnaK, PspA and IbpA have been shown to aid stabilisation and export 
efficiency of Tat substrates (DeLisa et al., 2004, Pérez-Rodríguez et al., 2007). It has been 
hypothesised that these chaperones are important for stabilising Tat substrates that do not 
undergo Tat proofreading (Graubner et al., 2007). This would certainly comply with 
observations that these proteins bind to extended strands of hydrophobic residues (Rudiger et 
al., 1997, Young et al., 2004, Zhu et al., 1996) . 
 
1.2 Respiratory capability of E. coli and Salmonella 
Respiration is essential in almost all cells, and is the process by which the cell is energised 
through ATP synthesis. In animals and plants the presence of oxygen is essential for respiratory 
oxidative phosphorylation to generate ATP. However, bacteria such as E. coli display 
considerable flexibility in their respiratory capability, both in use of electron donors and 
acceptors, and are able to produce ATP in processes generally termed anaerobic respiration. 
Bacterial respiratory chains begin by donation of electrons from low redox-potential electron 
donors to higher redox potential electron acceptors. This process continues with transfer of 
electrons through a range of successively higher redox potential molecules forming a 
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continuous electron transport chain. This process ends with the reduction of a terminal 
electron acceptor, and the free energy is conserved in the form of an electrochemical gradient 
(i.e. the proton motive force – PMF) across the membrane. Oxygen is the most energetically 
favourable electron acceptor, with the highest redox potential of +0.82 V, and so if available 
this is always used as the terminal electron acceptor. In the absence of oxygen, anaerobic 
respiration can be undertaken, but is significantly less productive than aerobic respiration 
(Richardson, 2000).  
E. coli is also capable of producing a large number of structurally and functionally diverse redox 
enzymes and also has the ability to adjust expression levels of these enzymes depending upon 
the environmental conditions (Figure 1.17). Amongst these enzymes are 15 dehydrogenases, 
able to act as quinone reductases and the first step in anaerobic respiration. Reduced 
quinones, termed quinols, enter the quinone pool where they can go on to be oxidised by any 
one of 10 terminal reductases, for example DMSO reductase or TMAO reductase (Unden & 
Bongaerts, 1997). The respiratory enzymes are highly variable in both the subunit composition 
and prosthetic groups. Many of these enzymes contain the molybdenum-based cofactor Mo-
bis-MGD. The molybdenum atom is greatly utilised in respiratory enzymes due to its ability to 
cycle between two oxidation states of Mo(IV) and Mo(VI), enabling two electron redox 
reactions to be performed (Hille, 1996, Hille, 2002). Many of these enzymes are periplasmic in 
location and are substrates of the Tat system. 
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Figure 1.17: Respiratory pathways in E. coli. 
Figure adapted from (Sargent, 2007a). Electron flow is from left to right, from electron donors to electron acceptors 
via the membrane associated quinone pool of ubiquinone (UQ), menaquinone (MK) and demethylmenaquinone 
(DMK). Respiratory enzymes (blue boxes) are indicated by their gene names whilst electron donor/acceptor 
substrates are also indicated. Enzymes with a periplasmic active site are highlighted red, whilst those with a subunit 
containing a Mo-bis-MGD cofactor are indicated with an asterisk. Those known to require a Tat chaperone for 
correct assembly are outlined light blue. 
 
1.2.1  Quinones and respiration 
Bacterial electron transport chains consist of a number of dehydrogenases and terminal 
reductases, and these are linked together by 2-electron carriers known as quinones. There are 
three quinones in E. coli: ubiquinone (UQ), menaquinone (MK) and demethylmenaquinone 
(DMK), with the redox potentials +0.11, -0.08 and +0.04 respectively (Unden & Bongaerts, 
1997). Under aerobic growth conditions, UQ acts as the major quinone, with this major role 
switching during anaerobic growth to MK in the presence of fumarate or DMSO acceptors, as 
well as nitrate (Magalon et al., 1997, Rothery et al., 2001, Unden & Bongaerts, 1997). DMK 
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appears to be utilised in the presence of succinate (Sharma et al., 2012). The additional 
adaptability this offers also counts towards the great flexibility in bacterial respiration. 
In facultative anaerobic bacteria such as E. coli, there is usually a specific hierarchy of electron 
acceptor usage. This is due to the differing energy yields of acceptors based on the redox 
potential so the reactions and the theoretical ATP yields when redox reactions are coupled 
together. Through the use of transcriptional regulators, E. coli ensures that the most 
energetically favourable acceptors available in the environment are rapidly preferentially 
utilised, thereby maximising growth under all circumstances (Unden & Bongaerts, 1997). In E. 
coli, transcriptional regulation is mainly influenced by the presence of O2 and nitrate, although 
there are other terminal electron acceptors, such fumarate and TMAO, that may also impart 
regulatory effects. O2 sensing regulators ArcA/B and FNR are responsible for O2 regulation. 
ArcA is most significantly utilised under microaerobic conditions, whilst FNR is normally 
inactive during microaerobic conditions and plays a major role during strictly anaerobic 
conditions (Liu & De Wulf, 2004, Shalel-Levanon et al., 2005, Unden & Guest, 1985). In addition 
nitrate is a major regulator, detected by homologous sensor regulator pairs NarX/L and NarP/Q 
(Unden & Bongaerts, 1997, Yamamoto et al., 2005). 
ArcB/ArcA is a two-component system of signal transduction, involved in the sensing of oxygen 
availability and coordinating oxidative and fermentative catabolism in response. ArcB is a 
membrane-bound sensor kinase that becomes activated under anaerobic conditions and 
causes the transphosphorylation of ArcA, the cytoplasmic response regulator containing an 
unusual very short periplasmic section with two canonical transmembrane segments (Alvarez 
et al., 2013, Iuchi et al., 1990). It appears that the kinase ability of ArcB is silenced during 
aerobic growth by ubiquinone, and upon a shift to anaerobic growth becomes reactivated 
involving menaquinone (Alvarez et al., 2013, Bekker et al., 2010, Sharma et al., 2013). ArcA-P 
directly represses and activates a number of operons, and has been shown to have over 170 
chromosomal binding sites in E. coli (Park et al., 2013b). These binding sites have been shown 
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to have at least two but up to five direct repeat sequences, each of 18 base pairs in length 
(Park et al., 2013b). Through examination of genome-wide mRNA expression profiles it was 
revealed that ArcA is involved in the direct regulation of eighty five operons, repressing 
seventy four in its predominant role as a global repressor of carbon oxidation, and activating 
eleven. In addition to this, ArcA also appears to act as an indirect regulator of a further 135 
operons (Park et al., 2013b). This massive range of regulation highlights the importance of this 
two-component system in control of gene expression. 
The FNR (fumarate nitrate reduction) is a one-component regulatory system discovered 
through studies showing the mutations at a locus encompassing the fnr gene negatively 
affected the synthesis of nitrate, nitrite and fumarate reductases. This led to the finding that 
this protein has a strong DNA affinity and is involved in regulation of anaerobic gene 
expression (Lin & Iuchi, 1991, Unden & Guest, 1985).  FNR is a member of the cAMP receptor 
protein (CRP)-FNR superfamily of homodimeric transcriptional regulators, which consist of an 
N-terminal sensory domain and a C-terminal DNA-binding domain. The FNR regulator protein 
in an active state is dimeric, with each monomer containing a [4Fe-4S] cluster (Moore & Kiley, 
2001). FNR undergoes a switch from monomer to dimer between unbound and bound forms, 
with the binding of the [4Fe-4S] cluster initiating dimerization (Crack et al., 2014). As oxygen 
levels increase, the [4Fe-4S] cluster rapidly converts to a [2Fe-2S] cluster, causing the reversal 
of FNR back to monomeric form lacking the ability to specifically bind DNA. The 
interconversion between [4Fe-4S] and [2Fe-2S] clusters and subsequent dimer-monomer 
interchange is thought to enable FNR to be highly responsive to changes in oxygen levels 
(Crack et al., 2008, Zhang et al., 2012). The conversion of the [4Fe-4S] cluster to the [2Fe-2S] 
cluster in the presence of oxygen appears to be enhanced two-fold when FNR is bound to DNA. 
This observation has led to suggestions that DNA-bound [4Fe-4S] FNR is the preferred target of 
O2 over the non-DNA-bound equivalent, thereby increasing the sensitivity of the system to 
oxygen (Crack et al., 2014). FNR appears to modulate ArcA expression, and it has also been 
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suggested that both FNR and ArcA are required for full expression of ArcA (Compan & Touati, 
1994). 
Nitrate and nitrite are the preferred electron acceptors in anaerobic environments. In order to 
allow maximum utilisation, E. coli has two systems for regulation with nitrate. These are the 
two-component systems NarX/L and NarP/Q, which work in conjunction to control gene 
expression anaerobically. NarX and NarQ are the membrane sensor kinases with NarL and 
NarP acting as the regulatory subunits. Each of the sensor proteins responds to both nitrate 
and nitrite, although the NarX/L system mainly acts as a nitrate regulator. NarX appears to be 
able to discriminate between ligands, with the protein acting primarily as a NarL kinase in 
response to nitrate, but as a phospho-NarL phosphatase in the presence of nitrite. This is 
different to the NarQ sensor, that is thought to acts in a similar fashion as a kinase in response 
to both nitrate and nitrite (Stewart & Bledsoe, 2003). These systems work in a similar fashion 
to the ArcAB system, with the sensor protein autophosphorylating and inducing 
transphosphorylation of the response regulator. The NarX/L and NarL/P systems function to 
both activate nitrate and nitrite catabolic genes whilst at the same time repressing expression 
of genes such as those of other anaerobic respiratory systems for example fumarate reductase 
(Lin & Iuchi, 1991, Unden & Bongaerts, 1997). Interestingly, NarX/L and NarQ/P regulatory 
systems have been shown to demonstrate crosstalk, and are thought to form a cross-
regulation network. This cross-regulation network appears to asymmetric in interactions, with 
the NarX sensor being more specialised for NarL phosphotransfer, whilst the NarQ sensor is 
more generalised and displays similar phosphotransferase activities whether with interactions 
with NarP or NarL (Noriega et al., 2010).  
NarL and its paralogue NarP are known to consist of two domains, the N-terminal receiver 
domain and the C-terminal DNA-binding domain. Crystal structures for the C-terminal domain 
of E. coli NarL in complex with a DNA fragment show an extensive NarL-DNA contact surface 
(Maris et al., 2005, Maris et al., 2002). Crystal structures of full-length and the receiver domain 
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of the putative NarL (Spr1814) of Streptococcus pneumonia have more recently been obtained 
(Park et al., 2012, Park et al., 2013a). These Spr1814 structures show that the receiver domains 
appear to demonstrate reorganisation upon phosphorylation, leading to the suggestion that 
there is an intermediate conformation between inactive and active states (Park et al., 2013b). 
Dimerization of NarL upon phosphorylation is thought to promote DNA binding and 
transcription activation, and has been observed in other response regulator proteins (Lewis et 
al., 2002, Maris et al., 2002, Park et al., 2013a). DNA binding is thought to be initiated upon 
phosphorylation through a conformational change in the hinge region of NarL, thought to 
separate the N-terminal receiver domain from the C-terminal DNA-binding domain, enabling 
transcription regulation by NarL to occur (Zhang et al., 2003). Regulation of DNA binding is 
thought to occur in a similar fashion in NarP (Lin & Stewart, 2010). 
 
1.2.2  The mononuclear molybdenum enzymes 
The mononuclear molybdenum enzyme family is a large class of enzymes that catalyse a great 
range of basic metabolic processes. The majority of these enzymes coordinates molybdenum 
at their active site, however a subset of these are also able to bind tungsten as an alternative. 
Although these enzymes can utilise both molybdenum and tungsten in similar fashions, the 
majority of the characterisation of these enzymes to date has been performed using 
molybdenum-containing enzymes. These enzymes can be broadly separated into two large 
classes of enzyme based on the chemical reaction they catalyse, giving the hydroxylases and 
the oxotransferases. These families can be further classified according to the cofactor 
coordination at the active site, resulting in three subfamilies (Hille, 1996, Hille, 2002, Magalon 
et al., 2011). These families are: Family I of the molybdoenzymes is the xanthine oxidase 
family, typified by the xanthine oxidase of Rhodobacter capsulatus, coordinating a Moco with a 
single pterin molecule (Truglio et al.); Family II, the dimethyl sulphoxide reductase (DMSOR) 
family, is a large well characterised family widespread in prokaryotes that coordinates a Mo-
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bis-MGD; and Family III, the sulphite oxidase family, that bind a single Mo-MPT cofactor (Hille, 
2002). In addition to these three families is an archaeal family of aldehyde oxidoreductases. 
These enzymes bind a tungsten-bis-MPT cofactor that is analogous to the molybdenum 
cofactor found in oxotransferases (Chan et al., 1995). 
The majority of these enzymes catalyse the transfer of an oxygen atom coupled to electron 
transfer during which the metal ion switches between redox states IV and VI, whilst also using 
additional cofactors such as Fe-S clusters. The structures of the molybdenum centre of the 
enzyme forms a basis for the reaction type performed and enzyme family the enzyme belongs 
to. The molybdenum atom is usually coordinated to the sidechain of a cysteine, 
selenocysteine, serine or aspartate residue, or may involve terminal oxo, hydroxo or sulphide 
groups (Figure 1.18). 
The first of these families, the xanthine dehydrogenase family, contains enzymes involved in 
hydroxylation of carbon centres. This family can be characterised by their oxidised 
LMoVIOS(OH) core, with one equivalent of the pterin cofactor (Figure 1.18). Enzymes of the 
xanthine dehydrogenase family characteristically catalyse the hydroxylation of carbon centres. 
The sulphite oxidase family contains an oxidised LMoVIO2(S-Cys) core, with a cysteine ligand to 
the Mo centre plus a single equivalent of the pterin cofactor (Figure 1.18). These catalyse 
transfer of an atom of oxygen to or from the substrate. Important to note here is the fact that 
these enzymes, unlike the other molybdoenzyme families, do not contain or interact with any 
Fe-S clusters.  
The largest family of enzymes is the DMSO reductase family, with both structure and function 
of these enzymes being much more diverse than other families, but in general they catalyse 
oxygen atom transfer. These enzymes contain two equivalents of the pterin cofactor bound to 
the centre, with the Mo-bis-MGD version of the molybdenum cofactor. The core consists of 
L2MoVIO(X), with four dithiolene sulphur atoms acting as ligands to the Mo atom in addition to 
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an oxo group. A sixth ligand is usually a serine, cysteine selenocysteine, hydroxide or water 
(Figure 1.18) (Hille, 2002, Leimkühler, 2007, Magalon et al., 2011) . 
 
 
Figure 1.18: Active site structures of molybdenum-containing enzymes. 
The three families of molybdoenzymes display different coordinations of their molybdocentres. Xanthine oxidase 
contains a single pterin bound plus additional coordination from oxygen, hydroxide and sulphur. The sulphite 
oxidase centre is similar but shows ligands donated by oxygen and sulphur from a cysteine. DMSO reductase are 
more diverse in nature, with binding of two pterins, oxygen, and coordination from an amino acid that can be either 
serine (DMSO reductase), cysteine (nitrate reductase), selenocysteine (formate dehydrogenase) or hydroxide 
(arsenite oxidase). Taken from (Hille, 2002). The biosynthesis and full structure of the molybdenum cofactor is 
shown in Figure 1.20 (Section 1.3.1). 
 
In E. coli the majority of molybdoenzymes belong to the DMSO reductase family. All the 
enzymes in this family contain the Mo-bis-MGD dipteran cofactor, and all catalyse reactions 
following the general equation:  
XO + 2e- + 2H+ ↔ X + H2O 
Although the general cofactor is the same throughout members of the family, differences in 
the Mo binding site do exist. These small variations are important in enzyme function and 
substrate specificity. Despite crystal structures of members of the DMSO reductase family 
show a high degree of homology in the overall fold, there are a great many subtle variations in 
active site structures. It appears that the amino acid involved in molybdenum atom 
coordination can vary amongst different enzymes, with cysteine, selenocysteine, aspartate and 
serine all having been observed binding Mo (Romao, 2009). These differences in complexity 
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allow for further subclassification of the DMSO reductase family (McEwan et al., 2002, Romao, 
2009).  
DMSO and TMAO reductase belong to a clade where the Mo atom is coordinated by both a 
terminal oxygen ligand from a serine residue found in the active site. Four sulphur atoms are 
also in interactions with the Mo, two from the dithiolene each MGD molecule. Whilst DMSO 
and TMAO reductase contain a single prosthetic group in the Mo-bis-MGD cofactor, Nap, FDH 
and arsenite oxidase enzymes contain an additional redox centre in the form of an Fe-S cluster 
of either the [4Fe-4S] or [3Fe-4S] types. A second clade is composed of formate 
dehydrogenases plus NasA and NapA nitrate reductases. In this clade enzymes contain an 
active site of four dithiolene sulphur ligands and a polypeptide ligand from a cysteine (nitrate 
reductase) or selenocysteine (formate dehydrogenase - FDH) to the Mo, plus a sixth ligand 
from a hydroxide or aquaoxide. The final clade contains the arsenite oxidase enzymes, a clade 
with similarities to the Nap/FDH clade. One prominent difference is the existence of a [3Fe-4S] 
cluster replacing the [4Fe-4S] cluster found in the previously described clade. IN addition, this 
third clade does not have a protein-based ligand at the active site, instead simply having four 
sulphur ligands and a hydroxo ligand coordinating the Mo atom (McEwan et al., 2002). 
 
1.2.3 N and S-oxide reductases 
E. coli encodes for a number of reductases required for the respiratory reduction of N- and S-
oxides, including the enzymes trimethylamine N-oxide (TMAO) reductase and 
dimethylsulphoxide (DMSO) reductase. These enzymes are both members of the type III clade 
of the DMSO reductase family of molybdenum-containing enzymes, which is characterised by 
the presence of a serine side chain ligand to the molybdenum in their active site. In these 
enzymes the molybdenum cofactor is in the bisMGD form (Jormakka et al., 2004, Kisker et al., 
1997, McDevitt et al., 2002, Romao, 2009). 
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The organic compound TMAO is present in high levels in the tissues of marine fish where it is 
thought to play an important role in the osmotic equilibrium, and was intensively studied after 
suggestions that its reduction to trimethylamine (TMA) by bacteria may be a major indicator of 
fish spoilage (Barrett & Kwan, 1985). A small number of bacteria are able to utilise TMAO as a 
sole carbon source (Raymond & Plopper, 2002), whilst the majority exploit this compound as a 
substrate for respiration, where TMAO can act as the sole electron acceptor for oxidative 
phosphorylation in the absence of oxygen (Kwan & Barrett, 1983). TMAO reduction to TMA 
can be catalysed by three systems: the periplasmic TorYZ (Gon et al., 2000), the membrane 
bound DmsABC, and the periplasmic TorCAD systems (Barrett & Kwan, 1985, Bilous & Weiner, 
1985b, Bilous & Weiner, 1988). 
The TorYZ system is the least well understood system. It appears to be expressed at low levels, 
with no obvious regulation so far identified. In particular, there does not appear to any up-
regulation by TMAO or DMSO (Gon et al., 2000). This system is also unable to complement a 
dmsABC torAC double mutant strain (Sambasivarao & Weiner, 1991). However, the expression 
of the torCAD operon has been well studied, and interestingly despite its anaerobic expression 
is independent of both global regulators FNR and ArcA, as well as the nitrate regulator NarL. 
Instead, TorCAD is regulated by a TMAO specific two-component regulatory system named the 
TorRS system (Simon et al., 1994). The TorCAD system is highly specific for N-oxide reduction, 
in particular TMAO (Gon et al., 2000). In the absence of oxygen and the presence of TMAO 
TorS, a histidine kinase sensor, autophosphorylates and in turn phosphorylates its partner 
protein TorR. This TorR protein in turn activates tor operon expression through binding to a 
decameric direct repeats called tor boxes in a region upstream in the promoter region (Gon et 
al., 2000, Jourlin et al., 1996a, Simon et al., 1995). In addition to TorRS and overlapping the 
torR gene is torT, encoding a periplasmic protein necessary for torCAD operon expression 
(Jourlin et al., 1996b). TorT binds TMAO in the periplasm and subsequently binds the 
periplasmic domain of TorS. Upon TMAO binding to TorT it is thought to induce a structural 
change that is transduced to TorS, leading to TorS autophosphorylation and subsequent TorR 
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phosphorylation as previously mentioned (Baraquet et al., 2006, Jourlin et al., 1996b). In the 
absence of TMAO, TorS can also dephosphorylate TorR, therefore limiting unnecessary gene 
expression (Ansaldi et al., 2001). An additional level of regulation is performed by the small 
response regulator protein of phage origin named TorI, shown to act downstream of TorS by 
abolishing torCAD expression. TorI is thought to function by binding to the effector domain at 
the C-terminus of TorR and preventing recruitment of RNA polymerase, which in turn 
negatively regulates torCAD expression (Ansaldi et al., 2004). Another form of regulation 
seems to be through TorC in its apoprotein form, appearing to exert a negative autoregulatory 
effect on the torCAD operon. This is thought to also be through the TorS/R system, either 
directly inhibiting TorS through conformational changes or indirectly by preventing the binding 
of TMAO and/or TorT to TorS (Ansaldi et al., 1999). 
The torCAD operon encodes three proteins, the first of which is TorC - a pentahaem c-type 
cytochrome that is anchored to the cytoplasmic membrane (Méjean et al., 1994). TorC is 
homologous to members of the NirT/NapC class of proteins, which contains multi-haem c-type 
cytochromes, with the TorC N-terminal region being homologous to NirT and NapC. TorC is 
anchored to the membrane by an N-terminal region that also contains four of its five haems, 
with the fifth being present in the C-terminal half of the protein (Gon et al., 2001). Intact TorC 
is required for TMAO reductase activity and is involved in the transfer of electrons to the 
catalytic subunit TorA by acting as the site of the menaquinol oxidation reaction involved in 
the TMAO reduction pathway, transferring electrons from MQ to TorA (Gon et al., 2001, Kwan 
& Barrett, 1983). TorC is transported to the periplasm via the Sec translocase, with maturation 
being accomplished through the use of a periplasmic set of cytochrome assembly proteins 
(Ansaldi et al., 1999). TorA, the active subunit of TMAO reductase, is a substrate of Tat that 
localises to the periplasm in its fully folded cofactor-containing state (Santini et al., 1998). The 
final gene of torCAD encodes for the cytoplasmic chaperone protein TorD which is a member 
of the TorD family of chaperones (Section 1.1.7.11). TorD is important for the correct assembly 
of TorA, and has been shown to enable insertion of the Mo-bis-MGD cofactor (Ilbert et al., 
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2003, Pommier et al., 1998). There are thought to be two binding sites for TorD on the TorA 
protein, one on the signal peptide and one in the ‘mature’ region of the protein (Dow et al., 
2013). However, whilst TorD is important in TorA assembly, it does not appear to be essential, 
with torD mutant strains still able to reduce TMAO at approximately 50 % wild-type levels 
(Pommier et al., 1998). It is possible that in addition to TorA binding TorD is also involved in 
direct interactions with proteins of the molybdenum cofactor biosynthetic pathway during 
TorA maturation (Genest et al., 2008). 
The enzyme DMSO reductase is encoded in the operon dmsABC, an operon that is controlled 
by FNR and is constitutively expressed in anaerobic environments. It is also strongly repressed 
ten-fold by NarL in the presence of nitrate (Bearson et al., 2002). The localisation of DMSO 
reductase within the cell was debated for a number of years, with publications appearing to 
show a cytoplasmic location (Rothery & Weiner, 1993, Sambasivarao et al., 1990, 
Sambasivarao et al., 2000). However, the location for both DmsA and DmsB has now been 
determined to be the periplasm (Stanley et al., 2002). Indeed this makes sense of the presence 
of an active Tat signal peptide on DmsA, with DmsB reaching the periplasm alongside DmsA 
through the use of the Tat hitchhiking mechanism (Berks, 1996, Berks et al., 2005, Stanley et 
al., 2002). DMSO reductase is a heterotrimeric enzyme, with DmsA being the active catalytic 
subunit. DmsA has a much broader spectrum of action than TorA, having been shown to be 
able to catalyse the reduction of a range of different N- and S-oxide compounds (Bilous & 
Weiner, 1985a, Gon et al., 2000, Simala-Grant & Weiner, 1998, Weiner et al., 1988). In fact, 
TMAO appears to be reduced at a much higher rate than DMSO, suggesting this may be the 
preferred substrate for DMSO reductase (Weiner et al., 1988). DmsB is a 4[4Fe-4S] containing 
protein that interacts closely with DmsC, the membrane anchor and site of menaquinol 
oxidation (Rothery et al., 1995, Weiner et al., 1988, Weiner et al., 1993a). 
Another enzyme expressed in E. coli and S. Typhimurium is encoded by the operon 
ynfEFGHdmsD. YnfE and YnfF are homologous to one another and also share identity with 
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DmsA (Lubitz & Weiner, 2003). The ynfEFGHdmsD operon is regulated in a similar way to 
DMSO reductase, with upregulation by FNR and negative regulation by NarL (Constantinidou et 
al., 2006, Xu et al., 2009). YnfE has been shown to catalyse reduction of selenate in both E. coli 
and S. Typhimurium, with YnfF also displaying similar capabilities, although perhaps to a lesser 
extent (Guymer et al., 2009). YnfF has also demonstrated DMSO reductase activity, although 
also to a poor extent compared to DmsA (Lubitz & Weiner, 2003). DmsD, a TorD-like 
cytoplasmic chaperone protein encoded for in this operon, is known to be required for the 
correct maturation of DmsA and DMSO reductase function (Oresnik et al., 2001, Ray et al., 
2003). DmsD has been shown to act in a similar way to TorD in that it only binds the unfolded 
DmsA protein, with specific interactions observed with the DmsA signal peptide (Oresnik et al., 
2001). Although it has not yet been shown to bind elsewhere on DmsA, going by what is 
known for the TorD chaperone it is likely that such a binding event can take place.  
 
1.2.4 Nitrate reductases 
Nitrate is the electron acceptor of choice for cells during anaerobic respiration, due to its 
properties as the most energetically favourable of the known anaerobic electron acceptors. 
Only when nitrate is depleted does the E. coli cell switch from using nitrate reductases to 
expression of the N- and S-oxide reductases. All nitrate reductases are molybdopterin 
enzymes, and E. coli encodes for three respiratory nitrate reductases containing Mo-bis-MGD 
in their catalytic subunits (Sparacino-Watkins et al., 2014). These are nitrate reductase-A (Nar-
A), nitrate reductase-Z (Nar-Z) and periplasmic nitrate reductase (Nap). 
Nar-A is the main nitrate reductase in E. coli, encompassing 98 % of cytoplasmic nitrate 
reductase activity (Bonnefoy & DeMoss, 1994). The heterotrimeric complex is made up of: 
NarG, the catalytic subunit containing Mo-bis-MGD in the active site; NarH, an [Fe-S] cluster-
containing electron transfer subunit; and NarI, an integral haem-containing cytochrome b 
membrane anchor that links the enzyme to the quinone pool (Bertero et al., 2005, Rothery et 
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al., 1998, Sodergren et al., 1988). These are encoded in the narGHJI operon, alongside the 
gene for NarJ, a protein required for assembly of the active enzyme (Sodergren & DeMoss, 
1988, Sodergren et al., 1988). NarJ has been identified as having homology with the 
cytoplasmic chaperone protein DmsD, surprising given the fact that Nar-A is a cytoplasmic 
protein, and NarG does not have a functional Tat signal peptide (Turner et al., 2004). NarJ 
appears to be pivotal to the activity of Nar-A, and is involved in many important stages of 
assembly. In addition to binding NarG and aiding cofactor insertion, NarJ is also important for 
FeS cluster insertion in the NarGH dimer. Furthermore, it safeguards NarI maturation by 
preventing premature membrane anchoring (Lanciano et al., 2007). After maturation of these 
proteins is complete NarJ becomes dissociated from the active enzyme (Blasco et al., 1998). 
The second nitrate reductase, Nar-Z, plays a less significant role than Nar-A as it is expressed at 
relatively low levels in high nitrate environments. The operon by which it is encoded, 
narZYWV, shares 73 % homology with narGHIJ and appears to have arisen from gene 
duplication (Blasco et al., 1990, Iobbi et al., 1987). However, despite similarities to Nar-A, the 
Nar-Z operon does not appear to be regulated by the same mechanisms and is not induced by 
nitrate or FNR. In addition, oxygen does not appear to repress expression of the operon 
(Blasco et al., 1990, Iobbi et al., 1987). Expression has also been shown to be up-regulated by 
the stress response regulator RpoS, suggesting this enzyme is involved in an adaptive 
response, perhaps during the change from aerobic to anaerobic respiration. RpoS is a 
stationary phase regulatory factor in addition to being involved in stress responses, and it 
appears to play an important role in respiratory metabolism through the increase of Nar-Z 
expression during stationary phase (Chang et al., 1999). By analogy with Nar-A, it is likely for 
NarZ to be the catalytic Mo-bis-MGD subunit, and NarY to be an Fe-S cluster containing protein 
in the enzyme complex. NarW is also a member of the TorD family of cytoplasmic chaperones, 
and it is likely to function in a similar manner to NarJ (Turner et al., 2004).  
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Whilst these two nitrate reductase enzymes are cytoplasmic in orientation and require the 
transport or nitrate into the cell cytoplasm for function, the third nitrate reductase in E. coli is 
a periplasmic enzyme. Periplasmic nitrate reductase (Nap) is encoded by the operon 
napFDAGHBC in anoxic conditions, and has been implicated in nitrate scavenging in nitrate-
limited conditions. Interestingly, Nap activity is not able to produce the same level of growth in 
the presence of nitrate compared to Nar-A, and it appears that expression of Nap is in part 
regulated by NarL (Constantinidou et al., 2006, Potter et al., 1999). Nitrate reduction by Nap 
has been shown to enable growth with nitrate as the sole respiratory electron acceptor in a 
respiratory chain with a proton translocating dehydrogenase (such as a formate 
dehydrogenase), but does not constitute a site for generating proton motive force itself 
(Stewart et al., 2002). The NapA component of this nitrate reductase is the catalytic subunit, 
containing a Mo-bis-MGD cofactor and [4Fe-4S] cluster (Jepson et al., 2007). Unsurprisingly 
due to its characteristics, NapA is a Tat substrate and bears an N-terminal Tat signal peptide 
that is subsequently cleaved after transport (Thomas et al., 1999). NapA works in complex with 
the dihaem c-type cytochrome NapB to produce the active complex. NapC forms the 
membrane anchor and is a member of the tetrahaem c-type cytochromes and acts to shuttle 
electrons to the active complex (Roldán et al., 1998). None of the iron-sulphur proteins 
encoded in this operon, NapF, NapG and NapH, are essential for nitrate reduction (Potter & 
Cole, 1999). However these components are thought to play roles in electron transfer from 
quinol to the NapAB complex (NapG/F), and [4Fe-4S] cofactor assembly of NapA (NapF) 
(Brondijk et al., 2004, Olmo-Mira et al., 2004, Potter & Cole, 1999). The NapD protein is 
extremely important for the function of this Nap enzyme, with NapA maturation dependent 
upon the presence of NapD. NapD is a Tat signal peptide-binding chaperone protein, however 
unlike the chaperones for Nar-A and Nar-Z this chaperone does not belong to the TorD family. 
Instead it is thought to represent a new family of cytoplasmic chaperones, adopting a 
ferredoxin-type fold (Maillard et al., 2007). 
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1.2.5 Hydrogenases 
A wide range of bacteria are known to be able to metabolize hydrogen for energy production, 
with hydrogen oxidation also implicated in pathogenesis of a number of species (Maier, 2005, 
Vignais & Billoud, 2007). Hydrogen metabolising enzymes are termed hydrogenases, and are 
typically involved in this simple and reversible chemical reaction: 
2H+ + 2e- ↔ H2 
The direction of this reaction is dependent upon the presence of either an electron acceptor 
with a high redox potential or an electron donor with a low redox potential. The organisation 
of the active site of hydrogenases enable the classification of these enzymes into three main 
groups: the [NiFe]-hydrogenases, containing one nickel and one iron atom; the [FeFe]-
hydrogenases, containing two iron atoms; and the [Fe]-hydrogenases, containing a single iron 
atom (Vignais & Billoud, 2007, Vignais & Colbeau, 2004). 
[Fe]-hydrogenases are unique to methanogens, and as such have not yet been extensively 
studied (Vignais & Billoud, 2007). This enzyme, formerly named H2-forming methylene-
tetrahydromethanopterin dehydrogenase (Hmd), is involved in CO2 reduction with H2 to 
methane, catalysing an intermediate step by which methenyltetrahydromethanopterin 
(methenyl-H4MPT+) is reduced with H2 to methylene-H4MPT and H+ (Shima & Thauer, 2007, 
Thauer et al., 2010). A number of crystal structures have been solved for [Fe]-hydrogenases, 
and appear to show a homodimer composed of a central unit composed of the C-terminal 
sections of each subunit, plus two peripheral globular units consisting of the N-terminal 
domains (Pilak et al., 2006). The structure of the active site has been further investigated and 
is shown to contain biologically unusual carbon monoxide molecules coordinating the iron 
centre (Shima et al., 2008, Thauer et al., 2010). 
[FeFe]-hydrogenases are found in anaerobic prokaryotes, and are also the only hydrogenase 
class to be found in eukaryotes, being present in chloroplasts and hydrogenosomes. These 
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enzymes are generally monomeric, although dimeric, trimeric and tetrameric enzymes have 
also been observed (Vignais & Billoud, 2007). The [FeFe]-hydrogenase active site contains two 
iron atoms, with one of these irons existing bridged to an Fe-S cluster through a bridging 
cysteine thiolate and is termed the H cluster (Peters et al., 2014, Vignais & Billoud, 2007). 
Oxygen is known to inactivate [FeFe]-hydrogenases, presumably through interaction and 
destruction of the H-cluster (De Lacey et al., 2007).The [NiFe]-hydrogenases are by far the 
most numerous and best studied of the hydrogenase classes. The core enzyme consists of two 
subunits; a large subunit (also termed the α-subunit) of approximately 60 kDa that contains 
the [NiFe] active site, and the small subunit (or β-subunit) of 30 kDa in size that contains up to 
three Fe-S clusters. The [NiFe] active site is buried deep within the large subunit and is 
coordinated by four cysteines, with the iron atom also ligated by three non-protein and 
unusual ligands: two cyanide molecules and one carbon monoxide molecule. The Fe-S clusters 
in the small subunit are arranged linearly and act to transfer electrons to or from the active 
site depending upon the presence of al electron donor or acceptor (Vignais & Billoud, 2007). 
Based on sequence alignments, the [NiFe]-hydrogenases could be classified into four groups 
that also are in agreement with cellular functions of these enzymes. These groups are the 
uptake [NiFe]-hydrogenases, the cytoplasmic H2 sensors and cyanobacterial uptake [NiFe]-
hydrogenases, the bidirectional heteromultimeric cytoplasmic [NiFe]-hydrogenases, and the 
H2-evolving, energy-conserving, membrane-associated [NiFe]-hydrogenases (Vignais et al., 
2001, Vignais & Colbeau, 2004). These enzymes are also known to be inactivated by trace 
amounts of oxygen (De Lacey et al., 2007). The Group 1 [NiFe]-hydrogenases are synthesised in 
the cytoplasm and display N-terminal signal peptides on their small subunits (Table 1.1, 
Section 1.1.7.7) (Sargent et al., 1998). These enzymes are located on the cytoplasmic 
membrane with the active sites facing the periplasm and so rely on the Tat system for their 
correct localisation. As these enzymes contain two subunits, but only the small subunits have 
Tat signal peptides, tight coordination between the subunits must be necessary to ensure 
successful translocation and localisation. 
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1.3 Biosynthesis of molybdoenzymes 
Molybdenum is utilised by a wide range of animals, plants and microorganisms due to its high 
levels in the environment, particularly in the oceans where it is the most abundant transition 
metal. Molybdenum is a second row transition metal, unusual in that it is the only metal of 
these that most living organisms require; indeed those that do not depend on molybdenum 
use tungsten instead, directly below molybdenum on the periodic table. There are over 40 
identified molybdoenzymes identified in prokaryotic and eukaryotic life so far, where 
molybdenum is used as the cofactor in redox enzymes involved in many reactions of the 
carbon, sulphur and nitrogen cycles (Leimkühler, 2007). In prokaryotic enzymes with the 
exception of nitrogenase, molybdenum is coordinated in a mononuclear form with an organic 
pyranopterin cofactor (Romao, 2009). Enzymes using this cofactor are oxidoreductases, 
involved in catalysing the transfer of an oxo group to or from a substrate in a two electron 
reaction. Molybdenum is extremely useful as it is able to cycle between oxidation states VI and 
IV, thereby allowing the catalysis of two-electron redox reactions (Leimkühler, 2007). 
 
1.3.1  Biosynthesis of the molybdenum cofactor 
The molybdenum cofactor (MoCo) biosynthesis pathway is a highly conserved ancient and 
ubiquitous pathway. The redox enzymes containing MoCo are extremely diverse, covering 
many phylogenetic families and varying greatly in their architectures. Molybdenum is 
coordinated to dithiolene group on the 6-alkyl side chain of the pterin named molybdopterin 
(Figure 1.19). Several variants of the molybdopterin-containing MoCo have been identified, 
including the molybdopteringuanine dinucleotide (MGD) form present in a large number of E. 
coli molybdoenzymes. 
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In E. coli, six genetic loci have been implicated in MoCo biosynthesis – moa, mob, moc, mod, 
moe and mog. These encode at least 17 genes involved in MoCo biosynthesis, and the proteins 
they encode are highly conserved in other organisms (Schwarz, 2005). Prior to the biosynthesis 
of the MoCo, molybdenum must first be imported into the cell in its soluble molybdate 
oxyanion form. This action is performed by an ABC transporter composed of proteins ModA, 
ModB and ModC. ModA appears to be targeted to the periplasm and acts as the high affinity 
periplasmic molybdate binding protein. Two copies of ModB and ModC act together to form 
the membrane domains and the ATP-binding cassette of the transporter (Maupin-Furlow et al., 
1995). Expression of the ModABC system is regulated by the sensor protein ModE in a 
molybdate-dependent manner. ModE can act as a repressor of mod genes and an activator of 
moa genes (McNicholas et al., 1997). ModE appears to bind to the modA promoter upon 
binding molybdate, in this way repressing modABC expression under high molybdate 
availability (Anderson et al., 2000, McNicholas et al., 1997). ModE also appears to play a 
regulatory role in expression of a number of molybdoenzymes themselves, including DMSO 
reductase and the nitrate reductases Nar-A and Nap, plus the molybdenum cofactor 
biosynthesis operon moaABCDE (Anderson et al., 2000, McNicholas et al., 1998, Self et al., 
1999).  
 
 
Figure 1.19: The structure of the molybdopterin component of the molybdenum cofactor. 
The molybdopterin component of the molybdenum cofactor is composed of a pyran ring fused to a pterin moiety. 
Upon formation of the molybdenum cofactor, Mo is coordinated with a dithiolene group present in the pyran ring. 
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In prokaryotes such as E. coli, the biosynthesis of molybdenum cofactor (Figure 1.20) can be 
divided into four steps: 1) formation of precursor Z from GTP; 2) formation of molybdopterin 
(MPT) from Precursor Z; 3) insertion of molybdenum into MPT to form MoCo; and 4) GMP or 
CMP attachment modifications to MoCo to form MGD and MCD respectively.  
 
 
Figure 1.20: Biosynthesis of the molybdenum cofactor. 
The biosynthetic steps involved in the formation of Mo-bis-MGD. Precursor Z is formed from GTP, molybdopterin 
(MPT) from precursor Z, MoCo from MPT and Mo-bis-MGD form MoCo. Enzymatic processes at each step are 
displayed. Adapted from (Leimkühler, 2007). 
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The first stable intermediate of the MoCo biosynthetic pathway is precursor Z, also named 
cyclic pyranopterin monophosphate (cPMP). Precursor Z, an oxygen sensitive 6-alkyl pterin 
containing a cyclic phosphate group, is thought to be produced from GTP through the actions 
of enzymes MoaA and MoaC. MoaA is a S-adenosylmethionine (SAM)-dependent enzyme that 
contains two [4Fe-4S] clusters, and is involved in the initial opening of the guanine imidazole 
ring of GTP and successive rearrangements required to give the formyl-diaminopyrimidine 
nucleotide intermediate (Sofia et al., 2001). MoaC then cleaves the phosphate group of this 
intermediate to form the cyclic ring of precursor Z (Hänzelmann et al., 2004).  
During the second step of biosynthesis precursor Z is converted to MPT through the 
incorporation of two sulphur atoms at positions C1’ and C2’, a reaction catalysed by the MPT 
synthase MoaDE. Purification of this enzyme showed it to be a heterotetrameric complex with 
two copies of both MoeA and MoeD (Pitterle & Rajagopalan, 1989). In this enzyme it is 
thought that the MoaD carries the sulphur for the reaction and MoaE acts to bind precursor Z 
(Daniels et al., 2007, Gutzke et al., 2001). In E. coli it has been shown that MoeB and the L-
cysteine desulphurase protein IscS are involved in assisting this reaction through the donation 
of sulphur (Leimkühler et al., 2001, Zhang et al., 2010). 
The next step involves the insertion of molybdenum into the MPT, a step requiring moeA and 
mogA gene products (Johnson & Rajagopalan, 1987, Joshi et al., 1996, Xiang et al., 2001). The 
crystal structure of MogA, the first MoCo biosynthetic protein structure to be solved, shows a 
trimeric protein with a high binding affinity for MPT (Liu et al., 2000). Meanwhile MoeA has 
four distinct domains, with one being similar in structure to MogA (Schrag et al., 2001, Xiang et 
al., 2001). The current model for this step involves MogA catalysing the adenylation of MPT to 
form an MPT-AMP intermediate.  MoeA then cleaves AMP from MPT and specifically inserts 
molybdate into the molecule, which binds to the MPT dithiolene sulphurs (Leimkühler et al., 
2011, Neumann & Leimkühler, 2008). 
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MoCo in E. coli is further modified through the attachment of either GMP or CMP. Only one 
enzyme, a sulphite oxidase homologue with an unknown function, is known to use the simple 
Mo-MPT form of the MoCo (Loschi et al., 2004). This final step encompasses the covalent 
addition of GMP or CMP to the C4’ atom of MPT by the MobA or MocA proteins respectively, 
forming either Mo-bis-MGD or Mo-bis-MCD (Neumann et al., 2011). The Mo-bis-MGD cofactor, 
that used by the DMSO reductase enzymes, is produced from MoCo by the MobA protein 
(Iobbi-Nivol et al., 1995, Palmer et al., 1996). This enzyme catalyses the transfer of the GMP 
moiety to the C4’ atom of MPT. Whilst it is understood that MobA is essential for this reaction 
the role of a second protein of the mob locus, MobB, is not yet understood. It has been 
suggested that MobB works alongside MobA, perhaps to enhance MoCo to MGD conversion 
(McLuskey et al., 2003, Palmer et al., 1996). 
It is clear that for this elaborate biosynthetic pathway, MoCo must be synthesised and 
assembled into apoenzymes within the regulated environment of the cytoplasm, and that 
extracellular MoCo-containing enzymes must be targeted via the Tat pathway. 
 
1.3.2 Biosynthesis of Fe-S clusters 
As well as the molybdenum cofactor, many proteins that are Tat substrates also contain Fe-S 
clusters. As with molybdenum, iron was available in high levels in its soluble form, Fe2+, in the 
ancient oceans, and so it is unsurprising that bacteria have evolved the ability to utilise this. In 
these early times sulphur was also readily available, and so Fe-S clusters were developed by 
early life as one of the earliest types of prosthetic groups (Ayala-Castro et al., 2008).   
Electron transfer is a major role for Fe-S clusters due to their physiologically relevant redox 
potentials of between -0.5 to 0.15 V. These cofactors can also be involved in other processes, 
for example substrate binding, enzyme activity control and gene expression (Fontecave & 
Ollagnier-de-Choudens, 2008). They can exist in many different molar ratios of iron to 
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elemental sulphur, with [2Fe-2S], [3Fe-4S] and [4Fe-4S] being the most common 
arrangements. In these clusters the Fe ions are normally coordinated by cysteine residues, and 
link to each other by sulphide bridges. 
The process of Fe-S assembly is an important one, as both Fe and S are highly reactive and 
toxic, and therefore biosynthetic pathways must be tightly controlled. There are three 
pathways so far identified for Fe-S cluster biosynthesis so far: the Isc (iron sulphur cluster) 
system, the Suf (sulphur formation) system, and the Nif (nitrogen fixation) system. It has been 
suggested that these pathways can be loosely divided into different physiological roles, where 
those used for housekeeping cluster assembly go through the Isc system, those under stress 
conditions are assembled by the Suf system and the Nif system makes those with complex and 
specialised clusters for specific enzymes (Ayala-Castro et al., 2008). The usage and relative 
importance of each pathway varies greatly between species, however in E. coli the primary 
system is the Isc system. 
A number of functional components are common to Fe-S cluster assembly. At the first stage of 
assembly a cysteine desulphurase enzyme, in the case of the Isc system, IscS, catalyses the 
conversion of environmental L-cysteine to L-alanine and sulphane sulphur (Mihara & Esaki, 
2002). Cysteine desulphurases characteristically have a cysteine residue that is essential for 
function, and it is to this that the sulphur atom is transferred once released (Fontecave & 
Ollagnier-de-Choudens, 2008).  The sulphur liberated in this reaction plus iron is then donated 
to a second protein that acts as a scaffold. The source of iron donation for Fe-S assembly is 
unknown, although it has been suggested that IscA is able to recruit and deliver intracellular 
iron for this system (Ding & Clark, 2004, Ding et al., 2004). The scaffold protein, for example 
IscU, binds both the sulphur and iron, and acts as the platform for synthesis of [2Fe-2S] and 
[4Fe-4S] cluster (Smith et al., 2005, Yuvaniyama et al., 2000). IscU has been shown to be able 
to mediate multiple rounds of [2Fe-2S] cluster formation (Agar et al., 2000, Ayala-Castro et al., 
2008, Fontecave & Ollagnier-de-Choudens, 2008). Scaffold proteins are also able to transfer 
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the iron sulphur cluster to the acceptor protein for insertion, presumably through formation of 
a transient complex. This appears to be an ATP-dependent reaction that is aided by a number 
of chaperones, in the Isc system HscA and HscB (Bonomi et al., 2008, Chandramouli & Johnson, 
2006), plus A-type carriers ErpA and IscA (Pinske & Sawers, 2012, Pinske & Sawers, 2011). 
The Isc system is regulated by the IscR repressor. This protein is encoded by the first gene of 
the iscRSUA operon, and acts as a direct negative regulator of the operon. IscR is a [2Fe-2S] 
protein that blocks transcription through binding of a promoter region upstream of the 
operon, regulating expression of isc genes as well as the downstream accessory protein 
hscBAfdx operon (Schwarz et al., 2001).  
It is clear, then, due to the complex and carefully regulated systems at play for assembly of Fe-
S clusters that they must be assembled into apoenzymes within the regulated environment of 
the cytoplasm and that extracellular Fe-S cluster-containing enzymes must be targeted via the 
Tat pathway. 
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1.4 Aims 
The overall aim of this study was to gain a greater understanding of the nature of interactions 
occurring in the Tat transport pathway. This study focused on a number of Tat substrates and 
their cytoplasmic chaperone partners, both in S. Typhimurium and E. coli, namely YnfE/DmsD 
and TorA/TorD. Genetic and biochemical techniques were used to elucidate important regions 
involved in interactions during the Tat proofreading. Super and high resolution microscopy was 
utilised as a way of monitoring protein interactions and localization within the cell. The project 
had three broad objectives: 
1. To understand the dual functions of some twin-arginine signal peptides 
 
2. To probe the mechanism of signal peptide recognition by Tat chaperones 
 
3. To explore the interactions and wider roles of Tat chaperones during Tat transport 
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2 Tat-dependent selenate metabolism in S. 
Typhimurium: the role of the twin-arginine 
signal peptide 
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 Introduction  2.1
Many bacterial species have been found to display the ability to utilise selenium in a number of 
enzymatic reactions, with selenate reduction to elemental selenium via the intermediate 
selenite being a well-known environmental process (Stolz et al., 2006). The enzyme selenate 
reductase is responsible for the initial reduction of selenate to selenite, catalysing the reaction: 
SeO4-2 + 2e- + 2H+ → SeO3-2 + H2O 
The best characterised bacterial selenate reductase is that of Thauera selenatis, which has 
been shown to be a molybdoenzyme localised to the periplasm and encoded by the serABCD 
operon (Dridge et al., 2007, Schröder et al., 1997).  
 
 
Figure 2.1: The selenate reductase from S. Typhimurium. 
Genes encoding for selenate reductase components (STM1495-STM1499) are present in an operon together with 
the gene encoding DmsD – a TorD-like cytoplasmic chaperone protein. YnfF is a protein with sequence similarity to 
YnfE, but does not contribute to selenate reduction in S. Typhimurium (Guymer et al., 2009). 
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In S. Typhimurium, selenate reductase was recently identified as being encoded by the 
ynfEFGHdmsD operon (Guymer et al., 2009) (Figure 2.1A). Sequence analysis of S. 
Typhimurium selenate reductase had shown similarities to the membrane-bound DMSO 
reductase rather than to the periplasmic selenate reductase of T. selenatis (Guymer et al., 
2009). Both YnfE and YnfF share sequence homology with DmsA, the catalytic subunit of DMSO 
reductase. Indeed E. coli YnfF has been shown to demonstrate low levels of DMSO reductase 
activity whilst interestingly also displaying the ability to reduce selenate (Guymer et al., 2009, 
Lubitz & Weiner, 2003). In S. Typhimurium, YnfE has been shown to have selenate reductase 
activity, whilst strains expressing only YnfF only have trace levels of selenate reduction 
(Guymer et al., 2009, Lubitz & Weiner, 2003). Continuing the comparison of selenate reductase 
to the DMSO reductase system, it is likely that YnfG and YnfH are associated with YnfE. YnfH 
likely acts as the membrane anchor and the site for menaquinol oxidation, passing electrons to 
a [4Fe-4S] cluster within YnfE via four [4Fe-4S] clusters in YnfG and onto the molybdenum-
containing active site of YnfE (Figure 2.1B) (Hille, 1996, Sambasivarao & Weiner, 1991, Weiner 
et al., 1993b). Both YnfE and YnfF have N-terminal signal peptides for transport through the 
Tat system, with a functional Tat translocase being essential for selenate reductase activity 
(Guymer et al., 2009). Another protein encoded within the ynf operon is DmsD, a member of 
the TorD family of Tat cytoplasmic chaperone proteins, which interacts directly with Tat signal 
peptides of YnfE and YnfF (Guymer et al., 2009). The ability of the YnfE signal peptide to 
interact with both the Tat translocase and the DmsD protein places this signal into a special 
class of dual-functional peptides (Ize et al., 2009b).  
 
 Aims 2.2
The aim of this Chapter was to characterise the role of the YnfE Tat signal peptide in S. 
Typhimurium selenate reductase. The YnfE signal peptide has two distinct biological functions - 
(1) directing assembly of the enzyme prior to translocation, and (2) transmembrane 
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translocation. Here, molecular genetic approaches were taken to identify specific regions of 
the signal peptide involved in interactions with the biosynthetic chaperone DmsD, and relate 
those to physiological activity of the enzyme.   
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 Results 2.3
2.3.1 Identification of the DmsD binding site on the YnfE signal peptide 
In order to understand the role of the YnfE signal peptide in S. Typhimurium selenate 
reductase activity and function, the first step was to identify the binding epitope for DmsD on 
the signal peptide. To do this, a glutamine scanning mutagenesis approach was taken 
combined with a rapid bacterial two-hybrid genetic screen (Karimova et al., 1998). The 
principles of the bacterial two-hybrid system chosen are described in Figure 2.2. This system 
utilises the fact that the adenylate cyclase domain of the toxin from Bordetella pertussis can be 
separated into two complementary inactive fragments, namely T18 and T25, that can form an 
active enzyme when brought in close proximity. The two fragments can together convert ATP 
to cyclic AMP, which then binds a protein known as both catabolite activator protein (CAP) or 
cAMP receptor protein (CRP) (Figure 2.2A). CRP is a pleiotropic regulator of gene expression in 
E. coli, and when in complex with cAMP is able to promote the expression of a number of 
resident genes, such as the lac or mal operons. This enables bacteria to utilize lactose or 
maltose as carbon sources, which can be easily detectable by growth on indicator plates or 
through enzymatic activity assays. When the T18 and T25 fragments are co-expressed as 
separate polypeptides, they do not interact and therefore no cAMP is produced and no gene 
activation occurs (Figure 2.2B). Creating fusions of T18 and T25 to proteins of interest enables 
interactions to be investigated (Figure 2.2C). In this work, plasmids encoding spYnfE-T18, plus 
individual signal peptide amino acid variants, and T25-DmsD were used, with interactions 
being quantified through the measurement of lac operon activation using a β-galactosidase 
activity assay. 
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Figure 2.2: The principles of the bacterial two-hybrid system. 
The adenylate cyclase domain from the Bordetella pertussis toxin catalyses the conversion of ATP to cAMP. Under 
normal conditions the two fragments are able to convert ATP to cyclic AMP (A). This cAMP then binds CRP, leading 
to the activation of several resident genes such as the lac or mal operons whose activity can be used as reporters 
for cAMP production. When the T18 and T25 fragments are co-expressed as separate polypeptides (B), they do not 
interact and therefore no cAMP is produced and no gene activation occurs. By fusing two potentially interacting 
polypeptides (X and Y) to fragments T18 and T25 (C), interactions can be observed through measurement of 
reporter gene activity. Adapted from (Karimova et al., 1998). 
 
First, a plasmid was constructed that encoded a fusion between spYnfE and the T18 fragment 
of the two-hybrid system. The 42-residue spYnfE (Figure 2.3) was placed at the N-terminus of 
T18, thus preserving the correct physiological context of the signal peptide. Next, a plasmid 
was constructed that encoded a T25-DmsD fusion protein, with DmsD covalently attached to 
the C-terminus of T25. Co-expression of both plasmids in the appropriate reporter strain 
demonstrated a strong interaction between spYnfE and DmsD (Figure 2.4). 
The YnfE signal peptide is a classical tri-partite Tat signal peptide (Figure 2.3). It contains a 
conserved SRRTLVK twin-arginine motif flanked by an extended polar n-region and 
hydrophobic h-region (Figure 2.3). Scanning mutagenesis of the YnfE sequence involved the 
substitution of each individual amino acid (from Glu-3 to Ala-42, but excluding Gln-6 and Gln-7) 
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of the signal peptide with glutamine through site-directed mutagenesis. Glutamine is a polar 
amino acid rarely present in Tat signal peptides (Cristóbal et al., 1999b), and therefore is an 
ideal amino acid for attempting to disrupt Tat signal peptide function. Glutamine has also 
previously been used to successfully identify important amino acids in the Tat signal sequence 
of NapA, the catalytic subunit of periplasmic nitrate reductase from E. coli (Grahl et al., 2012), 
and TorA, the catalytic subunit of TMAO reductase (Buchanan et al., 2008). In the case of YnfE 
Gln-6 and Gln-7, these side chains were substituted with tryptophan, which has proved useful 
in dissecting the role of the signal peptide in E. coli hydrogenase-1 (Bowman et al., 2013). 
Glutamine variants were constructed using QuickchangeTM PCR and validated by DNA 
sequencing of the signal sequence (DNA Sequencing & Services, University of Dundee). 
 
 
Figure 2.3: Tat signal peptide of S. Typhimurium YnfE. 
The twin arginine motif is shown in bold, with the essential twin arginines being underlined. Also highlighted are the 
n-, h- and c-regions 
 
Site-directed mutagenesis produced 40 individual spYnfE variants for which interactions with 
chaperone DmsD could be investigated (Figure 2.4). Interestingly, the amino acids of the highly 
conserved twin-arginine motif did not appear to have any function in chaperone binding, with 
near native levels of reporter activity being observed (Figure 2.4). This was also true of the 
entire n-region of the signal peptide, with no significant disruption in interactions occurring for 
any of the variants tested (Figure 2.4). Similarly, the c-region of the peptide was deemed to 
have no importance in signal peptide interaction, as there was no significant changes in β-
galactosidase activity observed (Figure 2.4). The data instead highlighted the hydrophobic 
stretch of the signal peptide as important in interactions with DmsD. The spYnfE L24Q, A28Q, 
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V31Q, L33Q and F35Q all displayed levels of β-galactosidase activity of approximately 10 % 
that observed for the native signal peptide (Figure 2.4), which are similar values to the 
background levels observed for the empty vector negative controls (Figure 2.4). 
 
 
Figure 2.4: Interaction study of cytoplasmic chaperone protein DmsD with spYnfE and spYnfE amino acid variants, 
measured in vivo using a bacterial two-hybrid system. 
MG1655 ΔcyaA::Apra was co-transformed with the vectors T25-DmsD and UT18-spYnfE variants, and β-
galactosidase was measured as an indicator of interactions. β-galactosidase activities are displayed relative to native 
spYnfE-DmsD activity (WT).  Cells containing both empty vectors were used as the negative control (labelled ‘UT18 + 
T25’). Data expressed as means (n = 3) ± standard error of means (SEM). 
 
2.3.2 Signal peptide amino acid substitutions affect selenate reduction in vivo 
Amino acids Leu-23, Ala-28, Val-31, Leu-33 and Phe-35 within the hydrophobic stretch of the 
YnfE signal peptide have been identified as playing a role in DmsD interactions. Next, the 
importance of these amino acids for normal selenate reduction in vivo was investigated. This 
required the introduction of DNA encoding the amino acid substitutions onto the chromosome 
of S. Typhimurium at the native ynfE locus. This was performed using the pMAK705 protocol, 
first described by (Hamilton et al., 1989),  which utilises a temperature-sensitive plasmid that is 
able to replicate at 30 oC but not at 44 oC. A pMAK705 plasmid derivative was designed with 
homologous genetic sequence with a length of approximately 500 base pairs on either side of 
the chromosomal region to be altered, enabling integration of the plasmid into the host 
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chromosome through homologous recombination (Figure 2.5A). Selection for cells where this 
recombination has taken place is achieved by growth at temperatures of 44 oC in the presence 
of chloramphenicol, where expression of the plasmid and chloramphenicol resistance is not 
permitted unless integrated into the chromosome. With subsequent growth at 30 oC, a single 
recombination event occurs leading to resolution of the plasmid, leaving behind either the 
native or altered gene in the chromosome depending upon the site of recombination (Figure 
2.5B). The presence of the amino acid substitutions could then be confirmed through PCR 
amplification of the chromosomal region and DNA sequencing.  
 
Figure 2.5: pMAK protocol for targeted chromosomal integration of spYnfE amino acid substitutions. 
A- pMAK705 vector containing YnfE signal sequence with flanking sequences of approximately 500 bp up- and 
down-stream. × indicates amino acid substitution on YnfE signal sequence. B – Principles of the pMAK protocol. 
Integration of the plasmid into the chromosome occurs via homologous recombination, resulting in strains that are 
screenable for chloramphenicol resistance at 44 oC. Resolution of the plasmid in the cell occurs with growth at 30 
oC, as this permissive temperature allows expression from the plasmids’ origin of replication, which is toxic to the 
cell. This occurs via a single recombination result that depending upon the site will lead to native or amino acid 
variant spYnfE on the chromosome. 
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For this work, S. Typhimurium strain DIG103 (∆ynfF) was used as the parental strain for 
introduction of YnfE signal peptide variants. This strain contains an in-frame deletion of the 
gene STM1498, coding for the protein YnfF, which shares 71 % sequence overall identity with 
YnfE. The DIG103 strain expressing only ynfE (Guymer et al., 2009) will enable all activity 
observed in the following mutagenesis experiments to be attributed to YnfE-containing 
selenate reductase complexes.  
Amino acid substitutions L24Q, A28Q and L33Q in the YnfE signal peptide were successfully 
introduced onto the S. Typhimurium chromosome using this protocol, giving rise to S. 
Typhimurium strains KM01, KM02 and KM03, respectively. Unfortunately, due to time 
constraints, it was not possible to introduce the ynfE V31Q and F35Q alleles onto the 
chromosome. 
It has been widely observed that E. coli and other prokaryotes are able to reduce selenate to 
elemental selenium, via selenite, which results in elemental selenium deposits that accumulate 
on the cell surface and in the supernatent and turn cells red in appearance (Butler et al., 2012, 
Gerrard et al., 1974, Turner et al., 1998). This phenomenon permits facile comparisons of the 
activity of selenate reductase within wild-type and mutant strains for cells grown micro-
aerobically or anaerobically in the presence of 10 mM sodium selenate (Na2SeO42-) (Guymer et 
al., 2009). 
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Figure 2.6: Selenate reductase ability of chromosomal spYnfE variants. 
Parental S. Typhimurium strain DIG103 (ΔSTM1498) and mutants DIG100 (Δtat), KM01 (ynfE L24Q), KM02 (ynfE 
A28Q), and KM03 (ynfE L33Q) were grown overnight in microaerobic conditions in LB + 10 mM sodium selenate. 
Activity of selenate reductase is visible through production of red deposits in the cell culture. 
 
The three mutant strains (KM01 [ynfE L24Q], KM02 [ynfE A28Q] and KM03 [ynfE L33Q]), and 
appropriate controls, were cultured in rich media containing selenate. From this experiment it 
was observed that DIG103 (∆ynfF), the parental strain, was able to reduce sodium selenate 
and therefore produce elemental selenium, turning the culture red (Figure 2.6). DIG100, a 
tatABC deletion strain, was unable to reduce sodium selenate, as would be expected (Guymer 
et al., 2009). However, interestingly, the spYnfE variants L24Q and A28Q were devoid of 
selenate reductase activity, with cultures lacking any red colouration after overnight growth 
(Figure 2.6). The spYnfE variant L33Q, on the other hand, appeared able to reduce selenate to 
elemental selenium, with the cell culture still appearing red after overnight growth (Figure 
2.6). These data corroborate in part the signal peptide interaction experiments (Figure 2.4) 
since they indicate that Leu-24 and Ala-28 on the YnfE signal sequence are important for 
mature selenate reductase production in S. Typhimurium and as such the mutant strains 
phenocopy a ∆dmsD mutant (Guymer et al., 2009). In contrast, the Leu-33 substitution with 
glutamine had no gross effect on the ability of the living cells to reduce selenate, which may 
suggest the bacterial two-hybrid data collected for YnfE L33Q are a “false-negative”. 
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2.3.3 Tools for probing YnfE assembly: antibodies to YnfE 
In order to further examine the assembly and subcellular localization of YnfE, it was decided to 
raise antibodies against this protein. The S. Typhimurium YnfE protein was overproduced from 
an E. coli strain harbouring the vector pQE70-stmYnfE, which produces C-terminally His-tagged 
YnfE alone. Following overproduction, a crude extract was subjected to immobilised metal 
affinity chromatography (IMAC). Resultant fractions were analysed by SDS-PAGE and observed 
to contain a double band at around 90 kDa (Figure 2.7). These two bands were excised from 
the gel and analysed by tryptic peptide mass fingerprinting (Fingerprints Proteomics Facility, 
University of Dundee). This confirmed that both bands were in fact YnfE, with the smaller band 
missing part of the N-terminal (Figure 2.8). This protein sample was therefore deemed pure 
enough to raise antibodies against, and so was sent to Eurogentec S.A.TM for polyclonal 
antibody production. 
 
Figure 2.7: IMAC purification of S. Typhimurium YnfE. 
YnfE was purified by IMAC and fractions separated by SDS-PAGE (12 % [w/v] acrylamide gel). Two electrophoretic 
variants of YnfE were observed. Bands marked with * were excised and analysed by tryptic peptide mass 
fingerprinting. 
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Figure 2.8: Tryptic mass spectrometry analysis of purified YnfE samples shows two forms of YnfE. 
Analysis of bands excised from SDS-PAGE gel in Figure 2.7. Identified peptides are indicated in bold red. A – higher 
molecular weight band from Figure 1.7. B – lower molecular weight band from Figure 1.7. 
 
Upon receiving the polyclonal antibody in the form of serum from two individual rabbits, the 
specificity of the antibody for YnfE was tested by Western blot (Figure 2.9A). Blotting against 
purified YnfE revealed an extremely strong signal, from which it was difficult to identify 
individual bands due to the high signals even at the shortest exposure times. However, the 
strongest signal did appear to be at approximately the correct size for 90 kDa YnfE. A number 
of unspecific bands at varying sizes were also present. Next tested were whole cell samples of 
several S. Typhimurium strains (Figure 2.9A). In all samples a nonspecific band of 23 kDa was 
seen. LT2a, the wild-type strain from which all other strains in this work were derived, 
displayed two bands of approximately 75 kDa and 60 kDa in size, which are smaller than would 
be expected for YnfE. There was also a faint band present at approximately 100 kDa, which is 
more likely to be YnfE. However, the same pattern of bands is present the sample of DIG101 
cells, a strain devoid of the genes encoding for YnfE and YnfF proteins. DIG102 (ΔynfE) also 
displays the two bands around the 75 kDa marker, but no band of 100 kDa is visible. Western 
blotting of DIG103 (ΔynfF), KM01 (ΔynfF spYnfE L24Q) and KM02 (ΔynfF spYnfE A28Q) also 
revealed a similar picture, with two stronger bands at around 75 kDa and 60 kDa respectively, 
and a 100 kDa band visible at varying degrees of intensity. From these results, the antibody 
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against YnfE does not appear to be able to specifically recognise and show YnfE on a Western 
blot. 
 
Figure 2.9: Testing the quality of antibody raised against purified YnfE. 
Western blots were all performed after 10 µl samples were separated by SDS-PAGE (12 % acrylamide gel). A – Initial 
tests with the antibody. Western blotting with anti-YnfE and anti-rabbit both at concentrations of 1:10,000 was 
performed. Samples tested were the purified YnfE protein used for antibody production, along with whole cell 
samples of wild-type S. Typhimurium strain LT2a and various mutant strains – DIG101 (ΔynfEF), DIG102 (ΔynfE), 
DIG103 (ΔynfF), KM01 (ΔynfF spYnfE L24Q), KM02 (ΔynfF spYnfE A28Q). B – Anti-YnfE was pre-incubated with 
nitrocellulose membrane containing whole cell samples of DIG101 (ΔynfEF) prior to use with Western blot of whole 
cell samples of DIG105 (ΔdmsA ΔtorA), DIG107 (ΔdmsA) and DIG101 (ΔynfEF). Anti-YnfE – 1:5,000. Anti-rabbit – 
1:10,000. C – Western blot after affinity clean-up of anti-YnfE antibody. Anti-YnfE – 1:200. Anti-rabbit – 1:10,000. 
Samples analysed were purified YnfE plus whole cell samples of DIG101 (ΔynfEF), DIG103 (ΔynfF), KM01 (ΔynfF 
spYnfE L24Q) and KM02 (ΔynfF spYnfE A28Q). 
 
Next, in an attempt to remove any unspecific interactions prior to use, a nitrocellulose 
membrane containing whole cell DIG101 (∆ynfEF) was pre-incubated with the antibody (Figure 
2.9B). Due to the lack of genes for both YnfE and YnfF in this strain, performing this pre-
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incubation step this should cause any antibody that recognises proteins other than YnfE that 
are present in whole cell S. Typhimurium samples to become immobilised on the membrane, 
therefore removing some of the unspecific bands observed. Western blotting was then 
performed using this pre-incubated antibody with whole cells of DIG105 (ΔdmsA, ΔtorA), 
DIG107 (ΔdmsA) and DIG101 (ΔynfEF). Strains DIG105 and DIG107 were selected as they are 
unable to produce TorA and DmsA, therefore eliminating the risk of any cross reactivity of the 
antibody with those proteins. It would be expected that if the antibody was able to detect 
YnfE, differences could be observed between these two strains and that of DIG101, where no 
YnfE or YnfF is produced. However, the bands observed for all three strains were identical, and 
as previously seen, with two stronger bands at around 75 kDa and a fainter band at 100 kDa, in 
addition to the unspecific band at 23 kDa. Therefore, YnfE was still not being successfully 
detected. 
In addition, three further S. Typhimurium strains were tested using the YnfE antibody. These 
strains were LT2, NCTC12023 and SL1344, and were tested alongside our own laboratory stock 
of LT2a for comparison. Cells were grown in both aerobic and anaerobic conditions, with cell 
cultures then being analysed by SDS-PAGE and Western blot using YnfE antiserum that had 
been affinity purified (Figure 2.10). Results showed bands in all samples at approximately 60 
and 75 kDa in size, similar to other Western blots performed using this antibody.  In addition 
there was a band of approximately 23 kDa, also present in all samples, although showing some 
level of variation in intensity between samples.  There appeared to be lower levels of this 
unidentified band in NCTC12023 samples, plus the anaerobic cell sample from the donated 
strain LT2. This band was also picked up by the antibody in previous Western blots (Figure 2.9). 
From this result it was not possible to elucidate any more information about YnfE expression in 
these strains using the YnfE antibody.  
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Figure 2.10: YnfE antibody test with S. Typhimurium strains LT2, NTCT12023 and SL1344. 
LT2a (Dundee) and LT2, NCTC12023 and SL1344 (London) were analysed using anti-YnfE serum after affinity clean-
up. Strains were grown either aerobically in LB or anaerobically in LB supplemented with 0.5 % (w/v) glycerol and 
0.4 % (w/v) fumarate. Whole cell samples were then resolved through SDS-PAGE (12 % acrylamide) before 
visualisation with Western blot. Anti-YnfE - 1:200. Anti-rabbit, 1:20,000. 
 
As a final effort to successfully visualise YnfE using this antibody, it was affinity purified against 
purified YnfE protein, using a protocol as described in Materials & Methods. After purification 
and elution steps, the antibody was again tested against purified YnfE, DIG101, DIG103, KM01 
and KM02. However, no differences could be seen amongst any of the S. Typhimurium strains 
(Figure 2.9C). Unfortunately, it seems that the native expression levels of the ynfEFGHdmsD 
operon are so low that the antibody appears to be unable to detect YnfE and therefore was 
not used for any further work. 
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 Discussion 2.4
2.4.1 A conserved DmsD binding epitope 
The signal peptide of Tat substrates is extremely important for protein translocation. No 
protein is able to be transported via the Tat system without itself having such an N-terminal 
peptide, or being tightly associated with a partner protein that has a signal peptide (Sargent et 
al., 2006). Whilst the conserved twin-arginine motif is essential for successful translocation via 
the Tat system (Stanley et al., 2000), indeed the other regions of the signal peptide must have 
their own roles to play in the Tat pathway. Some signal peptides are known to have a second 
role and so be important in protein maturation prior to transport. Such Tat Proofreading is an 
important step in the biosynthesis of Tat substrates, for example during incorporation of redox 
cofactors, particularly in molybdenum-containing proteins. In this case cytoplasmic chaperone 
partner proteins are known to bind the signal peptide of these substrates (Jack et al., 2004, 
Sargent, 2007a). A large amount of research has been carried out on the substrate-chaperone 
pair DmsA and DmsD, with E. coli DmsD in fact being one of the best characterised Tat 
proofreading chaperones (Chan et al., 2008). This work instead focussed on the characteristics 
of the signal sequence of YnfE and its importance in the YnfE-DmsD binding interaction in 
Salmonella. 
Glutamine scanning of the signal peptide of YnfE revealed key residues towards the C-terminus 
of the hydrophobic region, rather than the essential twin-arginine motif, were involved in 
interactions with chaperone DmsD. By two-hybrid analysis alone, five amino acid substitutions 
apparently completely disrupted interactions. As DmsD is known to interact with at least three 
Tat substrates (YnfE, YnfF and DmsA) the signal sequences of these three proteins were 
compared (Figure 2.11A).  
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Figure 2.11: Multiple sequence alignments of Tat signal sequences from S. Typhimurium (stm) and E. coli (ec). 
A - Primary amino acid sequences of the signal sequences of the three binding partners of DmsD (DmsA, YnfE and 
YnfF) from both E. coli and S. Typhimurium were aligned using ClustalW (http://embnet.vital-
it.ch/software/ClustalW.html), with conserved residues highlighted using BoxShade (http://embnet.vital-
it.ch/software/BOX_form.html). The hydrophobic stretch of the signal peptides is labelled. Arrows indicate amino 
acids L24, A28, V31, L33 and F35, implicated in interactions with DmsD by bacterial two-hybrid studies. B - Primary 
amino acid sequences of the signal sequences of chaperone-dependent Tat substrates of E.coli and S. Typhimurium. 
Aligned using ClustalW and conserved residues highlighted using BoxShade. Arrows indicate amino acids L24, A28, 
V31, L33 and F35, implicated in interactions between ssYnfE and DmsD by bacterial two-hybrid studies. 
 
When the primary amino acid sequences of E. coli and S. Typhimurium YnfE, YnfF and DmsA 
signal peptides were aligned, it was observed that a number of these highlighted amino acids 
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are conserved or conservatively differ between enzymes, with all bar one amino acid being 
conserved between YnfE from S. Typhimurium and E. coli, pointing to a critical role for the 
hydrophobic region. Certainly, the n-regions and c-regions of these peptides are much less 
conserved at amino acid level (Figure 2.11A), suggesting that they are less important for signal 
peptide function than the twin-arginine motif or the h-region, or perhaps have more substrate 
specific roles instead of being important for recognition either by the Tat translocase or Tat 
cytoplasmic chaperones. 
The two key side-chains implicated here in DmsD binding are YnfE L24 and YnfE A28. 
Substitution of these residues with glutamine impaired DmsD binding in vivo and abolished 
physiological selenium formation. It is important to note that L24 is completely conserved in all 
known DmsD binding peptide from both E. coli and S. Typhimurium (Figure 2.11A). The YnfE 
A28 residue, on the other hand, is specific to YnfE in E. coli and S. Typhimurium, being 
substituted by serine in all other DmsD-binding peptides (Figure 2.11A). Sequence alignments 
of a range of other Tat substrate signal peptides do no show any significant level of 
conservation of equivalent residues, indicating a DmsD specific motif (Figure 2.11B) 
As experiments such as growth in the presence of sodium selenate are not quantitative, rather 
allowing just facile comparisons of selenate reductase activity, it could be questioned as to 
why a more quantitative approach was not taken. It has previously been mentioned by 
Guymer et al. (2009) that attempts to quantify selenate reductase activity using classical 
redox-dye based enzyme assays were unsuccessful, and this could be due to low levels of gene 
expression as well as difficulties in coupling of redox dyes such as benzyl viologen to the 
specific enzyme reaction. In addition, quantifying the amount of elemental selenium produced 
in cell cultures through spectrophotometric measurement of samples was not possible due to 
the particulate nature of the selenium deposits as well as the presence of bacterial cells 
containing selenium particles on their surfaces. For these reasons such quantitative routes of 
investigation were not taken. 
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It has been suggested that Tat chaperone proteins function to prevent premature 
translocation of Tat substrates by masking the signal peptide from the Tat translocase. So why 
is the binding epitope of DmsD located in the hydrophobic region of the peptide, several 
amino acids away from the twin-arginine motif, the recognition motif essential for transport? 
Certainly the suggested importance of the hydrophobic region for chaperone binding is 
supported in the literature. In recent work probing the interactions of the E. coli DmsA signal 
peptide with DmsD by Shanmugham et al. (2012) it was proposed that it was the hydrophobic 
region that is required for interactions with DmsD. Through the construction/design of region-
swapped chimeric signal peptides containing n-, h- and c-regions from either DmsA or TorA, 
interactions with DmsD were observed to occur only in signal sequences containing DmsA h- 
and c- regions. The n-region was shown to be interchangeable with that of TorA with no great 
effect on DmsD binding. Further studies using various synthesised portions of the DmsA signal 
sequence in isothermal titration calorimetry (ITC) with DmsD also demonstrated the 
importance of the hydrophobic stretch for interactions (Winstone et al., 2013b).  Investigations 
into other TorD family chaperones have suggested the RR motif is not important in signal 
peptide interactions (Coulthurst et al., 2012, Hatzixanthis et al., 2005). This suggests that the 
signal peptide functions of Tat targeting and substrate proofreading are two separate 
processes. It may be that binding of DmsD to the hydrophobic region of the signal peptide 
indirectly prevents interactions with the Tat translocase without requiring an interaction with 
the Tat motif specifically, perhaps by inducing a change in the secondary structure of the 
peptide. Alternatively, it should be considered that the binding of DmsD to the signal peptide 
out with the twin-arginine motif means that DmsD is never in direct competition with TatC for 
signal peptide binding. Instead, attached DmsD would prevent translocation by steric 
hindrance until assembly of the selenate reductase is complete. 
From the literature, signal peptide binding epitopes appear to differ between classes of 
cytoplasmic chaperone proteins. For example, work performed investigating the TorA signal 
peptide and its chaperone partner TorD in E. coli pointed towards residues in the hydrophobic 
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region and in particular the border between the hydrophobic and c-terminal regions of the 
peptide as comprising the binding epitope (Figure 2.12) (Buchanan et al., 2008). As TorD is 
closely related to DmsD this ties in nicely with the identification of residues in the hydrophobic 
region of YnfE as the binding epitope for DmsD in S. Typhimurium, and similarly of E. coli DmsA 
as described previously (Shanmugham et al., 2012, Winstone et al., 2013b). Interestingly, Tat 
substrate-chaperone pairs do not all follow the same rules. Another E. coli pair NapA and NapD 
have been shown to have a completely different binding interaction. In this case, residues in or 
near the n-region of the signal peptide were shown as encompassing the NapD binding 
epitope, including two in the conserved Tat motif - Arg-6, one of the invariant arginine 
residues, and Lys-10 (Figure 2.12) (Grahl et al., 2012). Whilst TorD and DmsD are closely 
related proteins and both adopt all α-helical structure, NapD represents a different family of 
chaperones and displays a ferredoxin-type fold (Maillard et al., 2007, Turner et al., 2004).  This 
data suggests that different chaperone families have developed different binding mechanisms 
to achieve the same overall objective of binding the Tat signal peptides of their substrate 
partners, in order to prevent interactions with the Tat system until maturation is complete.  
 
 
Figure 2.12: Predicted cytoplasmic chaperone binding epitopes of Tat substrate signal peptides. 
Amino acid sequences of E. coli NapA and TorA are shown alongside S. Typhimurium YnfE, with residues identified 
through glutamine scanning and bacterial two-hybrid studies as having a potential role in binding to their cognate 
chaperone partners highlighted in red (Buchanan et al., 2008, Grahl et al., 2012). The conserved Tat motif is shown 
in bold, with the transport essential twin arginine being underlined. The n-, h- and c-regions are indicated. 
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The properties of amino acid residues highlighted as important for interactions may shed some 
light on areas of DmsD that may be involved. All the amino acids found to be important on 
spYnfE are of a hydrophobic nature, unsurprising due to their location in the hydrophobic 
stretch of the signal peptide, and due to their exposed location on the signal peptide are likely 
to form interactions with a hydrophobic region on DmsD. Interestingly, the amino acids on the 
TorA signal peptide involved in TorD interactions are also all hydrophobic, apart from glycine 
which is able to fit into any environment due to its extremely short side chain and therefore 
could also be involved in this hydrophobic interaction. The similarities in the types of amino 
acids involved in both spYnfE and spTorA interactions with their chaperone partners also 
indicates the potential similarities in the mechanism of interactions between these protein-
chaperone pairs. It should be noted however, that despite appearing to have similar binding 
epitopes, TorD and DmsD may not function in exactly the same way. TorD has been shown to 
be involved in binding the mature region of TorA and aid cofactor loading, whilst it appears 
that DmsD does not bind YnfE in the same manner. NapA, with its cytoplasmic chaperone 
NapD belonging to a different family of chaperone proteins, unsurprisingly has a number of 
different properties in its signal peptide binding site. Whilst there are a number of 
hydrophobic residues, the binding site appears to overlap the twin arginine motif and so also 
contains a number of positively charged residues. This implies that whilst interactions between 
spNapA and NapD require hydrophobic bonds, electrostatic interactions are also important for 
binding. Therefore it may be concluded that different chaperone families undertake different 
mechanisms of interaction involving different types of non-covalent bonding. 
The DmsD chaperone protein is unusual in that it appears to be involved in interactions with at 
least three Tat substrates, rather than having just one substrate partner as is more often the 
case with TorD family chaperones. Because of this unusual characteristic, it may come as no 
surprise that the h-region of DmsA, YnfE and YnfF signal peptides are rather similar in amino 
acid sequence. Although the h-region as a whole is a common feature of Tat signal sequences, 
the individual amino acid sequence itself can vary greatly between Tat substrates (Figure 
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2.11B). By having a binding epitope in the h-region, interactions of DmsD are immediately 
limited to those Tat substrates with the specific h-region, in this case YnfE, YnfF and DmsA 
peptides.  
 
 
Figure 2.13: Alignment of a number of E. coli and S. Typhimurium bona fide and remnant Tat signal peptides. 
Primary amino acid sequences of Tat signal peptides from TorA, NarG and YnfE of both E. coli and S. Typhimurium 
plus TorZ from E. coli were aligned using ClustalW (http://embnet.vital-it.ch/software/ClustalW.html), with 
conserved residues highlighted using BoxShade (http://embnet.vital-it.ch/software/BOX_form.html). NarG is the 
active subunit of the cytoplasmic enzyme respiratory nitrate reductase, and although it is not transported through 
Tat, a remnant signal peptide has been identified on the N-tail of the protein (Ize et al., 2009a). 
 
What enables DmsD to differentiate its binding partners DmsA, YnfE and YnfE from other Tat 
substrates is not known. Analysis of N-terminal signal peptides from a number of Tat 
substrates, as well as the remnant signal peptide of NarG may help elucidate this (Figure 2.13). 
Whilst a number of amino acids are conserved, particularly between YnfE and TorA signal 
peptides, they also show several differences. Out of the signal peptides compared, spYnfE 
appears to have the greatest number of hydrophobic residues and actually the longest 
hydrophobic stretch. The spTorZ and spNarG sequences have very few hydrophobic residues in 
comparison, also when compared to spTorA from both E. coli and S. Typhimurium. The spTorZ 
sequence also appears to have a shorter hydrophobic region than the other signal peptides 
and this may also deter binding by DmsD. It may be that a very hydrophobic region is required 
for DmsD interactions, and the lack of such a strong hydrophobic region in these signal 
peptides deters interactions. Indeed, in the region normally expected to be hydrophobic the 
remnant signal peptide NarG has a number of charged and polar amino acid residues, further 
supporting the suggested requirement of hydrophobic amino acids for DmsD binding. If a 
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hydrophobic interaction is involved in DmsD binding to the signal peptides of YnfE and DmsA, 
the different characteristics of other signal peptides may in fact repel DmsD, thereby 
preventing incorrect interactions from occurring. Certainly it has been shown that slight 
differences between signal peptides have potential in determining binding. Studies with 
spTorA were able to highlight residues required for TorD binding, and also show those that 
were not, through substitution of specific amino acids (Buchanan et al., 2008). Interestingly, 
Leu-21 on spTorA was not required, but when the equivalent amino acid on spDmsA, Leu-28, 
was replaced by a glutamine interactions with DmsD were disrupted (Winstone et al., 2013a). 
This lends to the idea that slight differences in signal peptide sequences are enough to enable 
recognition by specific chaperones.  
Whilst the signal peptides of TorA and YnfE share a much greater sequence identity, there are 
still subtle differences that may affect DmsD binding ability. In place of spYnfE Gly-30, spTorA 
has a proline residue. In addition, at position 31, where in spYnfE the strongly hydrophobic 
valine has been shown as essential for DmsD binding in this work, spTorA has a serine residue. 
With this region differing in hydrophobicity to that of spYnfE, it may deter interactions with 
DmsD. 
 
2.4.2  The structure of the YnfE signal peptide 
With interactions between the signal peptide and DmsD disrupted by the amino acid 
substitutions described here (L24Q, A28Q, V31Q, L33Q, F35Q), it is hypothesised that these 
amino acids are in some way involved in the proofreading and therefore maturation of YnfE.  
It is thought that some Tat signal peptides are perhaps able to adopt an alpha-helical 
conformation (San Miguel et al., 2003, Zakian et al., 2010). When the hydrophobic region of 
the YnfE signal sequence is plotted in an alpha-helical projection, four of the five amino acids 
highlighted in the bacterial two-hybrid study can be seen to be located in the same region of 
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the helix (Figure 2.14). Whilst Leu-24, Ala-28, Val-31 and Phe-35 appear to form this alpha-
helical face, amino acid Leu-33 is shown on the opposite side of the helix. This makes it seem 
highly unlikely that Leu-33 can be involved in interactions with DmsD alongside the other 
amino acids highlighted. Indeed, upon introduction of amino acid substitutions L24Q and A28Q 
to chromosomal YnfE, the activity, and by implication binding, of DmsD appeared to be 
completely disrupted. Meanwhile, L33Q did not appear to disrupt selenate reductase activity 
to any great degree, this demonstrating that L33 is not critical to either assembly or targeting. 
With L33 now discounted, the remaining data nicely complements the modelling of the 
apparent locations of these amino acids when the h-region sequence is organised in an α-helix 
(Figure 2.14). 
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Figure 2.14: Modelling of spYnfE. 
A – Secondary structure prediction of spYnfE, performed using PSIPRED v3.3 (http://bioinf.cs.ucl.ac.uk/psipred/). 
Conf – confidence of prediction. Helix (H) is shown in pink, random coil (C) is displayed as a black line. B - spYnfE 
hydrophobic region displayed as an α-helical wheel projection. Amino acids Ala-19 to Glu-36 were mapped onto an 
α-helical wheel projection. Amino acids highlighted as important in DmsD interactions are circled red. Leu-24, Ala-
28, Val-31 and Phe-35 form a face on one side of the helix, whilst Leu-33 appears to be localised on the opposite 
side of the helix. Created using heliQuest (http://heliquest.ipmc.cnrs.fr/cgi-bin/ComputParamsV2.py). 
 
These data suggest the binding epitope for DmsD is hydrophobic in nature. This indicates that 
there may be a hydrophobic groove on DmsD involved in binding spYnfE. Indeed, in other 
substrate-TorD family chaperone interactions studied, this appears to be the case. For 
example, the 3D structure of the TorD-like chaperone TtrD from Archaeoglobus fulgidus has 
been solved to a resolution of 1.35 Å and displays two hydrophobic patches close to the ‘hinge’ 
region containing the conserved EPxDH motif (Coulthurst et al., 2012). One of these 
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hydrophobic pockets, involving helix α5 and α7, is very similar to a hydrophobic area of DmsD 
and so it may be that this region is involved in signal peptide binding in this family of proteins.  
Hydrophobic interactions have long been known to be important in protein folding and 
interactions between protein faces. It has been demonstrated that surface hydrophobicity of 
proteins often plays a role in protein-protein recognition (Young et al., 1994). Hydrophobic 
interactions are driven by entropy, and interactions between DmsD and spDmsA have been 
shown to be entropic in nature, indicating a role for the hydrophobic effect in signal peptide 
binding (Winstone et al., 2013a).  It has been shown in other protein interactions that, whilst 
hydrophobic interactions are important, these interactions are stabilised by additional 
electrostatic hydrogen bonds forming and helping to maintain the interaction (Chang et al., 
2013, Zhang et al., 2007). It is therefore likely that in addition to the apparent hydrophobic 
interactions involved in signal peptide binding, there are additional stabilising interactions 
occurring at the interface with the DmsD chaperone. It has already been proposed that 
electrostatic interactions are involved in initial binding of the signal peptide to the lipid 
membrane through the positive n-region of the signal peptide and the negatively charged lipid 
headgroups (Shanmugham et al., 2006). Hydrophobic interactions are then thought to come 
into play and allow further binding of the signal peptide to the membrane to occur.  
The DmsA signal peptide has been shown to be able to interact with artificial phospholipid 
bilayers, with the presence of DmsD appearing to decrease the level of membrane binding, 
with previous studies also suggesting lipid interactions by DmsD, TorA and OmpA signal 
peptides (Shanmugham et al., 2012, Shanmugham et al., 2006). It may be that the hydrophobic 
region of the signal peptide is involved in both interactions with the DmsD chaperone and 
initial interactions with the cytoplasmic membrane. It could be hypothesised that the binding 
interactions to spDmsA by both DmsD and the lipid bilayer is of a competitive nature, with 
DmsD being forced to release the signal peptide upon spDmsA interactions with the 
membrane. DmsD was unable to recruit large amounts of spDmsA back from the membrane 
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(Shanmugham et al., 2012), likely due to reduced accessibility, and this could be the final step 
in passing of substrates from chaperone to Tat translocase. 
Of course, as this work has involved altering the native sequence of the YnfE signal sequence, 
it could be argued that Tat transport of this substrate has been adversely affected in some 
way, and this is the real reason behind the disruption of selenate reductase activity observed 
in KM01 and KM02 mutants. For this reason, we attempted to raise antibody towards YnfE 
with the idea that fractionation and Western immunoblots could be performed to identify the 
localisation of spYnfE variants in comparison to the native protein. Unfortunately, the antibody 
produced did not appear to identify YnfE when produced at native levels in the cell. Even after 
attempts to affinity-purify the antibody, it was still impossible to identify  differences by 
Western analysis between wild-type S. Typhimurium strains and those with deletions in genes 
for YnfE and YnfF, and was therefore of no use for analysing YnfE localisation in cells. Because 
of this issue, we are unable to say for sure that the effects observed with spYnfE variants are 
because of disruptions to the interactions of the signal sequence to DmsD. However, one 
possible indication that these results are predominantly due to affected DmsD interactions 
(and so incorrectly assembled enzyme) rather than inhibited Tat transport per se is that of 
KM03, producing the S. Typhimurium spYnfE L33Q, variant still able to reduce selenate to 
selenium. This shows that the introduction of a single glutamine on the signal peptide is 
tolerated and selenate reductase is still transported. Whilst overall hydrophobicity of the signal 
sequence is important for transport (Cristóbal et al., 1999b), altering the hydrophobicity of the 
peptide by introducing a single additional glutamine, especially close to the polar c-region, is 
unlikely to cause such a change as to affect Tat transport.  
It was also attempted to document transport activity of signal peptides in the absence of 
DmsD binding. To do this an in vivo screening assay was designed to show if any of the amino 
acids highlighted in previous work were important in Tat translocation ability of substrates. 
Signal peptides of Tat substrates YnfE, YnfF and DmsA were fused to chloramphenicol acetyl 
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transferase (CAT) on the plasmid pSU-PROM. CAT confers resistance to the antibiotic 
chloramphenicol when located in the cytoplasm of the cell, where it catalyses the acetyl-S-
CoA-dependent acetylation of chloramphenicol at the 3-hydroxyl group, rendering it inactive. 
Therefore, with CAT fusions to Tat signal peptides, if transport is active cells will be sensitive to 
high levels of chloramphenicol, whereas if transport is disrupted cells will become resistant. In 
this way it would be possible to investigate whether disruptions to DmsD binding affected 
transport. 
Cells were co-transformed with both pSU-PROM signal peptide vectors and pUNI-
PROM_DmsDst. It was then attempted to obtain the minimal inhibitory concentration of 
chloramphenicol with these cells before the assay could be used, as E. coli has an inherent low 
level of resistance. However, despite originally determining an approximate MIC of 150 µg/ml, 
in further tests using the same controls expressing native signal peptide fusions and DmsD it 
was not possible to obtain the same results, with cells growing on all concentrations of 
chloramphenicol tested. Because of this, the experiments had to be abandoned. However, if it 
were possible to obtain working negative controls then this reporter system would be useful in 
investigating the effects of signal peptide amino acid substitutions had on Tat transport 
activity. It could also be ideal for use in screening a dmsD mutant library to identify variants 
with disrupted transport. 
In summary, this Chapter has shed new light on the involvement of the Tat signal sequence of 
YnfE in DmsD interactions. The binding epitope for DmsD has been identified as within the 
hydrophobic stretch of the signal peptide, with at least amino acids Leu-24 and Ala-28 within 
this binding site also being important for overall physiological selenate reductase activity.  
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3 Tat-dependent selenate metabolism in S. 
Typhimurium: the role of DmsD 
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 Introduction 3.1
It has been widely reported that many enzymes transported out of the bacterial cell cytoplasm 
by the Tat system require incorporation of metal cofactors prior to translocation, and this 
biosynthetic process is monitored in many cases by cytoplasmic chaperone proteins in an 
event termed ‘Tat proofreading’ (Dubini & Sargent, 2003a, Sargent, 2007a).  The cytoplasmic 
chaperone protein DmsD is a member of the TorD family of cytoplasmic chaperone proteins, 
and is encoded for in S. Typhimurium by the gene STM1495 as part of the ynfEFGHdmsD 
operon (Turner et al., 2004).  
 
Figure 3.1: Three dimensional crystal structure of S. Typhimurium DmsD. 
The monomeric structure shows an all-α fold arrangement with 12 helices. The N- and C-terminal helices are 
separated by a loop region. Another feature to note is a protruding solvent-exposed N-terminal helix containing a 
number of hydrophobic residues (Qiu et al., 2008). 
 
The 3D crystal structure of S. Typhimurium DmsD has been solved to a resolution of 1.38 Å 
(Figure 3.1), and displays an all α-helical fold structure with 12 helices (Qiu et al., 2008). DmsD 
interactions have been studied using isothermal titration calorimetry, and unusually for a Tat 
chaperone protein, has been shown to interact with the signal peptides of at least three 
different Tat substrates - DmsA, YnfE and YnfF. Signal peptide fusions to MalE were found to 
bind to DmsD with varying affinities, with spYnfE interacting with an apparent Kd of 45 nM, 
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spYnfF with an apparent Kd  of 10 nM and spDmsA with an apparent Kd  of 104 nM  (Guymer et 
al., 2009). It has also been suggested that DmsD may play a role in recruiting other proteins, 
such as those involved in molybdenum cofactor biosynthesis, to the Tat substrates in order to 
aid enzyme maturation (Li et al., 2010). In Chapter 2, the binding epitope for DmsD on the S. 
Typhimurium YnfE signal peptide was determined. However, the regions of importance on 
DmsD for binding to Tat signal peptides are yet to be fully described. Work has previously been 
done on investigating the residues of E. coli DmsD involved in interactions with the signal 
peptide of E. coli DmsA. A number of residues were inferred to be involved in signal 
recognition through mutagenesis as having a role in the binding of DmsD to spDmsA, 
appearing to form a number of so-called “hot-pockets” in the N-terminal region (Figure 3.2) 
(Chan et al., 2008). 
 
 
Figure 3.2: ‘Hot pocket’ for signal peptide interactions shown on 3D crystal structure of E. coli DmsD 
Crystal structure of DmsD as solved by Stevens et al. (2009). Indicated in yellow are residues highlighted to play a 
role in DmsA signal peptide binding from site-directed mutagenesis studies (Chan et al., 2008).  
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In terms of the wider DmsD/TorD family of peptide binding proteins, studying DmsD activity 
has advantages over studying TorD. The main advantage is that dmsD mutants, from both S. 
Typhimurium and E. coli, are completely devoid of selenate reductase activity. In contrast, torD 
mutants retain at least 50% TMAO reductase activity. This enables a facile colourimetric assay 
to be used in order to follow DmsD function in vivo, which has the potential to be used as a 
powerful genetic screen. 
 
 Aims 3.2
The aim of this Chapter was to characterise the YnfE signal peptide binding site on S. 
Typhimurium DmsD. In order to better understand the role of DmsD in YnfE biosynthesis, a 
dmsD random mutant library was used to identify DmsD variants that had negative effects on 
YnfE interactions/proofreading. Purified DmsD protein was also utilised in biochemical studies 
for in vitro characterisation of the ssYnfE binding activity of this protein. 
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 Results 3.3
3.3.1 Genetic analysis of the YnfE  – DmsD interaction. 
 Isolating DmsD variants affecting selenate reductase activity 3.3.1.1
A S. Typhimurium dmsD mutant library was prepared using an error-prone PCR protocol in 
collaboration with Dr Holger Kneuper, a temporary postdoctoral researcher in the Sargent 
team. The library was prepared in the pUNI-PROM vector (Jack et al., 2004), which drives gene 
expression from the constitutive tat promoter. In Chapter 2, S. Typhimurium strains KM01 
(spYnfE L24Q) and KM02 (spYnfE A28Q) were constructed. Both these strains lack selenate 
reductase activity under normal conditions, and were considered ideal candidates for the 
selection of second-site suppressor variants of DmsD that could rescue selenate reductase 
activity in the ssYnfE amino acid substituted strains.  
First, KM01 (spYnfE L24Q) and KM02 (spYnfE A28Q) were transformed with pUNI-
PROM_DmsDst, and the empty vector pUNI-PROM, as controls. Following overnight growth 
with sodium selenate, KM01 (spYnfE L24Q) expressing either pUNI-PROM or pUNI-
PROM_DmsDst demonstrated a lack of active selenate reductase (Figure 3.3). Next, the KM01 
(ssYnfE L24Q) strain was screened using the dmsD mutant library. This involved transformation 
of KM01 (spYnfE L24Q) with the mutant library and transformed cells being plated directly 
onto LB agar plates containing 10 mM sodium selenate. Plates were then incubated for 36 
hours anaerobically, with colonies then being picked for further analysis according to colour. 
For KM01, red colonies were desired as this would indicate an amino acid substitution on 
DmsD able to overcome the L24Q substitution present on the YnfE signal peptide. 
Unfortunately, following numerous attempts involving approximately 10,000 colonies, no 
selenate reductase-positive colonies were identified in this screen (Figure 3.4A). 
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In the case of KM02, when this strain (ssYnfE A28Q) was transformed with pUNI-
PROM_DmsDst only selenate reductase activity was surprisingly rescued and red selenium 
deposits were observed (Figure 3.3). This suggested that by simply expressing excess S. 
Typhimurium dmsD using the tat promoter present on a multicopy vector was enough to 
overcome the original disruption to selenate reductase biosynthesis caused by the A28Q 
substitution within the YnfE signal sequence. This result prevented to screening the dmsD 
mutant library for second-site suppressors. Instead it was decided to adapt the screen to 
identify inactive mutants of dmsD. 
 
 
Figure 3.3: An spYnfE A28Q phenotype can be rescued by excess DmsD. 
S. Typhimurium strains KM01 (ynfE L24Q) and KM02 (ynfE A28Q) were transformed with either empty pUNI-PROM 
or pUNI-PROM_DmsDst. A resultant colony was then grown overnight in microaerobic liquid LB culture containing 
10 mM sodium selenate. 
 
Since transformation of KM02 (spYnfE A28Q) with pUNI-PROM_DmsDst alone was enough to 
restart selenate reduction, the dmsD mutant library was screened instead for white colonies 
indicating DmsD activity was not present. Cells were transformed with the dmsD mutant 
library and directly plated onto LB agar plates containing sodium selenate. In this case, both 
red and white colonies could be observed on the plate after 36 hours of anaerobic growth. 
Individual white colonies, along with a small number of red colonies to check observations 
were correct, were then patched onto fresh LB agar + selenate plates and again grown 
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anaerobically for 36 hours. Red and white colonies could then clearly be distinguished (Figure 
3.4B).  
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Figure 3.4: Identification of amino acid substitutions in DmsD that disrupt selenate reductase activity. 
A – Screen of dmsD random mutant library in KM01 (ynfE L24Q). Cells were transformed with the pUNI-
PROM_DmsDst mutant library and plated directly onto LB agar plates containing 10 mM sodium selenate. Positive 
control (1) was DIG103 pUNI-PROM and negative control (2) was KM01 pUNI-PROM_DmsDst. The presence or 
absence of selenate reductase activity can be observed through the lack or appearance of red cells. After 36 hours 
of anaerobic growth, plates were examined and colonies displaying the desired phenotype, for KM01 red cells, were 
patched onto LB agar + 10 mM sodium selenate plates to confirm the observed phenotype. B – Screen of DmsD 
random mutant library as in A in KM02 (ynfE A28Q). Positive control (1) was KM02 pUNI-PROM_DmsDst and 
negative control (2) was KM02 pUNI-PROM. C – DmsD variants observed as disrupting selenate reductase activity in 
KM02 were tested for expression and stability by Western analysis of whole cell samples. Arrows indicate DmsD. 
Antibodies: Anti-DmsD – 1:20,000. Anti-rabbit – 1:10,000. Plasmids expressing DmsD variants present at similar 
levels to native DmsD were mini-prepped and sequenced (*). D – Primary amino acid sequence of S. Typhimurium 
DmsD with amino acid residues highlighted that were substituted in DmsD variants found to have reduced selenate 
reductase activity. 
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With a negative screen such as this it is possible that a number of the errors introduced into 
dmsD in the library could have generated nonsense codons that affect expression levels, 
protein synthesis and protein stability. In order to filter out these types of mutation all of the 
white colonies identified were therefore tested by Western analysis in order to select the 
DmsD variants that are being expressed properly (Figure 3.4C).  By comparing the levels of 
DmsD present in these samples to those in cells expressing native DmsD (Figure 3.4C), three 
clones were identified that appeared to be expressing stable DmsD in similar levels to the 
native pUNI-PROM_DmsDst. Vectors expressing these three DmsD variants were isolated from 
cells and analysed by DNA sequencing. It was found that in the three dmsD mutants 
sequenced, a total of seven codons had been mutated (Figure 3.4D). In one variant DmsD four 
amino acid residues were substituted, namely V16G, S96G, T103I and G171R. Another DmsD 
variant had just one substitution at position 91, where the tryptophan was substituted for an 
arginine. The final variant contained two amino acid residue substitutions – R94H and G100S. 
 
 Analysis of DmsD variants for effects on selenate reductase activity 3.3.1.2
Amino acids of S. Typhimurium DmsD identified in the library screen were investigated for 
their importance during selenate reductase biosynthesis. In order to do this, each of the seven 
amino acid residues identified in the screen was individually substituted for a glutamine. 
Mutations were introduced onto both vector pT25-DmsD, from the two-hybrid system, and 
pUNI-PROM_DmsDst.  
The seven pUNI-PROM_DmsDst mutants were tested for their importance in the production of 
functional selenate reductase by testing in both KM01 and KM02 strains. This was done 
through transformation of the cells individually with the seven mutant vectors before 
overnight growth in liquid LB cultures containing 10 mM sodium selenate. It was observed that 
substitutions R94Q, S96Q, T103Q and G171Q were individually not enough to disrupt selenate 
reductase activity alone (Figure 3.5). W91R was picked as an inactive variant from the original 
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screen, and this was confirmed here with selenate reductase activity again observed to be 
disrupted in a W91Q version. In addition, it is clear that a single V16Q or G100Q substitution in 
DmsD is sufficient to inactivate the chaperone (Figure 3.5). 
 
 
Figure 3.5: DmsD residues V16, W91 and G100 are required for selenate reductase assembly and activity. 
S. Typhimurium strain KM02 was transformed with pUNI-PROM_DmsDst single amino acid variants. Single colonies 
were inoculated into LB media containing 10 mM sodium selenate before being grown overnight in microaerobic 
conditions. Activity of selenate reductase is visible through production of red deposits in the cell culture. 
 
 Analysis of DmsD variants for interactions with spYnfE 3.3.1.3
For quantification of the ability of the identified DmsD variants to interact with the signal 
sequence of YnfE, the bacterial two-hybrid system was utilised. In this experiment, DmsD 
variants were encoded for by the plasmid pT25-DmsD, producing DmsD variant proteins 
covalently fused to the C-terminus of the T25 fragment of the adenylate cyclase. Interactions 
of these DmsD variants were tested against the spYnfE-T18 fusion. Interactions were 
quantified through use of the β-galactosidase assay (Figure 3.6). The results show that DmsD 
R94Q, S96Q, G100Q and T103Q displayed β-galactosidase activity levels of between 150 and 
200 % that of the native DmsD-spYnfE interaction, with W91Q and G171Q having closer to 100 
% β-galactosidase activity levels. These are therefore considered to be unimpaired in signal 
peptide recognition. However, the V16Q experiment clearly differed in its β-galactosidase 
activity, with levels almost identical to that of the empty vector negative control (Figure 3.6). 
This suggests that of these amino acid residues identified from the random mutant screen, 
only Valine 16 is actually important in DmsD interactions with the signal peptide of YnfE.  
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Figure 3.6: DmsD V16Q variant is unable to recognise the YnfE signal peptide. 
MG1655 ΔcyaA::Apra was co-transformed with vectors UT18-spYnfE and T25-DmsD plus variants and β-
galactosidase was measured as an indicator of interactions. β-galactosidase activities are displayed relative to native 
spYnfE-DmsD activity (‘WT’).  Cells containing both empty vectors were used as the negative control (‘UT18 + T25’). 
Data expressed as means (n = 3) ± SEM. 
 
 Alternative roles for DmsD in YnfE maturation 3.3.1.4
The genetic screens employed so far in this Chapter have identified three amino acid residues 
important for DmsD function. The first is V16. When substituted with glutamine, the resultant 
V16Q variant DmsD is unable to bind the YnfE signal peptide and therefore cannot rescue the 
activity of the KM02 strain. The second and third are W91 and G100. When substituted with 
glutamine, the resultant W91Q and G100Q variant DmsD cannot rescue the activity of the 
KM02 strain, but retains the ability to bind the YnfE signal peptide. Thus it may be that DmsD 
in fact has two different roles in selenate reductase biosynthesis. Other cytoplasmic Tat 
chaperones are known to be important for cofactor insertion as well as signal peptide 
interactions, for example TorD is thought to bind the signal peptide of TorA but simultaneously 
interact with the mature region of the protein (Dow et al., 2013). This second interaction is 
believed to aide cofactor loading, probably by holding the active site of TorA in a conformation 
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that promotes insertion (Dow et al., 2013). Potential additional interactions of DmsD with full-
length YnfE, and its partner protein YnfG, were therefore investigated. 
In order to characterise DmsD interactions vectors were constructed to express several 
different protein fusions to the UT18 fragment for bacterial two-hybrid analysis. A truncation 
of YnfE, lacking the signal peptide, was to be tested to identify the ability of DmsD to interact 
with YnfE in another region other than that already identified. In addition to this, a fusion of 
UT18 to full length YnfE was generated, as previous work had used a construct encoding for 
just the signal peptide itself. A fusion with YnfG, an Fe-S subunit of selenate reductase that 
lacks a Tat signal peptide, was also constructed. 
 
 
Figure 3.7: DmsD interacts preferentially with the twin-arginine signal peptide. 
Vectors T25-DmsD and UT18-spYnfE, YnfE Δsp, YnfE or YnfG were co-transformed into MG1655 ΔcyaA::Apra and β-
galactosidase was measured as an indicator of interactions. β-galactosidase activities are displayed relative to 
spYnfE-DmsD activity (spYnfE).  Cells containing both empty vectors were used as the negative control (UT18 + T25). 
Data expressed as means (n = 3) ± standard error of means (SEM). 
 
Interactions of these fusion proteins with a DmsD-T25 fusion were tested using the bacterial 
two-hybrid system and β-galactosidase activity as an indicator (Figure 3.7). In comparison to 
the interaction between DmsD and spYnfE, truncated YnfE displayed activity levels of 13 %, 
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very similar to negative control levels and indicating there was no interaction with YnfE when 
the signal peptide is missing. Full length YnfE showed 31 % activity, whilst YnfG showed 35 %, 
both relatively low levels of interaction. From this result it would appear that DmsD does not 
interact to any great extent with the mature region of YnfE or YnfG. Of course, through the 
fusing of proteins of the size of YnfE and YnfG to UT18 fragment of adenylate cyclase, there is a 
chance that folding of these proteins could be negatively affected. This could lead to problems 
with stability that could not be tested for. Stability issues would also result in low β-
galactosidase activity as observed in this experiment. Therefore we cannot conclude for 
definite that DmsD is not interacting with these proteins, rather that interactions cannot be 
detected in this particular experiment.  
 
3.3.2 Biochemical investigations of the spYnfE interaction with DmsD 
 Overproduction and purification of DmsD 3.3.2.1
In order to purify S. Typhimurium DmsD a vector was constructed using pQE-80L as a backbone 
in order to allow for IPTG-inducible overproduction. Primers were designed to introduce a His-
tag followed by a TEV cleavage site onto the N-terminus of DmsD, and this was cloned into 
pQE-80L. This allowed for purification of His-tagged DmsD (DmsDHis) followed by cleavage of 
the His-tag to produce native DmsD protein for use in in vitro experiments (Figure 3.8A). 
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Figure 3.8: Purification of recombinant DmsD. 
A – Construct design for pQE80-NHis TEV DmsD. Primers designed are indicated by green arrows. B – BL21 pLysS 
cells overexpressing DmsDhis were lysed, with the resultant soluble fraction being subjected to Ni-IMAC. Fractions 
were analysed through SDS-PAGE (12.5 % acrylamide gel), and those containing DmsDhis were pooled and incubated 
overnight in the presence of TEV protease in order to cleave the His-tag. Cleaved DmsD was then isolated by reverse 
Ni-IMAC. C – DmsD isolated from reverse Ni-IMAC was pooled, concentrated and subjected to further purification 
by SEC through a Superdex 75 10/300 GL column. Fractions were visualised by SDS-PAGE (12.5 % [w/v] acrylamide 
gel). 
 
To isolate DmsD using this vector, the soluble cell fraction from cultures overproducing 
DmsDHis was subjected to immobilised metal affinity chromatography (IMAC). Fractions from 
peaks observed during the initial IMAC elution profile were taken and analysed by SDS-PAGE 
(Figure 3.8B). Through staining of the SDS-PAGE gel the presence of a strong band 
corresponding to the approximate size of monomeric DmsDHis was observed. Fractions 
appearing to contain DmsDHis were then pooled and mixed with purified TEV protease for 
overnight cleavage of the N-terminal His-tag. Cleaved DmsD was separated from uncleaved 
DmsDHis by reverse IMAC, and fractions again analysed by SDS-PAGE (Figure 3.8C). Those 
containing the purest DmsD were pooled and concentrated, ready for further purification 
through size exclusion chromatography using a Superdex 75 column. The resulting protein was 
confirmed to be DmsD through Western analysis, before being concentrated and flash frozen 
to be stored until used. 
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 Crosslinking analysis of purified DmsD and synthetic spYnfE 3.3.2.2
In order to probe YnfE signal peptide binding ability of DmsD, a chemical crosslinking approach 
was undertaken. It has been shown in Chapter 2 that DmsD binds the hydrophobic region of 
the YnfE signal peptide. However, less is known about the binding site on DmsD. This was 
investigated by a chemical crosslinking approach, using purified DmsD protein and a number of 
synthesised peptides of various sequence stretches of the YnfE signal peptide (Table 3.1). 
 
Table 3.1 Details of synthetic peptides used in this study. 
Name Amino acid sequence Length Molecular 
weight 
Use 
Peptide 1 SRRTLVKSAALGSLALAAGGVSLPFGMRK 29 a.a. 2.915 kDa crosslinking 
Peptide 2 SLALAAGGVSLPFGMRK 17 a.a. 1.675 kDa crosslinking 
Peptide 3 SRRTLVKSAALGSLALAAGGVSLPFGMR 28 a.a. 2.787 kDa crosslinking 
Peptide 4 SLALAAGGVSLPFGMR 16 a.a. 1.547 kDa ITC, crystal trials 
 
In a first experiment, purified DmsD and the synthetic peptide named peptide 1 were 
incubated together in solution, and three different chemical crosslinkers were tested for their 
ability to induce crosslinks to form. Disuccinimidyl suberate (DSS) is a chemical crosslinker that 
is able to covalently link lysine residues and other primary amine groups that are within 11.4 Å 
of each other. 1-Ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride (EDC) is a zero-
length crosslinker capable of inducing crosslinks between carboxyl groups and primary amines. 
The well-known chemical formaldehyde is a bifunctional crosslinker that can be used to form 
covalent bonds over distances of approximately 2.3 Å, and primarily reacts with lysines and 
tryptophans as well as primary and secondary amines at the N-terminus (Sutherland et al., 
2008). After induction of crosslinking, levels of crosslinked protein-peptide could then be 
analysed through SDS-PAGE and Western blotting. 
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Figure 3.9: DSS or formaldehyde, but not EDC, can crosslink a peptide ligand to DmsD 
Purified DmsD (2 mM) and synthetic peptide 1 (100 mM) were incubated together in a final volume of 100 µl prior 
to the addition of chemical crosslinkers to induce crosslinks between DmsD and synthetic peptide. Crosslinker 
concentrations were: 1 mM DSS, 1 mM EDC or 1% formaldehyde. Reactions were stopped after 30 minutes with 50 
mM Tris. 10 µl samples were analysed by: (A) SDS-PAGE (17 % acrylamide gel) and (B) western blotting. Antibodies 
used were anti-DmsD (1:20,000) and anti-rabbit (1:10,000). 
 
Analysis of DmsD samples exposed to chemical crosslinkers in the presence and absence of 
synthetic peptide 1 were compared to DmsD with no crosslinker present (Figure 3.9). Samples 
incubated with DSS had an additional two bands in the presence of peptide 1 compared to that 
without, one a strong band of higher molecular mass and the other a weaker band at still 
higher molecular mass (Figure 3.9). This indicated DSS was probably able to form a covalent 
crosslink between DmsD and the synthetic peptide. In comparison, samples with EDC did not 
show any additional band in the presence of peptide 1 (Figure 3.9). This suggests that EDC is 
not a suitable crosslinker for such experiments. In addition, it is recommended to include N-
hydroxysuccinimide (NHS) or its water-soluble analogue sulfo-NHS in the reaction with EDC to 
improve efficiency of the reaction. This was not done in these experiments and may be the 
reason for a lack of crosslinking. Formaldehyde was able to induce a large amount of crosslinks 
(Figure 3.9). However, it was notable here that in the sample of DmsD without peptide 1 
formaldehyde formed covalent bonds between DmsD monomers, leading to the presence of a 
band at approximately 40 kDa, the correct size for DmsD dimer (Figure 3.9). Interestingly, upon 
the addition of peptide 1, the amount of DmsD dimer noticeably decreased and an additional 
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band appeared of the correct size for crosslinked DmsD-peptide (Figure 3.9). From these 
results, EDC was no longer used for these crosslinking experiments, whilst DSS and 
formaldehyde both appeared suitable. 
 
 
Figure 3.10: SDS-PAGE and Western blot analysis of DmsD crosslinked by DSS with synthetic peptide 1 and 2. 
Purified DmsD (2 mM) and synthetic peptides 1 & 2 (100 mM) were incubated together in a final volume of 100 µl 
prior to the addition of 1 mM DSS, with the reaction being stopped after 30 minutes with 50 mM Tris. 10 µl samples 
were analysed by: (A) SDS-PAGE (17 % acrylamide gel) and (B) western blotting. Antibodies used were anti-DmsD 
(1:20,000) and anti-rabbit (1:10,000). 
 
As it had now been shown that crosslinking could be induced using DSS and peptide 1, 
interactions of the DmsD protein with a smaller region of the signal peptide of YnfE was tested 
using synthetic peptide 2 (Figure 3.10). This peptide 2 was limited to only the hydrophobic 
region of the signal sequence, and contained just one non-native lysine at the C-terminal end 
with the intention for use in DSS crosslinking (Table 3.1). These synthetic peptides do not 
contain primary amines at the “N-termini”. Covalent links were introduced between DmsD and 
synthetic peptides with DSS, with samples then being evaluated through SDS-PAGE and 
Western analysis (Figure 3.10). For peptide 2 a weak crosslinked band was observed above 
that of noncrosslinked DmsD (Figure 3.10), whilst for peptide 1 a very strong crosslinked band 
was present, along with a further band slightly larger again (Figure 3.10). In addition the 
presence of a band at approximately 40 kDa could be observed in the DmsD only sample, as 
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was observed in Figure 3.9. Interestingly, the dimer band appears to reduce in intensity upon 
the addition of peptide 1 and can barely be seen at all in the presence of peptide 2 (Figure 
3.10). This suggests that DmsD is capable of interacting in a dimeric form that becomes 
disrupted upon spYnfE binding, perhaps hinting at a shared binding site on the chaperone 
protein. 
Given peptide 1 contains two lysine residues, next the requirement of the additional non-
native lysine residue present in these peptides was tested. A third synthetic peptide was 
generated of the full Tat motif and hydrophobic region of spYnfE, but without the lysine at the 
C-terminus, therefore only containing one internal native lysine (Table 3.1). The ability of this 
peptide to form covalent links with DmsD will give information on how much the native and 
non-native lysines are involved in interactions and DSS crosslinking. Western blots showed 
crosslinked bands in both 1:25 and 1:100 ratio of DmsD protein to peptide 3. 1:1 ratio sample 
did not appear to have DmsD crosslinked (Figure 3.11). This indicates that peptide 3 is also able 
to form interactions with DmsD. 
 
 
Figure 3.11: Ability of synthetic peptide 3 to form crosslinks with DmsD. 
DSS crosslinking was induced between purified DmsD and synthetic peptide 3 lacking the C-terminal lysine present 
in peptides 1 and 2. Varying millimolar ratios of DmsD protein to peptide as indicated were incubated for 1 hour 
prior to addition of 1 mM DSS. Reactions were stopped by the addition of 50 mM Tris, before 10 µl samples were 
analysed by SDS-PAGE (17 % acrylamide gel) and Western blot (Anti-DmsD – 1:20,000. Anti-rabbit – 1:10,000). 
 
 Investigating the location of the crosslinks between DmsD and ssYnfE 3.3.2.3
As it was observed that purified DmsD was able to reliably crosslink synthetic peptides using 
DSS, it was attempted to analyse this crosslinking further through mass spectrometry. This was 
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hoped to give a more definitive picture of where the crosslinks are occurring between DmsD 
and the peptide. However, results only indicated crosslinks between the synthetic peptide 
itself (data not shown). Examination of the amino acid sequence of DmsD shows only two 
lysines in the entire protein (Figure 3.12A), and these do not fall in ideal areas for analysis with 
trypsin digest and mass spectrometry to be successful, with the fragments obtained after 
digest being too large for identification. Therefore a different approach to analyse where 
interactions were occurring was required. 
It was decided that DmsD-peptide interactions would instead be investigated through the use 
of genetics – a bank of DmsD lysine variants was prepared. The reasoning behind this was that 
because DSS forms covalent links between free amines, and as there are only three potential 
crosslinking sites on DmsD (including the N-terminus), it should be fairly straightforward to 
identify which of these free amines is involved in crosslinking through the individual and 
double substitution of lysines for a glutamine. Any disruption in crosslinking caused by the loss 
of a lysine can be observed by SDS-PAGE and western as a lack of crosslinked sample bands. 
Using the pQE80 NHis-TEV-DmsD vector as template, Lys-61 and Lys-200 were individually 
substituted by Gln residue along with a double Lys-Gln variant using Quikchange site-directed 
mutagenesis. Substitutions were confirmed by DNA sequencing. Proteins were then purified as 
before by IMAC, TEV cleavage and reverse IMAC, and SEC. DSS crosslinking was then 
performed using the purified variant proteins and native DmsD protein with synthetic peptide 
2 (Figure 3.12). 
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Figure 3.12: Evidence that peptide ligands are crosslinking to the N-terminus of DmsD. 
A – DmsD (S. Typhimurium) primary amino acid sequence. The two lysines present in DmsD are highlighted. It was 
observed that they are located in different halves of the protein sequence.  These were substituted for glutamines 
by site-directed mutagenesis, and purified by Ni IMAC and SEC. B – Expression tests with native DmsD and K61Q and 
K200Q variants. Overnight cultures of BL21 pLysS cells containing vectors for these DmsD variants were subcultured 
and grown at 37 oC for 1 hour. Samples were taken before addition of 1 mM IPTG (-) and after three hours growth in 
the presence of IPTG (+). These were mixed 1:1 with Laemmli buffer before being visualised by staining of SDS-PAGE 
gels (12.5 % acrylamide gel). C - Western blot analysis of purified DmsD Lys variants crosslinked with synthetic 
peptide 2. DmsD and peptide were incubated together in varying molar ratios as indicated (DmsD:peptide) before 
the addition of 1 mM DSS to induce crosslinking. The reaction was stopped after 30 minutes by the addition of 50 
mM Tris. 10 µl samples were separated by SDS-PAGE (17 % acrylamide gel) and visualised by western blot (anti-
DmsD – 1:20,000 & anti-rabbit – 1:10,000).  
 
Western blots showed the presence of an additional band that corresponds to a crosslinked 
DmsD-peptide complex in all protein samples incubated with synthetic peptide 2 (Figure 
3.12C). This result indicates that neither a single nor a double Lys substitution was able to 
disrupt crosslinks between synthetic peptide 2 and DmsD. It was concluded that DSS crosslinks 
must be able to form between the synthetic peptide and the N-terminus of DmsD, which 
contains a free amine, as crosslinking was not completely disrupted even with the loss of both 
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lysines within DmsD (Figure 3.12C). To investigate this further, purified native DmsD was used 
that did not have the added histidine-tag removed, which should result in an additional 15 
residues at the N-terminus. All other purification steps were performed as described before, 
but TEV-cleavage and reverse Nickel IMAC was not required. The resulting DmsDHis from SEC 
purification was checked and seen to be of a relatively high purity through SDS-PAGE (Figure 
3.12A). Western analysis was used to confirm the presence of the His-tag (Figure 3.12B).  
 
 
Figure 3.13: Analysis of purified DmsDhis interactions with synthetic ssYnfE peptides. 
A - DmsDhis was purified by Ni IMAC and SEC, with resultant fractions checked for purity by SDS-PAGE (12% 
acrylamide gel). B – The presence of the N-terminal His-tag was checked through Western blot of pooled fractions 
from SEC with anti-His (1:5,000) and anti-rabbit (1:10,000) antibodies. C - DmsDhis was incubated with synthetic 
peptides 1 and 2 at varying molar ratios (His-DmsD:peptide). 1 mM DSS was added to induce crosslinking and after 
30 minutes the reaction was stopped by the addition of 50 mM Tris. 10 µl samples were analysed by SDS-PAGE (17 
% acrylamide gel) and western blot (anti-DmsD – 1:20,000 & anti-rabbit – 1:10,000).  
 
As a test to see if interactions could be disrupted to the N-terminal free amine, DmsD with His-
tag still attached was also subjected to DSS crosslinking. DmsDHis was incubated with both 
synthetic peptides 1 and 2, with crosslinked samples then analysed by Western blot (Figure 
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3.13C). It appeared that both synthetic peptides were still forming covalent bonds with 
DmsDHis, although crosslinked peptide 2-DmsDHis did appear at very much lower levels than 
that of peptide 2-DmsD (Figure 3.9, Figure 3.10) 
 
 DmsD can be co-purified in solution with synthetic spYnfE 3.3.2.4
The crystal structure of S. Typhimurium DmsD in its monomeric form was solved several years 
ago by Qiu et al. (2008). However the protein arrangement whilst in interactions with a signal 
peptide of one of its Tat substrate partners remains unknown. It was therefore attempted to 
obtain crystals of DmsD whilst in complex with a synthetic peptide of the hydrophobic region 
of spYnfE (residues 23-38), named synthetic peptide 4 (Table 3.1). For this experiment, purified 
native DmsD was incubated with synthetic peptide 4 prior to the final purification step of size 
exclusion chromatography, in order to attempt to co-elute protein and peptide together in a 
complex.  
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Figure 3.14: Elution profile for SEC of DmsD purified protein, with or without synthetic peptide 4. 
DmsD protein purified by IMAC was subjected to SEC through a Superdex 75 10/300 GL column, either alone or 
after several hours incubation with synthetic peptide 4 in a 1:1 molar ratio. Elution of protein was monitored by 
measurement of absorbance at 280 nm. 
 
The soluble fraction of cells overexpressing DmsD was subjected to the initial IMAC purification 
followed by overnight TEV-cleavage and reverse IMAC as described previously. The resulting 
purified DmsD was then incubated with synthetic peptide in an approximate 1:1 molar ratio 
for three hours before the sample was concentrated and eluted through a Superdex 75 10/300 
GL column. A single peak was observed during elution, similar to that observed for SEC 
purification of DmsD alone (Figure 3.14). Fractions were visualised by SDS-PAGE, with those 
appearing to contain pure DmsD being pooled. As synthetic peptide 4 is too small to be 
visualised using SDS-PAGE, its presence in solution with DmsD required a more sensitive 
analytic approach. This was performed using electrospray ionisation (ESI) mass spectrometry. 
Samples from pooled fractions of DmsD alone and DmsD plus peptide 4 after SEC were 
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analysed (Figure 3.15). This confirmed the presence of peptide 4, as an additional mass peak of 
1546.8 Daltons was seen in the DmsD plus peptide sample from SEC compared to DmsD alone, 
exactly corresponding to the mass of peptide 4. These data show that DmsD and synthetic 
peptide 4 are able to interact with each other strongly enough to co-elute when subjected to 
size-exclusion chromatography. 
As DmsD and synthetic peptide 4 had been shown to have co-eluted during SEC, it was 
concluded that they had most likely formed a complex. It was decided that this complex should 
be subjected to crystal screens in an attempt to obtain crystals. As the crystal structure of 
DmsD from S. Typhimurium has already been solved, it should be possible to obtain a crystal to 
elucidate the DmsD-spYnfE complex structure using the original crystallisation conditions as a 
starting point. The protein-peptide sample was concentrated down to approximately 18 
mg/ml, with this then being entered into crystallisation trials using a number of commercially 
available crystallisation screens. A number of conditions were therefore taken further and 
trays screening around these conditions were manually set up. The original conditions from 
which a crystal was acquired and used to solve the DmsD structure by (Qiu et al., 2008) were 
also used and optimised around. Unfortunately these manual crystal screens did not yield any 
usable crystals, and as such it has not yet been possible so far to gain a clearer picture of the 
spYnfE-DmsD interface using this approach. 
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Figure 3.15: ESI mass spectrometry analysis of DmsD subjected to size exclusion chromatography (SEC) with and 
without synthetic peptide 4. 
The ability of synthetic peptide 4 to co-purify with DmsD was tested. DmsD alone or DmsD and synthetic peptide 4 
(1:1 molar ratio) were eluted through a Superdex 75 10/300 column, with resultant protein being analysed through 
ESI mass spectrometry. A – Analysis of sample from DmsD alone. A single peak was identified with a mass of 23538 
Daltons. B - Purified DmsD protein incubated with synthetic peptide 4 prior to SEC was also analysed by ESI and 
showed a profile with two peaks, having masses of 1546.8 Daltons and 23538.3 Daltons respectively. Inset boxes 
show base peak chromatograms for each sample, whilst main boxes show averaged mass spectra. 
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 Does nucleotide binding affect peptide crosslinking? 3.3.2.5
Finally, previous experimental and bioinformatics analysis of DmsD and other TorD family 
chaperone members has hinted at a possible involvement of nucleotide in the activity of these 
chaperones. For example, it has been shown that TorD from E. coli is able to bind to and 
hydrolyze GTP in the presence of magnesium chloride (Guymer et al., 2010, Hatzixanthis et al., 
2005). In addition, although the protein sequence itself does not possess the entirety of the 
highly conserved guanine nucleotide-binding domain  found in canonical GTPases, it does have 
some similarities and contains a potential G-4 guanine specificity motif (Guymer et al., 2010). 
Surface analysis of Shewanella massilia TorD and S. Typhimurium DmsD revealed 
corresponding surfaces with similarities to a GTP binding surface from guanylyl cyclase from 
Homo sapiens (Qiu et al., 2008). Many GTPases are thought to act as molecular switches 
through conformational changes induced through GTP/GDP binding, and it could be 
hypothesised that such GTPase activity may be involved in conformational changes required 
for Tat signal peptide binding, or vice versa. Therefore, the effects of the presence of GTP as 
well as several other nucleotides were tested on crosslinking of DmsD with synthetic peptide. 
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Figure 3.16: Analysis of crosslinking interactions of DmsD and peptide 1 when pre-incubated with various 
nucleotides. 
Purified DmsD (2 mM) and synthetic peptide 2 (100 mM) were incubated together with varying molar 
concentrations of the nucleotides ATP, GTP, ADP, XTP, GMP and cGMP with MgCl2 added to HEPES buffer, prior to 
the addition of 1 mM DSS and the reaction eventually being stopped with 50 mM Tris after 30 minutes. 10 µl 
samples were separated by SDS-PAGE (17 % acrylamide gel) before the gel was stained to reveal protein bands. 
 
DmsD was incubated with synthetic peptide 1 in addition to various nucleotides. ATP, GTP, 
ADP, XTP, GMP and cGMP were all added to the reaction mixture at final concentrations of 0.1 
mM, 0.2 mM and 0.5 mM. MgCl2 was also included as a number of GTPases have been shown 
be magnesium-dependent (Zhang et al., 2000). DmsD alone was also incubated with each 
molar concentration of nucleotide to act as negative control. After several hours incubation 
the chemical crosslinker DSS was introduced to the reaction mixture in order to crosslink any 
closely interacting proteins. After ending the reaction by the addition of Tris samples were 
analysed through SDS-PAGE and Western blot. Upon staining, acrylamide gels did not appear 
to show any significant differences in the levels of peptide binding between samples 
containing DmsD and peptide 1 without any nucleotide and those with a nucleotide present 
(Figure 3.16). 
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 Discussion 3.4
3.4.1 New insight into the Tat proofreading function of DmsD using a genetic 
screen 
Through the utilisation of a random mutant DmsD library, it was possible to identify a number 
of amino acids on DmsD that had potential importance in interactions with YnfE. In S. 
Typhimurium strain KM02 (ynfE A28Q) three DmsD variants with a total of seven amino acid 
substitutions were identified that had disrupted selenate reductase activity. When plotted on 
the crystal structure of DmsD from S. Typhimurium it could be observed that five of these 
residues, namely W91, R94, S96, G100 and T103, are located within the same region on the 
protein, with these five all also being exposed on the surface. These residues are nearby the 
loop region that is known to separate the N- and C-terminal regions of the protein. This loop 
region contains the conserved E(Q)PxDH motif that is found in all TorD family chaperone 
proteins and has been previously suggested to be involved in DmsA signal peptide binding 
(Chan et al., 2008). Val-16 and Glu-171 are present in separate regions of the DmsD protein. 
V16, the only amino acid found to be involved in signal peptide recognition, is found near a 
region of DmsD that has been extensively studied and suggested as the region involved in 
peptide binding (Figure 3.17) (Chan et al., 2008, Shanmugham et al., 2012). 
 
129 
 
 
Figure 3.17: Potential amino acid residues on DmsD involved in signal peptide binding. 
Amino acids have been highlighted in a number of studies as playing a role in signal peptide binding. Residues of 
interest are indicated in yellow. A – V16, identified in this work with a DmsD mutant screen as displaying disrupted 
selenate reductase activity in S. Typhimurium strain KM02. B – Residues of importance for spDmsA interactions as 
shown through random and site-directed mutagenesis (Chan et al., 2008). C – Residues found to display chemical 
shift perturbations in their 15N-HSQC TROSY spectra upon binding spDmsA (Stevens et al., 2013). These are 
highlighted on the crystal structure of S. Typhimurium DmsD (PDB 1S9U). 
 
In a multiple alignment of a number of DmsD and TorD sequences, it was observed that all 
amino acids that were highlighted in this study apart from Gly-171 are conserved at least 
amongst DmsD, with a number being conserved or conservatively substituted across all 
sequences used (Figure 3.18). This high level of conservation does indeed suggest these amino 
acids have some level of importance in DmsD function. V16 is conserved in DmsD proteins, as 
is the nearby G18 residue, which was shown by NMR as displaying perturbations in the 
presence of DmsA signal peptide (Shanmugham et al., 2012).  
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Figure 3.18: Multiple alignment of DmsD/TorD-like family chaperones showing possible signal peptide interacting 
residues. 
Aligned amino acid sequences of TorD from S. Typhimurium, E. coli and Shewanella, DmsD from S. Typhimurium and 
E. coli and predicted cytoplasmic chaperone protein STM0610 from S. Typhimurium. Amino acid residues 
highlighted through random mutant screen are indicated by arrows. V16, shown to be significant in this work, is 
indicated by a red arrow. Residues discussed by Stevens et al. (2013) are shown in blue, whilst those of significance 
from Chan et al. (2008) are shown in green. 
 
Through individual DmsD variant testing, it was observed that Val-16, Trp-91 and Gly-100 were 
important for selenate reductase activity, with substitutions in these positions disrupting this 
activity. From this result it could be suggested that these three amino acids are involved in the 
proofreading activity of DmsD with YnfE, with substitutions disrupting the interaction and 
therefore preventing proofreading and formation of mature YnfE. Interestingly, a more specific 
look at interactions of DmsD variants with the signal peptide of YnfE through bacterial two-
hybrid analysis revealed only DmsD V16Q to be obviously impaired in signal recognition. Val-16 
is on a separate face from the majority of other residues highlighted through the mutant 
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screen, near to a region of the protein that has been previously highlighted as a putative 
binding site for the signal peptide of DmsA (Chan et al., 2008). DmsD Val-16 substitutions were 
also shown in Chan et al. (2008) to show a decreased interaction with the signal peptide. 
Valine is a hydrophobic amino acid rarely found on the surface of proteins, and there appears 
to be a number of additional hydrophobic residues in the surrounding area, so it is feasible 
that it forms interactions with the hydrophobic stretch of the YnfE signal peptide important for 
binding. It is already known that the hydrophobic region of the signal peptide is important for 
binding, at least in the case of DmsA and its cognate substrate protein DmsD. It has been 
shown that for E. coli the hydrophobic region of spDmsA, and potentially the C- and H- regions 
in combination, are essential for interactions (Shanmugham et al., 2012, Winstone et al., 
2013a). This agrees with the idea of a hydrophobic pocket or groove being required for signal 
peptide binding via this hydrophobic stretch. In addition, negatively charged amino acids are 
also found nearby, potentially interacting with the positively charged amino acids of the Tat 
motif and n-region of the signal peptide. However, this part of the signal peptide does not 
appear to be essential for binding and so this is less likely to be important in primary 
interactions (Shanmugham et al., 2012, Winstone et al., 2013a). 
Whilst Val-16 was unable to bind spYnfE in bacterial two-hybrid studies, Trp-91 and Gly-100 
retained this ability despite displaying disrupted selenate reductase activity in KM02 (spYnfE 
A28Q). It may be that these two residues are not involved in signal peptide binding. 
Alternatively, from this result it could be proposed that these residues are required for signal 
peptide binding, hence the positive bacterial two-hybrid result, and are in fact involved in 
binding the A28 residue of spYnfE. This would explain the lack of selenate reductase activity 
observed in KM02 expressing these DmsD variants, as substitution of A28 could disrupt DmsD 
interactions and subsequently interfere with YnfE proofreading.  
Recent work into the signal peptide binding site of DmsD has highlighted a particular region of 
the protein as having importance in interactions. Through analysis of NMR chemical shift 
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patterns of DmsD residues in the presence and absence of spDmsA, the area around helices 6 
and 7 and including the loop between these helices, was suggested to form part of a 
hydrophobic cleft in DmsD that extends around towards the front of the protein (Stevens et 
al., 2013). This potential binding site was also thought to extend towards the front of the 
protein and perhaps also involve helices 3 and 4. Whilst not in one of these helices, residue 
G18 was one of a number of amino acids shown to display a perturbation in the presence of 
spDmsA, indicating it also plays a role in peptide binding. Residues V16 and G18 may form one 
end of the hydrophobic binding cleft involved in signal peptide interactions, being relatively 
close to the hydrophobic pocket previously identified. These two residues are conserved 
between S. Typhimurium and E. coli DmsD, as are many of the other residues thought to play a 
role in signal peptide binding (Figure 3.18), and this conservation suggests an important role in 
function. 
 
3.4.2 Chemical crosslinking as a tool to study the signal peptide binding site on 
DmsD 
A synthetic in vitro approach with purified DmsD protein was also used to investigate regions 
of importance for signal peptide binding on DmsD. Using synthetic peptides of differing lengths 
and sequences, the presence of covalent crosslinks formed by DSS was observed. Three 
different peptides were utilised during this work; a peptide covering the entire hydrophobic 
region containing just one Lys residue artificially added to the C-terminus of the peptide 
sequence (Peptide 1, Table 3.1), another covering both the twin-arginine motif and the 
hydrophobic stretch and containing two lysines – one native Lys present in the Tat motif plus 
the synthetically introduced Lys at the C-terminus (Peptide 2, Table 3.1), and a third peptide 
also covering both the twin-arginine motif and the hydrophobic stretch but without the 
addition of a Lys to the C-terminus, therefore containing just one lysine in the Tat motif 
(Peptide 3, Table 3.1). It was observed that all three synthetic peptides were able to crosslink 
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with purified DmsD, with peptide 2, the longest and only peptide containing two lysine 
residues, appearing to be the most efficient at interacting with DmsD. Peptides 1 and 3 also 
appeared to be able to crosslink with purified DmsD but at a lower level. This suggests that 
both the hydrophobic region and the twin-arginine motif regions of spYnfE interact with DmsD, 
and whilst one of these regions is enough for an interaction to occur, interactions and DSS 
crosslinking can occur much more efficiently with the peptide covering both these regions. 
It had been originally planned to induce crosslinks between DmsD and the synthetic peptides 
before identifying the crosslinked residues in more detail using tryptic digest and mass 
spectrometric analysis. Unfortunately, however, this was unsuccessful and no crosslinks in 
DmsD-peptide samples could be detected other than peptide-with-peptide. DmsD only 
contains two lysines to which peptides could be crosslinked using DSS (Figure 3.19) (plus the 
primary amine at the N-terminal), and upon digest with trypsin which cleaves next to Lys and 
Arg residues, the resulting fragments containing the crosslink would be too small to be 
detected by a mass spectrometer. An alternative genetic approach therefore was developed.  
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Figure 3.19: Locations of the two lysines of DmsD. 
A - Lysine residues 61 and 200 are shown in yellow on the 3D structure of S. Typhimurium DmsD. Both are present 
in loop regions of the structure. B - Aligned amino acid sequences of TorD from S. Typhimurium, E. coli and 
Shewanella, DmsD from S. Typhimurium and E. coli and predicted cytoplasmic chaperone protein 610 from S. 
Typhimurium, as before. Lysine residue locations in S. Typhimurium DmsD are indicated with red arrows. 
 
It was decided to create genetic variants of DmsD where the lysines in the sequence were 
substituted, either individually or together for glutamines, with purified protein of these 
variants then being used in DSS crosslinking experiments as before. If crosslinking could be 
completely disrupted by substituting either one or both lysines of DmsD, this would reveal the 
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important lysine residue and point to the region involved in peptide interactions. To this end, 
DSS crosslinking of peptide with all three DmsD variants was performed, however was not 
observed to be disrupted in any of the three samples. From this it could be suggested that the 
free amine at the N-terminus is able to interact with the peptide and this is where crosslinks 
are forming. Attempts to prevent this interaction by testing purified, nonprocessed DmsDHis 
were also unsuccessful. Of course, testing of the crosslinking ability of a nonprocessed His-
tagged double lysine variant would be the key experiment to further confirm the DmsD N-
terminus as the region of interaction. 
Although crosslinking did not appear to be completely inhibited in any of the described 
conditions, it did appear to be reduced to some extent in some cases. Both DmsD K61Q and 
DmsDHis show slightly lower intensity crosslinked bands with Western analysis when compared 
to native DmsD or other variants. One hypothesis that could be put forward from these results 
is that the peptide interacts with a region of DmsD that enables it to form crosslinks with both 
the N-terminal residue and with Lys-61. By removing the primary amine either present on the 
lysines or the N-terminus individually crosslinking would not be completely prevented, perhaps 
instead merely limiting the amount of crosslinking occurring. This would also fit with the 
apparent importance of the amino acid residue Val-16 for signal peptide binding, as Val-16 and 
the N-terminal region are both relatively near to Lys-61. With the chemical crosslinker DSS 
having a spacer arm of 11.4 Å, it may be close enough to form crosslinks with a peptide 
interacting with this region. Study of the amino acid residues present in the surrounding area 
indicates a number of hydrophobic residues are present around Lys-61, as well as at the N-
terminus. This information reinforces this as the proposed binding site for the YnfE signal 
peptide, as hydrophobic interactions may be possible between this region and the 
hydrophobic region of spYnfE. From these results however, it is not possible to comment on 
the stoichiometry of the synthetic peptide binding to DmsD, and this would require further 
testing using the different synthetic peptides with DmsD variants. In addition, further work is 
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required on crystallisation of the DmsD-spYnfE complex purified by SEC, as this would divulge 
much greater detail about the location of these interactions. 
Similar (unpublished) interaction studies were carried out by former PhD student Dr Jennifer 
Dow in Professor Palmer’s group (Dundee), investigating interactions between the substrate 
chaperone pair TorA and TorD in E. coli. DSS crosslinking experiments were performed using 
purified TorD and TorAD complexes (with and without native TorA signal peptide) with 
synthetic TorA signal peptide containing a non-native lysine on the C-terminal end. Using mass 
spectrometry it was possible to identify three crosslinking sites on TorD, forming crosslinks 
with two sites on the synthetic peptide. Both the N-terminal primary amine and the C-terminal 
non-native lysine were able to crosslink to K105 on TorD, in addition to K98 being shown to 
crosslink in TorAΔspTorD samples (Figure 3.20). The occurrence of crosslinks between the non-
native lysine on the synthetic peptide and K98 of TorD hints at interactions of amino acids near 
the C-terminus of the TorA signal peptide. Looking at this information together with previous 
DmsD studies highlighting additional residues (Figure 3.17) it could be suggested that the C-
terminal area of the DmsA signal peptide may interact with DmsD near these residues Leu-92 
and Arg-107, with the hydrophobic and n-regions of the signal peptide likely to stretch across 
the DmsD molecule along the hydrophobic groove identified and past residues such as P86, 
W87, P124 and D126 (Stevens et al., 2013). This would bring the peptide into close proximity 
to residue V16, and may explain its apparent importance in spYnfE binding. 
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Figure 3.20: Residues of DmsDSt equivalent to those identified in E. coli TorD crosslinking experiments. 
Crosslinking experiments have identified residues K98 and K105 of E. coli TorD as interacting with a synthetic TorA 
signal peptide. The equivalent amino acids in S. Typhimurium DmsD are L92 and R107, highlighted here in red. 
 
3.4.3 Evidence for DmsD biochemical activities other than signal peptide binding 
Whilst interactions with spYnfE were disrupted in DmsD V16Q, DmsD G100Q appeared to be 
able to interact with spYnfE at normal levels, in fact with the highest level of interaction of all 
DmsD variants tested. In addition, W91Q displayed near normal levels of interaction, despite 
completely disrupting selenate reductase activity in KM02. Therefore it must be concluded 
that DmsD Val-16 is required for YnfE signal peptide interactions, whilst Trp-91 and Gly-100 is 
not, instead playing a role elsewhere in the biosynthetic pathway of selenate reductase. Whilst 
DmsD residue Val-16 is implicated in YnfE signal peptide binding (as shown by bacterial two-
hybrid analysis), the role of residues Trp-91 and Gly-100 must also be questioned. Through 
examination of chaperone protein sequence alignments, it can be seen that G100 is conserved 
in DmsD proteins but not in TorD. In addition, G100 is found at the end of a loop region of the 
protein that does not appear to exist in TorD, suggesting this region may be involved in some 
function not conserved in TorD (Figure 3.21). Meanwhile, W91, present just before this DmsD 
loop region, is conserved amongst DmsD proteins and conservatively substituted in all other 
proteins aligned (Figure 3.21). The apparent importance of these residues in selenate 
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reductase activity despite the lack of a clear role in peptide binding suggests another role in 
enzyme biosynthesis. There are a number of possibilities for additional functions of the DmsD 
chaperone in enzyme biosynthesis.  
 
Figure 3.21: W91 and G100 residues are conserved amongst DmsD proteins. 
A – W91 and G100 residues shown in yellow were demonstrated in this work to play a role in YnfE activity outside 
of signal peptide binding during proofreading. Also highlighted in pale cyan is the loop region of which G100 is a 
part of. This loop is unique to DmsD proteins. B - Aligned amino acid sequences of TorD from S. Typhimurium, E. coli 
and Shewanella, DmsD from S. Typhimurium and E. coli and predicted cytoplasmic chaperone protein 610 from S. 
Typhimurium, as before. W91 and G100 residues identified in DmsDst is indicated with red arrow, whilst the loop 
region of which it is a part is outlined in purple. 
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In the past it has been demonstrated that in addition to showing interactions with a number of 
substrates of the Tat system, DmsD is in fact able to interact with a large range of general 
molecular chaperones involved in protein biosynthesis (Li et al., 2010). It is possible that Gly-
100 and this area of DmsD is involved in bringing more general chaperone proteins into close 
proximity with YnfE in order to aid protein maturation, or to guide the Tat substrate along a 
cascade of a number of molecular chaperones. There have also been suggestions that DmsD is 
involved in interactions with components of the twin-arginine translocase in the cytoplasmic 
membrane, and it may be that DmsD functions both as a proofreading chaperone and also to 
shuttle the Tat substrate towards the twin-arginine translocase itself (Papish et al., 2003).  
Another way DmsD may be required for selenate reductase activity is perhaps through 
bringing subunits together. YnfG does not have a Tat signal sequence and so must be 
transported to the periplasm via Sec or act in a ‘hitch-hiking’ fashion and be transported 
through Tat with YnfE. Therefore it could be hypothesised that whilst interacting with YnfE, 
DmsD also forms an interaction with YnfG in order to bring it into close contact with YnfE and 
aid this so-called ‘hitch-hiking’ across the cytoplasmic membrane. However, bacterial two-
hybrid work showed that DmsD was not able to interact with YnfG (Figure 3.7). Of course, 
negative results from bacterial two-hybrid analysis can also occur through production of an 
unstable protein. Therefore it may be tentatively concluded that DmsD is not required for 
aiding formation of the complex that is selenate reductase through bringing its subunits 
together. 
A third option could be that DmsD is required for correct assembly of the molybdenum 
cofactor in YnfE. It is known that other Tat cytoplasmic chaperones are important for this 
process and play an active part in cofactor insertion. For example the chaperone TorD, a 
cytoplasmic chaperone highly similar in amino acid sequence to DmsD, has been shown to be 
able to interact with the mature region of TorA when in an unfolded state, thought to promote 
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cofactor insertion  (Pommier et al., 1998). TorD also demonstrates interactions with enzymes 
of molybdenum cofactor synthesis and the molybdenum cofactor itself (Genest et al., 2008). 
Bacterial two-hybrid analysis apparently revealed that full length or the mature region only of 
YnfE did not interact with DmsD (Figure 3.7), in agreement with previous studies (Winstone et 
al., 2013a). However, whilst DmsD may not be involved in active site interactions as TorD is 
with TorA, it could still be involved in cofactor biosynthesis. In addition to finding interactions 
of DmsD with general molecular chaperone proteins, Li et al. (2010) also observed interactions 
with protein components of the molybdopterin (MPT) biosynthetic pathway, for example 
MoeA, MoeB and MobB. This suggested that DmsD may take its substrates to a ‘metabolon 
complex’ where proteins required for molybdenum cofactor biosynthesis are localised. This is 
a possibility for the Trp-91 and Gly-100 residues and the surrounding region of DmsD, and the 
potential role of DmsD in molybdenum cofactor assembly through recruitment of 
molybdopterin biosynthetic proteins would be an interesting route of inquiry. In summary, 
DmsD may have important additional roles in Tat substrate maturation yet to be revealed. 
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4 Understanding the biosynthesis of E. coli 
TorA and its relationship with the Tat 
pathway 
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 Introduction 4.1
One of the first cytoplasmic chaperone proteins to be reportedly involved in Tat proofreading 
was TorD from E. coli. This is a 22.5 kDa protein encoded by the torCAD operon that also 
encodes for the molybdoenzyme trimethylamine N oxide reductase (TorA) and the membrane 
bound pentahaem cytochrome TorC (Figure 4.1). Periplasmic TorA is the catalytic subunit of 
the enzyme possessing a Mo-bis-MGD cofactor, and receives electrons from TorC to reduce 
TMAO to TMA.  
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Figure 4.1 Organisation of TMAO reductase in E. coli. 
A – TMAO reductase components TorA and TorC are encoded in an operon alongside the torD gene coding for the 
cognate chaperone protein of TorA. Expression of the torCAD operon is under the control of the torSTR and torI 
genes and is positively regulated by TMAO. The torSTR genes are proximal to the torCAD operon whilst torI is 
encoded elsewhere on the chromosome. Chromosomal locations as base numbers are indicated. B – Arrangement 
of TMAO reductase subunits at the cytoplasmic membrane. Membrane-bound TorC contains five haems and acts as 
the site for menaquinol (MQH2) oxidation, whilst periplasmic protein TorA transiently interacts with TorC and 
catalyses the reduction of TMAO to TMA. Crystal structures of TorA (1TMO) (Czjzek et al., 1998) and TorD (PDB 
1N1C) (Tranier et al., 2003) from Shewanella massilia are shown, which share high sequence identity with the E. coli 
equivalents.  
 
The 3D crystal structure of homodimeric TorD from Shewanella massilia was determined a 
number of years ago and follows the typically all-helical architecture as seen throughout the 
TorD cytoplasmic chaperone family. Interestingly, when in dimeric form TorD exhibits a unique 
structural feature of extreme domain swapping between subunits, where the N-domain of one 
subunit interacts with the C-domain of the other (Tranier et al., 2003). This fold has not been 
observed in any other solved TorD-like chaperone structures to date and this level of domain 
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swapping, which is often restricted to a single helix or strand between proteins, is considered 
very unusual. 
Early investigations demonstrated that cells devoid of TorD were affected in the stability and 
activity of TorA, with TMAO reduction decreasing two fold in a torD- strain, hinting at the 
importance of TorD for TMAO reductase activity (Pommier et al., 1998). E. coli TorD shares 24 
% overall sequence identity with E. coli DmsD, and is thought to prevent premature export as 
well as stabilizing the apoprotein and facilitating cofactor insertion (Genest et al., 2009, 
Sargent, 2007a).  
Recent work showed binding of TorD to TorA appears to occur with a 1:1 stoichiometry (Dow 
et al., 2013). Moreover, Dow et al. (2013) demonstrated that that even a signal-less TorA could 
bind tightly to the TorD protein. Indeed, the low-resolution small angle X-ray scattering (SAXS) 
envelope generated from this signal-less complex appeared very similar in architecture to the 
SAXS envelope of the signal-containing complex (Dow et al., 2013). These data suggest a single 
TorD molecule binds to the TorA precursor at two different, but nearby, sites within the N-
terminus. It also suggests that there are two distinct binding sites for different TorA epitopes 
on the surface of TorD. The work of Dow et al. (2013) concluded with some evidence that 
corroborated long-held views on the role of TorD, which was that the chaperone could 
maintain TorA in a conformation conducive to cofactor loading where “Domain IV” at the 
extreme C-terminus of TorA was displaced. In follow-up, unpublished, experiments a complex 
of TorD with truncated TorA (lacking Domain IV) was isolated (J.M. Dow, T. Palmer & F. 
Sargent). SAXS analysis of this complex revealed that TorD was bound to truncated TorA 
exactly as before, thus corroborating the view that a single TorD molecule bind directly to the 
N-terminus of TorA (Figure 4.2A,B). 
 
145 
 
 
 
Figure 4.2: The TorAD binding interaction. 
A – Ab initio dummy atom models of full length (grey) and ΔC-terminus (blue) TorAD complexes generated from 
experimental SAXS data, superimposed for direct comparison. Both complexes appear to display similar structures, 
with the slightly shorter appearance of the truncated complex due to its lacking domain IV. B – Superimposition of 
ab initio and rigid body models of ΔC-terminus TorAD complex. Rigid body modelling was created using PDB 
structures 1TMO (Czjzek et al., 1998) and 3CWO (Ramasamy & Clemons Jr, 2009), with green representing TorD and 
cyan representing TorA domains I-III. NMR data in the absence (C) and presence (D) of TorA signal peptide. A 
number of chemical shifts can be seen in the presence of signal peptide, highlighted in red. Work in (A) and (B) was 
performed by Dr Jennifer Dow, whilst (C) and (D) was performed by Dr Julian Maillard.    
 
Additional unpublished work from this laboratory has attempted to understand the binding 
mechanism between TorD and the TorA signal peptide (J. Maillard, G. W. Vuister, & F. 
Sargent). NMR experiments were attempted where 15N-labelled TorD was incubated with 
unlabelled synthetic TorA signal peptide in the spectrometer (Figure 4.2C,D). The peptide–
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protein interaction was attempted to be followed through perturbation of the cross-peaks in 
the [1H-15N]–heteronuclear single quantum correlation (HSQC) spectrum (Figure 4.2C,D). 
However, upon addition of the peptide, a general broadening of some of the resonances was 
observed, which is consistent with a complex in “intermediate exchange” i.e. a complex with 
neither very tight nor very loose binding, and so not straightforward to study by NMR. 
Although quantitative measurements of binding affinities, or the determination of solution 
structures, cannot be made from this data, it can be concluded, however, that those peaks 
most readily affected are likely closely involved with the signal peptide binding site. Those 
include conserved residues such as His-125 and Asp-124, which were already implicated in 
TorD function (Jack et al. 2004), and a number of new candidates including Glu-23 and Gly-122  
(Figure 4.2C,D). 
 Aims 4.2
The aims of this Chapter were to elaborate on previous knowledge of the E. coli TorA-TorD and 
TorD-TorD binding interactions in an attempt to gain further information on the TorD binding 
surface and its physiological function and the interrelationship between Tat substrates and the 
Tat translocase. To assess the Tat proofreading activity of TorD, site-directed mutagenesis and 
biochemical assays were employed. To study TorD-TorD dimerization in live cells, high 
resolution microscopy techniques were attempted. Finally, a new approach employing super 
resolution microscopy was taken to explore the interplay between Tat components and Tat 
substrates. 
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 Results 4.3
4.3.1 Molecular dissection of TorD activity 
TorD is a 200 amino acid residue polypeptide that folds into an all-helical conformation 
dedicated to sequence-specific peptide binding. TorD binds a hydrophobic motif on the TorA 
twin-arginine signal peptide with high affinity (apparent Kd by ITC ~59 nM (Buchanan et al., 
2008). The location of the peptide binding site on E. coli TorD has not been described, and 
indeed the location of the peptide binding site of other TorD-like proteins remains a point of 
contention. For example, the peptide binding pockets derived for E. coli DmsD by mutagenesis 
(Chan et al., 2008) and by NMR (Stevens et al., 2013) do not fully agree. Initial NMR work in 
the laboratory has identified a number of TorD residues implicated in peptide binding (Figure 
4.2C,D). At least two of these residues (Asp-124, His-125) had been previously investigated 
(Jack et al., 2004), and here the additional side chains identified in the NMR experiments were 
targeted. Those residues are Glu-23, Gly-112, Thr-115, and Glu-142. The glycine and threonine 
at positions 112 and 115, respectively, are of particular interest because they lie at the N-
terminus of the unstructured ‘loop’ region implicated in domain swapping (Tranier et al., 
2003). These residues, together with the conserved Pro-122 residue within the loop that would 
not be visible by 15N-NMR and lies between Thr-115 and Asp-124/His-125 at the C-terminus of 
the loop, were chosen for mutagenesis. 
The vector pUNI-PROM_TorD was chosen for these studies at it produces E. coli TorD 
constitutively and has been used previously in Tat proofreading assays (Jack et al., 2004). Site-
directed mutagenesis was performed in order to substitute the amino acids in question with 
alanine (Figure 4.3A). Alanine is often used in this way due to the extremely low biochemical 
reactivity of its side chain without loss of secondary structure. Six side-chains were targeted, 
including Glu-23, Gln-31 (previously studied by Hatzixanthis et al. (2005)), Gly-112, Thr-115, 
Pro-122, and Glu-142. In addition, a Gly-112-Ala / Pro-122-Ala double mutant was prepared 
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based on the hypothesis that these side chains may confer some flexibility to the hinge region. 
Once mutagenesis was confirmed by DNA sequencing, the TorD proteins being produced were 
checked for stability through Western blotting. E. coli strain MC4100 was transformed with 
pUNI-PROM_TorD plus its derivatives encoding the variant proteins. Strains were grown 
anaerobically in LB medium (without TMAO to prevent transcription of the native torCAD 
operon) before whole cell samples were taken for Western blotting after separation by SDS-
PAGE. It was observed that all TorD variants appeared to be produced at levels similar to that 
of the native protein (Figure 4.3B), and so it could be concluded that introducing these point 
substitutions does not affect protein expression or stability.  
 
 
Figure 4.3: Production of TorD variants. 
A – Primary amino acid sequence of TorD from E. coli. Amino acids targeted for substitution are shown in red. 
Secondary structure predictions are indicated by blue cylinders for α-helices and red cylinders for 310 (η)-helices 
(Tranier et al., 2003). B – Western blot analysis of pUNI-PROM_TorD variant stability. Plasmids were expressed in E. 
coli strain MC4100, with whole cell samples being separated by SDS-PAGE (12 % acrylamide gels) prior to 
visualisation by Western blot. Primary antibody – in-house anti-TorD rabbit serum, 1:20,000. Secondary antibody – 
anti-rabbit, 1:10,000. 
 
149 
 
 Assembly of TMAO reductase by TorD 4.3.1.1
It was clear that TorD variants were synthesised and likely stable (Figure 4.3B). Next, the 
effects of amino acid substitutions on activity of TMAO reductase were tested. This assay is 
designed to show whether the TorD variants can still participate in cofactor loading and 
maturation of TorA. In this assay the oxidation of reduced benzyl viologen is coupled to the 
reduction of TMAO, allowing the amount of TMAO reduced in µmol per minute per mg of 
protein to be determined. The redox-dye benzyl viologen (BV) can be oxidised by TMAO 
reductase and acts as an indicator of enzymatic activity as it turns from blue/purple to 
colourless as it is oxidised. Using periplasmic samples from FTD100 (∆torD) cells producing the 
seven TorD variants, the TMAO reductase activity was calculated (Figure 4.4). Interestingly, in 
contrast to many published reports, in this case the ∆torD strain transformed with empty 
vector exhibited only 10% of the activity of a strain harbouring pUNI-PROM_TorD (Figure 4.4). 
TMAO reductase activity in the periplasm of cells producing TorD variants Q31A, G112A and 
T115A was similar to the cells with native TorD (Figure 4.4), thus the mutant phenotype was 
clearly complemented in trans by these plasmids. However, TorD E142A appeared to have a 
defect in TorA assembly since a two-fold decrease in activity levels compared to native TorD 
was observed (Figure 4.4). Moreover, TorD P122A had near 30 % native levels and the double 
variant TorD G112A/P122A had approximately 14 % of the activity observed in the native 
control. These results indicate that Pro-122 and Glu-142 are important for the ability of TorD 
to direct the maturation of TMAO reductase. 
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Figure 4.4: TMAO reductase activity directed by TorD variants. 
E. coli strain FTD100 (ΔtorD) containing the pUNI-PROM_TorD and variants was grown in anaerobic overnight 
cultures in LB supplemented with 0.5 % glycerol and 0.4 % TMAO, prior to isolation of the periplasmic fraction from 
cells. Using the redox-dye BV as an electron donor, TMAO reductase activity (µm/min/mg) could be determined 
through measurement of the colourimetric change at A600 as BV is oxidised. Results are displayed as a percentage of 
native TorD sample activity. Data expressed as means (n = 3) ± SEM. 
 
 Tat proofreading by TorD. 4.3.1.2
The TMAO reductase assay relies on the coordination of a number of biosynthetic processes 
including Tat proofreading (signal peptide binding), cofactor insertion, protein folding, and 
protein transport. In order to specifically assess the Tat proofreading abilities of these TorD 
variants, a proofreading assay was utilised that was previously developed by (Jack et al., 2004). 
In this system, the TorA signal peptide is fused to the N-terminus of HybO, the small subunit of 
hydrogenase-2, replacing its own native Tat signal peptide. This results in a strain that has low 
levels of hydrogenase-2 activity, which can be subsequently boosted by the expression of 
excess torD. Because hydrogenase-2 does not contain a molybdenum cofactor, this then leaves 
hydrogenase activity dependent upon the Tat proofreading activity of TorD. For this work, E. 
coli strain RJ607-D was used, encoding the described ɸtorA::hybO chimera as well as 
containing a torD gene deletion (Jack et al., 2004). Hydrogenase activity can be measured in a 
similar way to TMAO reductase activity, although in this case BV acts as an artificial electron 
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acceptor and becomes reduced during the assay. Again through spectrometric measurement 
of the rate of colour change the activity of the TorA::HybO chimera can be determined. 
 
 
Figure 4.5: Tat proofreading ability of TorD variants. 
pUNI-PROM_TorD variants were expressed in E. coli RJ607-D, a strain containing a deletion in torD and a TorA signal 
peptide fusion to the hybO gene at the native hyb locus on the chromosome generating a ɸtorA::hybO chimera. 
Therefore TorD proofreading of this chimeric protein is essential for production of functional hydrogenase-2. 
Enzymatic activity (µm/min/mg) of whole cell samples grown anaerobically in LB supplemented with 0.5 % [v/v] 
glycerol and 0.4 % [w/v] TMAO was determined through measuring the rate of reduction of BV over time, observed 
as a colour change measurable at A600. Results are displayed as a percentage of native TorD sample activity. Data 
expressed as means (n = 3) ± SEM. 
 
E. coli strain RJ607-D was transformed with pUNI-PROM_TorD and derivatives encoding TorD 
variants, before overnight cultures were grown anaerobically in the presence of 0.5 % [v/v] 
glycerol and 0.4 % [w/v] TMAO. Whole cell samples were taken for use in the activity assay. It 
could be observed that RJ607-D encoding the empty vector pUNI-PROM had relatively low 
levels of hydrogenase activity, whilst upon introduction of native TorD hydrogenase activity 
could be restored (Figure 4.5). This demonstrates that pUNI-PROM_TorD can rescue 
hydrogenase-2 activity in this strain. TorD variants were able to complement the strain to 
varying degrees. TorD E23A, G112A and E142A all demonstrated near or above 100 % Tat 
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proofreading activity, whilst TorD G112A/P122A showed only slightly decreased levels at 
approximately 85 % native levels. TorD Q31A and T115A displayed activity levels of 66 % and 
70 % respectively, whilst the largest decrease in activity could be seen in TorD P122A with 53 % 
native TorD levels. These data suggest that Pro-122 plays an important role in Tat proofreading 
and TorA assembly overall. 
 
4.3.2 Imaging TorD-TorD interactions in live cells 
Having studied the relationship between TorD and the TorA signal peptide, attention then 
turned to the relationship between TorD and itself. A number of biochemical and structural 
studies have suggested that TorD-family proteins can dimerize, or further oligomerize, 
sometimes with consequences for biological activity (Guymer et al., 2010, Sarfo et al., 2004, 
Tranier et al., 2002). Here, the aim was to address whether dimerization occurred in living 
cells. The TorD protein was tagged with fluorescent proteins (and FRET pair) mCerulean or 
yellow fluorescent protein (YFP) on the N- and C-termini in varying combinations on the same 
plasmid backbone of pUNI-PROM (Figure 4.6). It was hoped that these fusion proteins would 
enable live cell imaging in E. coli cells in order to gain an idea of TorD interactions and possibly 
movement and subcellular location within the cell during the Tat translocation cycle. These 
plasmids were named pFLUOR_mCerN-TorD_YFPN-TorD, pFLUOR_mCerN-TorD_TorD-YFPC, 
pFLUOR_TorD-mCerC_ TorD-YFPC and pFLUOR_TorD-mCerC _YFPN-TorD, but will be referred 
to as pFLUOR _CC, _NC, _CC and _CN, respectively, for ease. 
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Figure 4.6: Diagram of fluorescent TorD fusions. 
Fusions of the fluorescent proteins mCer and YFP to either the N- of C-termini of TorD in various arrangements were 
encoded on the same plasmid. Fluorescent proteins were either fused to both N-termini (NN) or C-termini (CC) of 
the two TorD molecules, or one to the N- and one to the C-terminus (NC and CN). These plasmids were designed 
and produced in collaboration with Dr Sarah J. Coulthurst, a former post-doctoral researcher in the Sargent group. 
 
Before cell imaging was carried out, it was necessary to test the activity of the TorD fusion 
proteins to identify any negative effects attachment to YFP and mCer may have, as it is 
possible such a fusion may cause mislocalisation or inactivation of the chaperone. In order to 
test the ability of these TorD-fluorophore fusions to function in TorA assembly, the activity of 
TMAO reductase was assayed. Parental strain MC4100 and its derivative FTD100 (ΔtorD) 
containing the plasmids pUNI-PROM or pFLUOR_CN were grown overnight in anaerobic 
conditions supplemented with TMAO, before the periplasm of these cells was harvested for 
use in TMAO reductase assays. The amount of TMAO reduced in µmol per minute per mg of 
protein was determined through spectrometric measurement of the rate of colour change of 
the sample. Activity levels of each sample was determined and converted to percentages of 
the MC4100 periplasmic activity recorded. 
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Figure 4.7: TMAO reductase activity in the presence of fluorescently-tagged TorD. 
E. coli strains MC4100 and FTD100 (ΔtorD) expressing vectors pUNI-PROM or pFLUOR-CerC-torD_YFPN-torD were 
grown in anaerobic overnight cultures in LB supplemented with 0.5 % glycerol and 0.4 % TMAO, prior to isolation of 
the periplasmic fraction from cells. Using the redox-dye benzyl viologen as an electron donor, TMAO reductase 
activity (µm/min/mg) could be determined through measurement of the colourimetric change at Ab600. Results are 
displayed as a percentage of native TMAO reductase activity. Data expressed as means (n = 3) ± SEM. 
 
From this assay, it was determined that the TMAO reductase activity for MC4100 not 
containing any plasmids was 1.48 µmol/min/mg, and this was used as the native TMAO 
reductase level to compare other samples to (Figure 4.7). MC4100 containing the empty 
plasmid pUNI-PROM had unusually increased levels of TMAO reductase levels compared to 
MC4100 alone, approximately 230 % native levels. MC4100 pFLUOR-CN had similar levels to 
MC4100 pUNI-PROM, of just under 200 % native levels. The E. coli strain FTD100 (ΔtorD) with 
no plasmids as well and both empty pUNI-PROM and pFLUOR_CN were also tested. Consistent 
with the data presented above (Figure 4.4) FTD100 had very little TMAO reductase activity, 
only 12 % that of MC4100. FTD100 containing pUNI-PROM was of a similar low level, also 
approximately 12 % that recorded for MC4100. In contrast, when pFLUOR_CN was expressed 
in FTD100 the plasmid was able to largely rescue the mutant phenotype, increasing TMAO 
reductase levels to approximately 80 % native levels. This indicated that at least one of the 
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TorD-fluorophore fusion proteins expressed from pFLUOR_CN was able to perform its TorA 
maturation function.  
The localisation of TorD-fluorophore fusions was also investigated through the use of cell 
fractionation and Western immunoblotting. FTD100 (∆torD) containing the plasmid 
pFLUOR_CC was grown overnight before being fractionated into cytoplasmic, periplasmic and 
membrane fractions. These fractions plus a whole cell sample for comparison were analysed 
through the use of SDS-PAGE and Western immunoblot, in order to identify the cellular 
localisation of fluorescently tagged TorD. In this case, TorD could be observed below the 50 
kDa marker, due to the presence of YFP or mCer fused to TorD making the overall protein size 
much larger than the 25 kDa TorD protein alone. The results of this Western analysis indicate 
the presence of TorD in whole cell, cytoplasm and membrane fractions, whilst the periplasm 
does not appear to contain any TorD (Figure 4.8). This demonstrates that the TorD-fluorophore 
fusion proteins tested are localising to the same areas of the cell as have been suggested for 
native TorD.  
 
 
Figure 4.8: Cellular localisation of TorD-mCer and TorD-YFP fusions  
FTD100 (∆torD) cells expressing pFLUOR_CC were fractionated into cytoplasmic, membrane and periplasmic 
portions. Along with a whole cell sample (WC), these samples were separated by SDS-PAGE (12 % acrylamide) and 
visualised by Western blot. Anti-TorD serum was used at 1:20,000 with secondary antibody anti-rabbit at 1:10,000. 
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 Confocal microscopy of mCer-TorD and YFP-TorD 4.3.2.1
In order to investigate localisation of TorD within the cell using a live cell imaging approach, E. 
coli MC4100 was transformed with pFLUOR plasmids encoding N- and C-terminal TorD fusions 
to both mCerulean and YFP. Cell samples from liquid culture were taken at exponential phase 
and imaged using a Leica SP5 SMD (Single molecule detection) confocal laser scanning 
microscope. Merged images of MC4100 containing pUNI-mCerN-TorD_YFPN-TorD (‘CC’) 
appear to show mCer and YFP fluorescence coinciding (Figure 4.9A). The two-dimensional 
histogram for this strain appeared to roughly follow the line of best fit in a linear fashion, 
indicating co-localisation of the two fluorophores. However, a small outlying region suggests 
there were some cells not demonstrating co-localisation. The average Pearson’s correlation 
coefficient for this plasmid was 0.838 (Figure 4.9B). For MC4100 pUNI-mCerN-TorD_YFPC-TorD 
(‘CN’) strong evidence for co-localisation was obtained (Figure 4.9A). The average Pearson’s 
correlation coefficient for this sample was 0.898 (Figure 4.9B). The MC4100 pUNI-mCerC-
TorD_YFPC-TorD (‘NN’) histogram displayed a fairly linear correlation (Figure 4.9A). The 
average Pearson’s coefficient was 0.869 (Figure 4.9B). For cells with pUNI-mCerC-TorD_YFPN-
TorD (‘MC’) the histogram indicated a high level of linearity but with one large outlying branch 
(Figure 4.9A). The average Pearson’s correlation coefficient was 0.857 (Figure 4.9B). 
Unfortunately, whilst it was possible to obtain these images we struggled with photobleaching 
effects that manifest particularly with confocal microscopy, and so it was not possible to follow 
up these results with further live cell imaging or fluorescence lifetime correlation spectroscopy 
experiments as we had hoped.  
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Figure 4.9: Co-localisation of mCer-TorD and YFP-TorD fusions within E. coli. 
A – MC4100 cells expressing plasmids pFLUOR_NN, CC, CN and NC respectively were grown to an OD600 0.3 before 
being immobilised onto coverslips using CellTak. Shown are mCerulean (false-coloured green) and YFP (false-
coloured red) channels, plus a merge of the two images. Yellow colour indicates co-localisation. Two-dimensional 
histograms of the images where locations of mCer and YFP fluorescence were plotted against each other were 
created using ImageJ software. Cells were imaged using a Leica SP5 SMD (Single molecule detection) confocal laser 
scanning microscope. B – Pearson’s correlation coefficients for TorD fusion proteins, indicating the level of co-
localisation between mCer-tagged and YFP-tagged TorD proteins. 
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4.3.3 Super-resolution imaging of the E. coli cell 
In recent years, a wide range of new microscopy techniques have been developed in an 
attempt to improve on the limitations of conventional optical microscopes. Collectively these 
techniques can be referred to as super-resolution microscopy. One such technique is termed 
three dimensional structured illumination microscopy, or 3D-SIM.  3D-SIM illuminates the 
sample with a known light pattern generated through the use of interfering multiple beams of 
light, in comparison to the single beam of light used in conventional microscopy. When this 
illumination pattern interferes with the sample of unknown structure it generates interference 
patterns known as Moiré patterns. By imaging numerous cross-sections of the sample and 
then processing and reconstructing the data, images with an axial resolution twice that of 
conventional microscopy can be obtained (Gustafsson, 2000). 
 
 Super-resolution imaging of chromosomally tagged TatA-YFP. 4.3.3.1
Through the award of a Euro-BioImaging Proof-of-Concept Studies grant we were able to use 
the OMX microscope located in the College of Life Sciences Microscopy Facility. With this we 
obtained high resolution images of the Tat translocase using E. coli strain JARV16 att tatA::YFP, 
where the TatA protein is tagged on the C-terminus with yellow fluorescent protein (YFP) and 
expressed at single copy from the attB locus. Cells were grown to an OD600 of 0.3 before being 
immobilised on coverslips using poly-L-lysine. The samples were then fixed with ice cold 
methanol and permeabilised with lysozyme. As it was discovered that YFP fluorescence was 
relatively weak, the cells were then incubated with GFP-booster (Chromotek), a GFP binding 
protein with a fluorescent dye attached that is excited into fluorescence at the same 
wavelength as GFP and YFP. This helps to enhance the fluorescent signal from YFP to enable 
imaging with the OMX. The coverslips were mounted onto slides using ProLong Gold antifade 
reagent (Life Technologies), designed to help prevent photobleaching during imaging as this 
was also a problem in the first instance.  
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Image stacks were taken using both conventional wide-field imaging (Figure 4.10A) and the 3D 
structured illumination imaging available on the OMX (Figure 4.10B) in order to demonstrate 
the increased resolution achievable. Images of these slides have revealed 2-3 bright spots in 
each cell indicating the Tat translocase pore was able to be observed. 3D-SIM images showed 
much clearer and more well-defined foci than those obtained using wide-field microscopy. 
 
 
Figure 4.10: Fluorescence imaging of TatA in E. coli. 
Imaging of JARV16 att tatA::YFP cells, where TatA is C-terminally tagged with YFP on the chromosome. A – Two cells 
as imaged by conventional wide-field microscopy, and B – the same field of view imaged using 3D-SIM microscopy. 
Cell culture was grown to OD600 0.3 before being immobilised on coverslips and fixed and permeablized using 
methanol and lysozyme respectively. Cells were then incubated with GFP-booster to enhance the fluorescent signal. 
Coverslips were mounted using ProLong Gold anti-fade reagent in an additional attempt to preserve fluorescence. 
Image stacks were taken of a thickness of approximately 125 nm through the sample, using an OMX microscope. 
 
 Effects of substrate overexpression on visible TatA-YFP spots 4.3.3.2
As TatA foci could be observed in E. coli cells using an OMX microscope, it was decided to 
image cells where Tat substrates were being overexpressed. It was hoped that a difference in 
the size of foci may be observed between cells with wild-type levels of Tat substrates and 
those where a protein substrate is being overproduced. The Tat substrates selected were HiPIP 
– high potential iron-sulphur protein, SufI – involved in cell division, and TorA – the catalytic 
subunit of TMAO reductase. These were overexpressed in JARV16 att tatA::YFP under high-
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IPTG conditions using the pQE80L vector. Cells were then fixed and imaged as previously 
described using 3D-SIM. 
 
 
Figure 4.11: The effects of Tat substrate overexpression on TatA-YFP foci. 
Images of JARV16 att tatA::YFP cells containing plasmids A – pQE80L; B – pQE80L-HiPIP; C – pQE80L-SufI; D – 
pQE80L-TorA. Cell cultures were grown to OD0.6 prior to induction of protein overexpression by the addition of IPTG. 
After growth in the presence of IPTG for approximately 180 minutes, cells were washed in sterile water and diluted 
to OD600 0.3 before being immobilised on coverslips and fixed and permeablilsed using methanol and lysozyme 
respectively. Cells were then incubated with GFP-booster to enhance the fluorescent signal. Coverslips were 
mounted using ProLong Gold antifade reagent in an additional attempt to preserve fluorescence. Image stacks were 
taken of a thickness of approximately 125 nm through the sample, using 3D-SIM with an OMX microscope. 
 
It was observed that upon the induction of high levels of Tat substrates, there may be a slight 
increase in the number of TatA foci per cell. In the images shown, cells with both increased 
HiPIP and TorA levels had six or seven TatA foci (Figure 4.11B & D), compared to the two or 
three seen in cells only expressing empty pQE80L vector (Figure 4.11A). However, in order to 
say for sure a more accurate way of analysing such data needs to be developed. In addition, 
MG1655 cells expressing the empty vector pQE80L were smaller in appearance to those grown 
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without, and so there may be detrimental effects due to growth in the presence of IPTG. 
MG1655 cells overexpressing SufI protein were abnormal in their appearance, displaying a 
single TatA spot of larger size than in all other samples.  
 
 Imaging TatA using fluorescent antibodies 4.3.3.3
It is known that the E. coli strain used in all previous work described to image TatA, JARV16 att 
tatA::YFP, has very low levels of Tat transport compared to wild-type cells where TatA is not 
fused to YFP (Leake et al., 2008). Therefore, any results obtained may not be applicable to 
wild-type E. coli. Because of this, we attempted to image TatA in wild-type MG1655 using 
fluorescent antibodies. MG1655 cells were treated similarly to JARV16 att tatA::YFP cells in 
previous experiments, where immobilised cells on coverslips were fixed using methanol before 
being permeabilised with lysozyme. They were then treated first by rabbit antiserum raised 
against TatA, before secondary incubation with the fluorescently labelled antibody DyLight 594 
goat anti-rabbit (Abcam). This antibody generates red fluorescence and should highlight TatA 
in cells by binding to any anti-TatA antibody left on the sample after washing. Image stacks 
were then taken using 3D-SIM (Figure 4.12). Although TatA foci were not as clearly visible as in 
JARV16 att tatA::YFP cells, a number of brighter foci could be observed. Fluorescence from the 
rest of the cell also appeared brighter in these samples. From this experiment it could be 
concluded that TatA is visible but perhaps to a lower extent than when TatA is chromosomally 
tagged with YFP.  
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Figure 4.12: Imaging TatA using fluorescent antibodies. 
MG1655 cells were grown to OD600 0.3 and immobilised on cover slips prior to methanol fixation and 
permeabilization by lysozyme. They were then incubated first by anti-TatA and secondly by DyLight 594 goat anti-
rabbit to fluorescently highlight any TatA bound by primary antibody. Coverslips were mounted using ProLong Gold 
antifade reagent in an additional attempt to preserve fluorescence. Image stacks were taken of a thickness of 
approximately 125 nm through the sample, using 3D-SIM with an OMX microscope.  
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 Discussion 4.4
4.4.1 TorD Pro-122 is important for TorD function 
From the results of the TMAO reductase activity assay with TorD variants, it was clear that a 
number of the amino acids tested were more important in TMAO reductase assembly than 
others. Whilst TorD E23A, Q31A, G112A and T115A did not show any significant decrease in 
TMAO reductase activities, P122A, E142A and double variant G112A/P122A all displayed 
activity levels of less than half that of that produced by native TorD (Figure 4.4). From this 
data, Proline 122 is the key novel finding as an important side-chain required for TorD activity.  
Proline is an interesting amino acid (or more correctly imino acid), with its unique side chain 
forming a five point nitrogen-containing ring. Being relatively non-reactive due to this unusual 
side chain structure, it is less common to find this amino acid in protein binding domains. 
However, it is often important in creating tight turns or kinks in protein structure. Therefore, it 
may be that TorD Pro-122 is required for the correct conformation of the TorD ‘hinge’ in order 
to enable binding to TorA. In the crystal structure of TorD from S. massilia (1N1C) the 
equivalent proline residue is on the edge of the hinge region in the TorD dimer, and it could be 
suggested that this proline is in fact important for the termination of the alpha-helix in order 
to enable formation of the hinge region. By substituting this amino acid for an alanine, it is 
clear that TorD no longer recognises TorA correctly, perhaps as the hinge region is not properly 
defined. Alternatively, whilst not being involved in a large amount of protein interactions, 
proline is known to be able to act as a hydrogen bond acceptor and so it is conceivable that it 
may be involved directly in TorA binding and this is the reason behind the decreased TMAO 
reductase activity levels in this TorD variant.  
The proofreading assay using the Tat substrate HybO with the native signal peptide replaced 
for that of TorA enables separation of TorD interactions with the signal peptide from 
interactions with the mature region of the TorA protein, in order to only investigate the 
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proofreading aspect of TorAD interactions. When the TMAO reductase activity assay is 
compared to the results of the TorD proofreading assay, a number of differences can be seen. 
Interestingly, although Glu-142 appears to be extremely important for the production of active 
TMAO reductase (Figure 4.4), an alanine substitution does not seem to affect interactions with 
the signal peptide of TorA to any great extent, with E142A maintaining hydrogenase levels of 
nearly 100 % wild-type TorD levels (Figure 4.5). From this it can be construed that Glu-142 is 
possibly involved in TorD interactions with the mature region of TorA rather than the signal 
peptide. In comparison the residue Pro-122, as well as being implicated in the TMAO reductase 
assay, is also highlighted here as having a hydrogenase activity level half that of the parental 
strain when substituted for an alanine in the Tat proofreading assay. This suggests that this 
amino acid is important for binding to the signal peptide of TorA. Such a role would concur 
with results of published work investigating the binding region of the related E. coli DmsD 
protein, that highlighted not only the Pro-122 equivalent in DmsD, residue Pro-124, but also 
additional residues nearby such as Glu-123, Asp-126 and His-127, were important for signal 
recognition (Chan et al., 2008, Stevens et al., 2013). This certainly emphasizes the importance 
of this region of TorD-like chaperones in signal peptide binding. In addition to Pro-122, Gln-31 
and Thr-115 have a lower Tat proofreading activity when substituted and so may be involved 
in signal peptide interactions too.  
In conclusion, taken together with recently published observations of TorD and related 
proteins, this work provides further evidence of the two distinct functions of these types of 
chaperones. It is clear that signal peptide binding activity can be separated from a second 
binding event, in addition to unusual GTPase and cofactor-binding functions.  
 
4.4.2 Imaging TorD and TatA in cells  
It was shown through TMAO reductase activity assays that TorD tagged with both mCer or YFP 
were still able to function in proofreading and enable the production of mature TorA (Figure 
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4.7). Whilst problems with photobleaching prevented a large amount of work to be performed 
through the use of live cell confocal imaging of TorD fusions to mCer and YFP, it was possible 
to acquire images indicating the localisation of TorD within the cell (Figure 4.9). From these 
images it could be observed that plasmid-encoded TorD was uniformly present throughout the 
cytoplasm of the cells, with images of both mCer and YFP-tagged TorD clearly showing the 
typical rod shape of E. coli cells. In addition, when images of cells using both fluorescent 
channels were super-imposed onto one another, it was shown, unsurprisingly, that the 
fluorescent regions with TorD-mCer and TorD-YFP were co-localised. Through statistical 
analysis using Pearson’s correlation coefficients, it was shown that for all four TorD-fusion 
arrangements, the Pearson’s correlation coefficients were all between 0.8 and 0.9. Pearson’s 
correlation coefficients give an indication of the linear relationship between two sets of data, 
in this case TorD-mCer and TorD-YFP localisation within the cell. Values such as those found 
here indicate a high level of correlation, a suggestion that corresponds with the 2D histograms 
showing a high level of conformity along the lines of best fit. This result is unsurprising, as TorD 
is a soluble cytoplasmic protein that is most likely present diffused across the cell rather than 
localised at any particular point. At the outset, it had been hoped that TorD fusions could be 
produced from single copy at the native tor locus. However, in the course of this work it 
became clear that the fluorescence produced was not bright enough or stable enough for 
extensive study, even from the multi-copy plasmid-based constructs. Ideally, fluorescence 
lifetime correlation spectroscopy could have been employed to understand the TorD-TorD 
interaction during the translocation cycle (i.e. in the presence of induced substrate, for 
example).  Unfortunately, it was extremely difficult to get past the problem of photobleaching 
in this work.  
One unexpected result was obtained through examination of cellular localisation of 
fluorescently tagged TorD using Western analysis (Figure 4.8). TorD is a cytoplasmic protein, 
not normally associated with the inner membrane. It may be that this unusual observation was 
due to an effect of the fusion of TorD to YFP and mCer. This would explain the decreased 
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TMAO activity noted in cells relying upon these fusion TorD proteins for TMAO reductase 
maturation (Figure 4.7). However, any potential membrane association did not affect the 
entire fluorescent TorD population due to the presence of low level TMAO reductase activity, 
plus fluorescence microscopy indicated the presence of these proteins in the cytoplasm of 
cells. 
In addition to imaging of the TorD chaperone, we also attempted to image the TatA protein, 
the subunit understood to form the pore of the Tat translocase. Using OMX 3D SIM we were 
able to demonstrate the power of the OMX microscope, with images taken using 3D SIM 
showing much higher resolution than conventional confocal imaging allows (Figure 4.10). This 
also demonstrated that it was possible to image chromosomally expressed TatA-YFP in the cell, 
with TatA appearing to form a small number of foci distributed around the surface of each cell. 
This high resolution imaging was then used to investigate the effects of Tat substrate 
overexpression on these TatA foci. It was observed that there was perhaps a slight increase in 
TatA foci in cells overexpressing HiPIP and TorA. This is in agreement with data from other 
studies where it has been shown that the overexpression of Tat substrates can cause an 
increase in the number of TatA foci seen in the cell (Alcock et al., 2013, Rose et al., 2013). 
Unexpectedly, upon induction of SufI overexpression TatA formed one individual spot in the 
cell that was much larger than the foci seen in other cell samples. It may be that by 
overexpressing SufI, the Tat translocase becomes saturated and causes the TatA protein to 
accumulate together in such a way.  
A published study using live cell imaging of E. coli TatA-YFP strains was able to show TatA foci 
forming  in a transport-active cell background (Alcock et al., 2013). These foci appeared to be 
independently mobile and able to transit between high numbers of assembled foci and 
dispersed halos with few foci, with this distribution being affected by substrate availability to 
induce TatA assembly, and the rate of substrate removal by translocation in order to cause 
TatA disassembly. The effects of substrate overexpression on TatA-YFP foci formation was also 
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investigated, with higher levels of Tat substrates clearly causing an increase in the numbers of 
TatA-YFP foci compared to TatA-YFP in the diffuse halos. These foci were dependent upon the 
substrate possessing a functional Tat signal peptide, as well as the cell containing the TatBC 
complex. The clear observations of higher TatA-YFP foci in this study differed from results 
obtained using E. coli strain JARV16 att tatA::yfp, with only slight increases in foci being 
apparent. Such differences could be due to the different imaging methods used between this 
study and Alcock et al. (2013). Whereas in this published work live cells were imaged, we 
imaged fixed cells for our study. This could mean that due to the constant turnover of TatA 
complexes during translocation, by using fixed cells only a snapshot of the process is acquired, 
and perhaps the highly increased foci number being observed required a certain period of 
time. 
Upon imaging of native TatA using fluorescent antibodies, individual TatA foci were observed 
similar to those seen in E. coli strain JARV16 att tatA::yfp, although the background 
fluorescence appeared to be greater than in cells with chromosomally tagged TatA. This 
demonstrated that the images obtained using a chromosomal TatA-YFP fusion did give an 
accurate representation of how TatA localises in wild-type E. coli cells. Clearly although 
transport through the Tat translocase is disrupted in JARV16 att tatA::yfp (Leake et al., 2008), 
this is likely not due to inhibition of the formation of the TatA pore and more probably a steric 
inhibition of Tat substrate binding or movement through the pore.  
Photobleaching was also a large problem in this study, particularly when imaging wild-type 
TatA using fluorescent antibodies, and this would require a better solution if this work were to 
be continued. In this work it was only possible to obtain images after cells had been fixed. This 
unfortunately meant that live imaging of the TatA protein during the cell cycle was not 
possible. It is possible that through the use of different more photostable fluorescent proteins 
or dyes this may allow for different techniques to be utilised such as a live cell imaging 
approach, which would be highly interesting as it may give an idea of the movement of TatA 
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within the cell throughout the Tat translocation cycle. This work represents a starting point for 
imaging of the Tat translocase using such high resolution microscopy. 
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5 Discovery of novel Tat-related phenotypes 
using phenotype microarrays 
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 Introduction 5.1
S. Typhimurium, a member of the Gamma branch of the Proteobacteria,  is closely related to E. 
coli and shares approximately 71 % of its genes (McClelland et al., 2001). The Tat system of S. 
Typhimurium is also thought to be similar to that of E. coli, with components TatA, TatB and 
TatC of S. Typhimurium shown to be able to form functionally active heterologous structures 
when expressed in E. coli (Oates et al., 2003). The genetics of the S. Typhimurium Tat system 
are also identical to that found in E. coli (Figure 5.1).  
 
 
Figure 5.1: Genetic organisation of the tat genes of S. Typhimurium LT2. 
The tat genes of S. Typhimurium are located in two clusters in the genome, encoding TatABCD (STM3973-6) and 
TatE (STEM0632). Genes of the Tat system are shown in green, whilst nearby genes are shown as white. 
 
The ability to adapt to differing environments is highly important for survival of bacterial 
species. Similar to E. coli, S. Typhimurium also has a highly flexible respiratory chain that is 
modular in design, enabling it to make use of many substrates for respiration. S. Typhimurium 
is able to utilise all the potential electron acceptors and donors that E. coli can use, and in 
addition is also able to use tetrathionate and thiosulphate as terminal electron acceptors 
(Clark & Barrett, 1987, Hensel et al., 1999). The central role of the Tat system in the 
biosynthesis of these types of enzymes (e.g. James et al., 2013), and the growing recognition 
that respiratory electron transport chains are central to the infection process (e.g. Winter et 
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al., 2010; Winter et al., 2013), has meant that the S. Typhimurium Tat system has come under 
the spotlight for infection studies. Indeed, during the course of this work it has been reported 
that S. Typhimurium tat mutants are impaired in their ability to both colonize and infect host 
organisms (Craig et al., 2013, Reynolds et al., 2011, Weatherspoon-Griffin et al., 2011).  
In terms of Tat proofreading research, the S. Typhimurium system has also been a happy 
hunting ground, with the reporting of the first crystal structure of DmsD (Qiu et al., 2008). 
However, the DmsD research field remains controversial in some areas, with some reports 
suggesting DmsD may interact directly with the Tat translocase (e.g. Papish et al., 2003; 
Kostecki et al., 2010) or with general housekeeping chaperones in the cell (e.g. Li et al., 2010). 
These works imply DmsD may have a more generalized role in Tat transport and protein 
folding than being a dedicated specific chaperone for DMSO and selenate reductases. 
 
 Aim 5.2
The aim of this Chapter was to characterise the broadest aerobic growth and aerobic 
respiratory phenotypes of a dmsD mutant strain of S. Typhimurium, alongside a number of 
other S. Typhimurium deletion strains, in order to better understand the general roles of these 
genes in the physiology of the bacterial cell.  
  
172 
 
 
 Results 5.3
5.3.1 Metabolic abilities of S. Typhimurium strains were investigated using high-
throughput phenotype microarray analysis. 
Through the use of genetic knockouts and specific assays, and a little insider knowledge, the 
specific functions of individual bacterial genes can often be determined. However, it can be of 
great advantage to perform an unbiased high-throughput screen in order to identify any 
unexpected effects of a specific gene deletion on phenotypes that could not have been 
predicted. In this case, three mutant strains of S. Typhimurium, namely DIG0610 (ΔSTM0610 – 
lacking a gene encoding a putative TorD-like chaperone protein for a predicted 
oxidoreductase); DIG100 (ΔtatABC); and DIG1495 (ΔdmsD), were investigated using such a 
high-throughput screen. The respiratory capability of these strains was compared using the 
Biolog Phenotype MicroArray technology. 
The Phenotype MicroArray system uses cell respiration with succinate as a universal reporter 
for cell viability, utilising the redox dye tetrazolium in order to demonstrate active respiration 
of the particular cell strains tested. Cells are incubated in 96 well plates, under aerobic 
conditions with shaking, where each well contains a defined cell media with a single carbon, 
nitrogen, phosphorus or sulphur source. If the cell phenotype is ‘positive’, cells are able to 
respire causing the dye to be reduced and initiating formation of a dark purple colour. If the 
phenotype is weakly positive or negative, respiration does not occur or occurs on a slower 
scale, leading to no or less colour formation. Incubation and monitoring of the phenotypic data 
is performed by the OmniLog system, enabling simultaneous monitoring of thousands of 
phenotypes over a particular time period to allow respiration activity to be observed. Through 
the use of this system, identification of any effects of gene deletions on a wide range of 
metabolic pathways can be visualised. 
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 Aerobic metabolism with carbon sources 5.3.1.1
The first Biolog plates to be examined were those containing sole carbon sources (Figure 5.2). 
These plates contained substrates such as glycerol, fumaric acid and dextrin, and totalled 190 
carbon sources. 
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Figure 5.2: Phenotype microarray data for carbon sources. 
Respiratory rates for strains grown over 24 hours in 96 well plates of defined minimal media, with each well 
containing a single carbon source. Duplicate respiratory curves of each strain are shown. Key: LT2a – blue. DIG0610 
(ΔSTM0610) – red. DIG100 (ΔtatABC) – green. DIG1495 (ΔdmsD) – yellow. Outlined in black is PM 1, well C10, 
containing maltose. Negative control wells were in position A01 of each plate, containing no carbon source. 
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Respiratory rates were recorded over 24 hours for the four strains tested, namely the parental 
strain LT2a, DIG0610 (ΔSTM0610), DIG100 (ΔtatABC) and DIG1495 (ΔdmsD), with any disparity 
between the wild-type LT2a and mutant strains being clearly observable in the consolidated 
data. Of these data (Figure 5.2), most wells appeared to show strains respiring similarly to 
parental control, with the majority showing either normal respiration of all strains or no 
respiration at all across all strains. Well number C10 of plate PM 1 (Figure 5.2) gave a more 
interesting result, however, where strain DIG100 (ΔtatABC – green trace in Figure 5.2) 
appeared to respire at a lower level than that of other mutant strains and the wild-type LT2a. 
This well contains maltose as the sole carbon source. 
 
 
Figure 5.3: The respiratory ability of S. Typhimurium strains in minimal media with maltose as the single carbon 
source. 
The respiratory curves of LT2a – blue, DIG0610 (ΔSTM0610) – red, DIG100 (ΔtatABC) – green, and DIG1495 (ΔdmsD) 
– yellow. Duplicate results for each strain are indicated by triangles and squares of the same colour. Open shapes 
indicate same strains in the negative control well of plate PM 1 (A01), whilst solid shapes refer to data of well C10. 
The metabolic activity as measured by respiration was recorded over 24 hour hours, in minimal media containing 
maltose as the sole carbon source. 
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The respiratory rates of well C10 containing maltose were analysed in isolation (Figure 5.3). It 
is clear that mutant strain DIG100, lacking a functional Tat system, is affected in its ability to 
respire in the presence of maltose. Respiratory activity appears to be much slower than wild-
type, with it appearing to stabilise at approximately half the level of LT2a. In comparison, 
respiratory rates of the DIG1495 and DIG0610 strains were unaffected under these particular 
conditions (Figure 5.3). 
 
 
Figure 5.4: Growth of a ΔtatABC mutant is defective in M9 media containing maltose. 
LT2a and DIG100 (ΔtatABC) were grown aerobically over 48 hours at 37 oC in M9 media supplemented with 0.5 % 
[w/v] maltose. Absorbance at OD600 was recorded at 20 minute intervals. Data expressed as means (n = 3) ± SEM. 
 
As the results of the Biolog phenotype microarray provide details in terms of respiration rate 
and metabolism, the growth rates of LT2a and DIG100 with maltose a sole carbon source were 
next examined (Figure 5.4). Cells were incubated for 48 hours in M9 media supplemented with 
0.5 % [w/v] maltose, with optical density OD600 being recorded every 20 minutes in order to 
obtain growth curves. It could be seen that the wild-type LT2a strain was able to grow faster 
than the tat mutant DIG100 across the entire 48 hour time period. DIG100 was unable to reach 
the same OD600 level as LT2a by the end of the 48 hours.  
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Figure 5.5: Location of maltose binding protein in S. Typhimurium strains. 
A – S. Typhimurium strains LT2a and DIG100 (ΔtatABC) were grown overnight in aerobic conditions with minimal 
M9 media supplemented with 0.5 % [w/v] maltose. Cells were fractionated into periplasmic (P), membrane (M) and 
cytoplasm (C) fractions, and these fractions plus a whole cell (WC) sample were separated by SDS-PAGE (12 % [w/v] 
acrylamide) before Western analysis. B – S. Typhimurium strains LT2a and DIG100 (ΔtatABC) were grown for 24 
hours in aerobic conditions with minimal M9 media supplemented with 0.5 % [w/v] maltose. Cells were pelleted 
and the supernatant was removed and filtered through a 0.2 µm filter. Cell (WC) and supernatant (SN) samples 
were then separated by SDS-PAGE (12 % [w/v] acrylamide) before Western analysis. Antibodies for both Westerns 
were: Primary – anti-maltose binding protein, 1:20,000. Secondary – anti-mouse, 1:10,000. 
 
Since a version of S. Typhimurium lacking a functional Tat system exhibits a growth and 
respiratory defect upon metabolism with maltose, it was then questioned as to how this defect 
could arise. Maltose uptake into the cell is governed by a very well-characterised transport 
system of the ‘ABC Superfamily’ (Bordignon et al., 2010). The maltose transporter consists of 
two transmembrane proteins (MalF and MalG) that together interact with a cytoplasmic ATP-
binding protein (MalK), and a periplasmic substrate binding protein (MalE or MBP). Once in the 
periplasm, exogenous maltose binds to the maltose binding protein (often termed MBP, which 
is the product of the malE gene) and this triggers the complete system to actively import 
maltose in an ATP-dependent manner. MalE is a Sec-dependent periplasmic protein and it was 
considered that this was the most likely component to have been affected in some way by the 
tat mutation. The subcellular localisation of MBP was tested and LT2a and DIG100 cells were 
fractionated into individual cell components of periplasm, total membranes and cytoplasm, 
and these alongside a whole cell sample were visualised by Western immunoblotting (Figure 
5.5A). Results for localisation of maltose-binding protein for both LT2a and DIG100 were the 
same, with it being found in whole cell, membrane and periplasmic fractions (Figure 5.5A).  
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It is known that tat mutants show defects in their cell envelope (Ize et al., 2003) and it was 
therefore subsequently considered a possibility that deletion of tatABC genes may result in a 
“leaky” periplasm. If MBP was being continually lost from the periplasm, perhaps this could 
explain the growth phenotype of a tat mutant on maltose. To test this, whole cell and filtered 
culture supernatant samples were subjected to Western analysis. Results showed MBP to be 
present only within the cells, with the supernatant showing no protein (Figure 5.5B). This 
implies the cells are still intact and the deletion of the Tat system does not affect MBP 
localisation. 
 
 Metabolism of other substrates 5.3.1.2
Four of the Biolog phenotype microarray plates are designed to screen for use of nitrogen 
sources, encompassing 380 substrates (Figure 5.6). The four S. Typhimurium strains under 
investigation were screened using these plates to identify any metabolic deficiencies.  Plate 
PM 3-B contained nitrogen sources such as ammonia, nitrate and nitrite, whilst plates PM 6, 7 
and 8 contained peptide nitrogen sources such as Ala-Ala, Ala-Arg and Leu-Ser. In these three 
plates there was an additional positive control well (A02) containing L-glutamine, a primary 
amine donor for key amino acid and nucleotide biosynthetic pathways (Figure 5.6).  
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Figure 5.6: Phenotypic microarray data for nitrogen sources. 
Respiratory rates for strains grown in defined minimal media with single specific nitrogen sources. Duplicate 
respiratory curves of each strain are shown. Key: LT2a – blue. DIG0610 (ΔSTM0610) – red. DIG100 (ΔtatABC) – 
green. DIG1495 (ΔdmsD) – yellow. Negative control wells were in position A01 of each plate, containing no nitrogen 
source. PM 6, 7 and 8 also had a positive control well (A02), containing L-glutamine. 
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Figure 5.6: Phenotypic microarray data for nitrogen sources (contd). 
 
Analysis of the phenotype microarray data for nitrogen sources demonstrated that all strains 
were able to respire as normal using most nitrogen sources (Figure 5.6). Very few differences 
were observed across the range of nitrogen substrates. On occasion the DIG100 strain 
181 
 
appeared to display a slightly slower metabolic activity compared to wild-type, for example in 
plate PM 3-B, well A10. This contains the amino acid L-aspartic acid. In addition, DIG100 and 
DIG1495 appear to demonstrate slightly decreased respiration levels compared to LT2a and 
DIG0610 in PM 3-B A12, with L-glutamic acid. Also on this plate, well G2 containing xanthosine 
demonstrated a lower level of respiration for the DIG100 strain. In PM 6 all strains displayed 
the same phenotype, and either all demonstrated metabolic activity or all did not respire at all. 
Respiration in PM 7 appeared normal for all except well B3, containing Lys-Thr, where DIG1495 
(∆dmsD) showed respiratory activity whilst all others did not (Figure 5.6). Lastly, PM 8 also only 
had one well where a difference between strains was seen (Figure 5.6). This was in well F7, 
containing the amino acid D-Ala-D-Ala (D-alanyl-D-alanine), in the presence of which DIG100 
(∆tat) was unable to respire. 
Biolog phenotype microarray plate 4-A contains 95 sources of phosphorus and sulphur (Figure 
5.7). In a number of these wells there appeared to be slight differences between strain 
respiration rates, however the duplicate samples shown did not always show the same 
patterns making it impossible to conclude on the actual effect from this data alone. One well 
with a clear difference in respiration rates was well D1, containing mannose-1-phosphate 
(Figure 5.7). Interestingly strains LT2a, DIG100 and DIG1495 were unable to respire in this 
condition, whilst DIG0610, containing a deletion of a gene encoding unknown protein 
STM0610 predicted to be a Tat chaperone, demonstrated strong respiration rates. 
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Figure 5.7: Phenotype microarray data for phosphorus and sulphur sources. 
Respiratory rates for strains grown in defined minimal media with single phosphorus or sulphur sources. Duplicate 
respiratory curves of each strain are shown. Key: LT2a – blue. DIG0610 (ΔSTM0610) – red. DIG100 (ΔtatABC) – 
green. DIG1495 (ΔdmsD) – yellow. Negative control wells were in position A01 of each plate, containing no 
phosphorus/sulphur source. 
 
Biolog also market a phenotype microarray plate containing a number of different nutrient 
supplements. Testing was also performed using this plate with the four S. Typhimurium strains 
(Figure 5.8). Interestingly with this plate, one of the supplements is L-glutamic acid (well A8), 
already highlighted in nitrogen source plate PM 3-B, well A12 (Figure 5.6). As with other plates, 
the ΔtatABC strain did show a slight decrease in respiration rates compared to the other 
strains in several wells.  
It was attempted to investigate a number of these substrates such as L-glutamic acid further 
through the production of growth curves, however the strains tested did not appear to grow at 
all and there was no obvious increase in OD600 even over a 48 hour period. It is clear that, in 
these assays, active respiratory activity is not always linked to growth and proliferation. 
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Figure 5.8: Phenotype microarray data for respiration rates of S. Typhimurium strains on nutrient sources. 
Respiratory rates for strains grown in defined minimal media with single specific nutrient supplements. Duplicate 
respiratory curves of each strain are shown. Key: LT2a – blue. DIG0610 (ΔSTM0610) – red. DIG100 (ΔtatABC) – 
green. DIG1495 (ΔdmsD) – yellow. Negative control wells were in position A01 of each plate, with a positive control 
media in well A02. 
 
 Discussion 5.4
5.4.1 A requirement of a functional Tat translocase for maltose metabolism? 
The S. Typhimurium strain DIG100, lacking a functional Tat system, appeared to have a defect 
in aerobic respiration when the sole carbon source provided was maltose (Figure 5.2). The 
maltose transport system of E. coli and S. Typhimurium is a member of the ATP-cassette 
binding superfamily of transporters. This membrane-associated transported consists of four 
subunits; two are transmembrane subunits MalF and MalG, plus two copies of the cytoplasmic 
ATP-binding cassette (ABC) subunits MalK. Maltose-binding protein (MBP), or MalE, is involved 
in delivering maltose to the maltose transporter through interactions with two periplasmic 
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loops of the MalFG subunits, stimulating ATP hydrolysis (Daus et al., 2007, Davidson et al., 
1992). Maltose-binding protein is now a popular protein for use as a fusion tag for purification, 
due to its ability to form stable soluble protein fusions and to bind tightly to maltose-based 
resins (Kapust & Waugh, 1999, Lebendiker & Danieli, 2011).  
The reasons behind the dependence upon the Tat system for maltose respiration remain 
unclear. From data presented here, the ΔtatABC deletion does not appear to disrupt cell 
integrity to such an extent that MBP is shed from the cell, and localisation of MBP which would 
in turn affect maltose uptake is potentially normal. Furthermore, the other components of the 
maltose transport complex are not substrates of the Tat system and so would not be expected 
to require the translocase for function. The maltose transporter system is known to be 
inhibited by the phosphorylatable protein enzyme IIA (EIIA) in conditions where a preferred 
carbon source such as glucose is available (Chen et al., 2013). However, in the conditions of 
the phenotype microarray maltose is the only carbon source and this so-called carbon 
catabolite repression system should not be working. Published work has shown that tatABCD 
tatE mutant E. coli is able to uptake maltose even in the absence of MBP, a phenomenon 
thought to arise through Δtat causing a loss of outer membrane integrity (Caldelari et al., 
2008). Moreover, the ΔtatABCD tatE strain used in this work was clearly able to utilise maltose 
as a carbon source. This at least provides some additional evidence that there is a link between 
Tat transport and correctly functioning maltose metabolism. It should be noted, however, that 
the growth rate of an E. coli tat mutant in maltose media has not been studied here. In 
addition, well E10 of carbon plate PM1 contains maltotriose, a sugar consisting of three 
glucose units and therefore very similar to maltose. Therefore it could be expected that a 
similar respiratory phenotype would be observed with strains in this well as with that 
containing maltose. However, all strains appear to be able to respire normally under this 
condition, surprising given the maltose phenotype of the ΔtatABC deletion strain. 
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5.4.2 Further involvement of the Tat pathway in cell wall synthesis and 
remodelling 
Unusually, strain DIG1495 (∆dmsD), lacking the chaperone protein DmsD, was able to respire 
with Lys-Thr as the sole nitrogen source. The parental strain, and the other strains tested, were 
unable to do this. The presence of this peptide could potentially interfere with the structure of  
the cell wall. Possibly by inhibiting penicillin binding protein 3 (PBP3), which contains three 
conserved sequence motifs for activity, one of which being Lys-Thr-Gly-Thr which is thought to 
interact with substrates (Sauvage et al., 2014). PBP3 is important for catalysing crosslinking of 
the cell wall peptidoglycan during cell division and performs a transpeptidase activity that is 
reliant upon these three conserved motifs. However, it is difficult to understand how a strain 
lacking DmsD might be able to use Lys-Thr as a nitrogen source, while the parental strain does 
not. It is possible that Lys-Thr could be rapidly degraded in the parental strain, while it is not in 
the dmsD mutant. An alternative is that DmsD itself binds tightly to Lys-Thr thus sequestering 
the potential nitrogen source. In any case, the identification of a distinct phenotype for a 
∆dmsD strain grown under aerobic, or microaerobic, conditions must be considered a 
tentative step forward in research into this protein. 
Also on the theme of cell wall synthesis, in PM8 well F7, containing D-Ala-D-Ala, DIG100 (∆tat) 
displayed very low metabolic activity (Figure 5.6). This peptide is present in the cell wall, where 
D-Ala-D-Ala makes up the peptide stem of each disaccharide tetrapeptide subunit (Vollmer et 
al., 2008a). In bacterial strains with vancomycin resistance, this may be changed to D-Ala-D-
lactate, creating a modified peptidoglycan that binds vancomycin 1000-fold less than the 
original D-Ala-D-Ala peptidoglycan (Walsh et al., 1996). The Tat system is, as previously 
mentioned, important for peptidoglycan modelling through the transport of cell wall amidases 
AmiA and AmiC that are involved in hydrolysis of peptidoglycan-side chain bonds during cell 
separation. The D-Ala-D-Ala part of the peptide stem are usually added as a dipeptide, 
synthesised by the enzyme Ddl (Bugg et al., 1991) and incorporated by the ligase MurF 
(Duncan et al., 1990). The deficiency observed here with using D-Ala-D-Ala as a nitrogen source 
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may reflect the fact that the cell wall of a Tat mutant is deficient in D-Ala-D-Ala and as such this 
molecule is captured and used in the periplasm in an attempt to repair the cell envelope, 
rather than being taken into the cytoplasm to be used as a nitrogen source. It may be useful to 
perform some basic microscopic analysis of a tat mutant growing in the presence of D-Ala-D-
Ala, in case this has an effect on the cell-separation phenotype normally observed. 
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6 Final Conclusions and Future Perspectives 
  
188 
 
 Final conclusions 6.1
The maturation and translocation steps of the twin-arginine translocation pathway are still 
being unravelled, with the mechanisms of ‘Tat proofreading’ involved in biosynthesis of the 
most complex substrates of the Tat system beginning to be understood in greater detail. A 
large family of proofreading chaperone proteins has been identified, with these chaperones 
appearing to play a number of vital roles in protein maturation prior to transport.  In this 
study, two substrate-chaperone pairs have been investigated, namely YnfE and DmsD, and 
TorA and TorD. We have been able to reveal a more specific model of interactions occurring 
during the Tat proofreading mechanism.  
Glutamine scanning of the signal peptide of YnfE indicated that the hydrophobic stretch of the 
signal peptide was the region of importance for interactions with the DmsD chaperone 
protein. This is in line with other work that has identified the so-called h-region of the DmsA 
signal peptide as being important for DmsD interactions. Certainly the signal peptides of all 
three known substrates (YnfE, YnfF and DmsA)  that interact with DmsD are conserved 
particularly in their h-regions, hinting at conservation in signal peptide recognition and Tat 
proofreading mechanism. Investigations into the binding site on DmsD have highlighted a 
hydrophobic groove on the DmsD surface that appears to be involved in signal peptide binding 
(Chan et al., 2008, Stevens et al., 2013). The work presented here demonstrated that the 
DmsD amino acid residue Val-16 was important in binding to the signal peptide of YnfE. This 
hydrophobic amino acid, whilst slightly outside of the groove suggested by other studies, still 
has the potential to interact with signal peptides if, as suggested in this work, the peptide 
binds to the chaperone in a specific orientation with the N-terminal of the peptide near the 
area containing this Val-16 residue. Given the fact that investigations into interactions of this 
substrate-chaperone pair from both the substrate and the chaperones perspective has shown 
hydrophobic residues as important suggest that hydrophobic interactions are at the heart of 
the binding interaction. Key questions remaining in the field are big ones. For example, what 
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are the chaperones actually doing when they are bound to the signal peptide? Do they simply 
supply some stearic hindrance, or is the location and mode of binding important? Is there 
some kind of molecular clock involved, timing binding and release of the chaperone, or is the 
hand-over of the signal peptide to the TatC protein driven purely by thermodynamics and 
binding affinities? Does the chaperone perform a biochemical activity when bound to a signal 
peptide, since variants can be isolated that are inactive for Tat proofreading in our in vivo 
assays, but seemingly unimpaired for peptide binding.  
In this project we have additionally demonstrated that DmsD may play a number of roles in 
YnfE maturation, rather than just binding the signal peptide until maturation is complete. As 
well as Val-16, residues Trp-91 and Gly-100 were highlighted in individual amino acid variants 
of DmsD as disrupting the activity of the selenate reductase enzyme despite there being no 
negative effects on signal peptide binding by these variant proteins. It is interesting to think of 
these chaperone proteins as involved in more than simple protein folding and prevention of 
premature transport, and certainly would be feasible. Both Trp-91 and Gly-100 are located 
around a loop region of DmsD that is not present in TorD chaperones, and it could be 
suggested that this loop region is involved in a number of possible functions, such cofactor 
assembly protein recruitment or general chaperone protein assembly. 
In addition to revealing the interactions involved in ssYnfE-DmsD interactions, the importance 
of TorD in TorA maturation was also studied. A number of amino acids were shown to have a 
potential involvement in TorA binding, both to the signal peptide and separately the mature 
region of the protein. We have presented further evidence of two distinct roles of TorD, as has 
been suggested in previous studies. Through the use of super high-resolution microscopy it has 
been shown that Tat components and chaperone proteins are able to be observed in vivo, and 
this represents a first step in the utilisation of such imaging for studies of the Tat pathway. 
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 Future Perspectives 6.2
In this study we have discussed the specific and essential roles of chaperone proteins during 
the maturation of Tat substrates. A major question that is still to be asked of these proteins is 
their importance in real terms in the cell. What are their roles during host symbiosis/infection? 
 
6.2.1 How are these Tat substrate enzymes and their chaperones involved in 
aiding cell survival, for example during host infection? 
With the great respiratory flexibility demonstrated by bacteria such as E. coli and S. 
Typhimurium, it should come as no surprise that a number of electron acceptors are utilised to 
the bacterial cells advantage during pathogenesis. Salmonella is one of the most common 
causes of food-borne infections and diarrhoea in developed countries (de Bruyn, 2000), and 
has been shown to be able to make use of a number of products of inflammation as terminal 
electron acceptors during infection in order to enhance competitive ability in the environment 
of the host.  
For example, the sulphur compounds tetrathionate (S4O6-) and thiosulphate (-S-SO3-) can be 
used as terminal electron acceptors during anaerobic respiration (Hensel et al., 1999, Hinsley 
& Berks, 2002). It has long been known that S. Typhimurium is able to use tetrathionate in 
anaerobic respiration, with this fact being exploited for many decades in order to allow 
isolation of Salmonella serovars through the technique commonly termed tetrathionate 
enrichment, enabling Salmonella to outcompete other species of microbe by growth in broth 
containing tetrathionate (Winter et al., 2010). It now appears that S. Typhimurium makes use 
of the inflammatory response induced in the host during infection, where reactive oxygen 
species generated during this response is used to oxidise thiosulphate (produced in the gut 
from hydrogen sulphide generated by the microflora) and produce tetrathionate, a compound 
that can be reduced by tetrathionate reductase under anaerobic conditions enabling anaerobic 
respiration. Growth of S. Typhimurium is promoted as this terminal electron acceptor is 
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provided through the respiratory burst, thereby giving it an advantage in the competitive 
environment of the gut (Thiennimitr et al., 2012, Winter et al., 2010). The Tat-dependent 
enzyme tetrathionate reductase in Archaeglobus fulgidus has been shown to bind the TorD-
family proofreading chaperone TtrD during maturation (Coulthurst et al., 2012), and whilst no 
chaperone has yet been identified in S. Typhimurium it is likely to require a similar protein 
chaperone due to its MGD cofactor. Tetrathionate reductase and its cognate chaperone is 
therefore an important tool in bacterial pathogenesis, at least in the case of Salmonella. 
Early studies involving TtrA and TtrB were performed during the course of this study. As there 
is yet to be an identified TorD chaperone participating in Tat proofreading of TtrA or TtrB, we 
screened a number of known and predicted S. Typhimurium TorD chaperone proteins (namely 
STM0610, STM4308, TorD, DmsD and YcdY) for their interactions against these two Tat 
substrates. From this bacterial two-hybrid study it was confirmed that none of these 
chaperones appeared to interact with TtrA or TtrB (Figure 6.1), and so any proteins that may 
be involved in Tat proofreading of these substrates remain elusive.  
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Figure 6.1: TorD family chaperone proteins did not display interactions with spTtrA or spTtrB. 
MG1655 ΔcyaA::Apra was co-transformed with vectors UT18-spTtrA or UT18-spTtrB and one of T25-
STM0610/STM4308/TorDst/DmsDst/YcdYst. β-galactosidase was measured as an indicator of interactions. β-
galactosidase activities are displayed relative to activity of the positive control (‘NarJ + spNarG’).  Cells containing 
both empty vectors were used as the negative control (‘UT18 + T25’). Data expressed as means (n = 3) ± SEM. 
 
In addition, studies into interactions of TtrB with the Tat component protein TatC were begun. 
A number of amino acid residues of TatC were targeted for site directed mutagenesis in order 
to observe regions of importance for interaction with the signal peptide of TtrB. These residues 
were V3, L9, E15, K101, R105, E187 and R241, and were substituted for glutamines before 
interactions were tested using the bacterial two-hybrid system. Results suggested the N-
terminal cytoplasmic region as playing a role in TatC interactions with spTtrB (Figure 6.2A), 
with both V3Q and E15Q displaying lower β-galactosidase activity (Figure 6.2B), in keeping 
with other published work highlighting the role of this region of TatC (Buchanan et al., 2002, 
Kneuper et al., 2012, Zouflay et al., 2012). Interactions of TatC and signal peptides of Tat 
substrates are important for Tat translocation, and so understanding the binding interaction at 
the amino acid level is important. A greater understanding of this may allow for the possibility 
of fragment screening in order to identify compounds capable of disrupting binding, and reveal 
potential antimicrobial targets. 
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Figure 6.2: Specific interactions between spTtrB and TatC were analysed. 
A – TatCst structure, based on figure of E. coli TatC from Buchanan et al. (2002). Amino acid residues targeted for 
site directed mutagenesis are outlined in colour, where green indicates no subsequent disruption of interaction 
with spTtrB, and red indicates spTtrB interactions were disrupted. B - MG1655 ΔcyaA::Apra was co-transformed 
with vectors UT18-spTtrB and T25-TatC plus variants. β-galactosidase was measured as an indicator of interactions. 
β-galactosidase activities are displayed relative to activity of the positive control (‘NarJ + ssNarG’).  Cells containing 
both empty vectors were used as the negative control (‘UT18 + T25’). Data expressed as means (n = 3) ± SEM. 
 
Tetrathionate reductase is not the only Tat substrate that is thought to be involved in giving an 
advantage to bacteria during infection. Another by-product of the host inflammatory response 
is nitrate, the preferred electron acceptor utilised by bacteria such as S. Typhimurium. The 
production of nitrate can be induced through S. Typhimurium expression of the secreted 
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protein SopE, an effector protein of the invasion-associated type III secretion system that 
activates a number of innate immune pathways and simultaneously leads to increased host-
derived nitrate production from the activity of the inducible nitric oxide synthase (Lopez et al., 
2012). Three operons encode for nitrate reductases in S. Typhimurium, namely narGHJI, 
narZYWV and napFDAGHBC. Cytoplasmic-oriented nitrate reductase A, although not an active 
Tat substrate, has been shown to harbour a remnant Tat signal peptide, and relies upon the 
TorD-family chaperone protein NarJ for assembly (Turner et al., 2004). This puts another (Tat) 
substrate-chaperone pair in an important role in infection. 
These examples of mechanisms by which S. Typhimurium is able to promote its own advantage 
during infection of a host all require the successful maturation and translocation of enzymes 
that are Tat substrates. Because of this, it can be said that the Tat proofreading activity of Tat 
chaperones of the TorD-like family are of great importance for Salmonella pathogenesis, and 
indeed a wide range of bacterial species, as the activity of many Tat enzymes requires 
successful Tat proofreading. A new direction of investigation could be to look at the roles of 
these cytoplasmic chaperone proteins during the process of infection. Given the dependence 
upon these chaperones for enzymatic activity, they could represent a new family of drug 
targets. Antimicrobial resistance is a major threat to human health, with many bacteria causing 
common infections in the community and in hospital settings now found to demonstrate high 
proportions of resistance (WHO, 2014). There is now an urgent need for the identification of 
new drug targets and new potential drugs. 
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Figure 6.3: Salmonella is able to utilise host inflammatory response during infection for competitive advantage in 
the intestine. 
Salmonella has been shown to be able to make use of products of the host inflammatory response during invasion 
in order to give itself a competitive advantage over the commensal microbiota. Production of reactive oxygen 
species (ROS) by neutrophils during inflammation enables both tetrathionate and nitrate respiration. ROS can react 
with nitric oxide, produced by nitric oxide synthase, to form peroxynitrate (ONOO-). This reactive nitrogen species 
quickly isomerises to nitrate (NO3
-) that can be reduced to nitrite (NO2
-) by Salmonella nitrate reductase enzymes, 
enabling nitrate respiration and energy production. In the same way, ROS can react with thiosulphate, produced 
from microbiotal hydrogen sulphide (H2S), to give tetrathionate that can then be reduced by Salmonella 
tetrathionate reductase. Again this allows Salmonella to carry out anaerobic respiration. Both pathways can lead to 
a growth bloom of Salmonella due to its competitive edge over other bacterial strains present in the microbiota. 
 
As the signal peptide binding sites on TorD-like cytoplasmic chaperone proteins of the Tat 
system are becoming more defined in their locations and composition through further study, 
they represent the potential for development of new mechanisms of antibiotic targeting. 
Targeting the proofreading function of these cytoplasmic chaperones would be an ideal 
mechanism to reduce the invasion capabilities of virulent bacterial strains, as it has been 
shown in the past that enzymatic activity of Tat substrates such as those mentioned is 
dependent upon this interaction. The creation of deletion mutants and examination of their 
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invasion abilities through the use of virulence models could give an indication to their 
importance during infection. The use of high throughput drug screens may be useful in 
identifying compounds that interfere with the proofreading mechanism in some way, perhaps 
through disruption to binding of the signal peptide. Targeting these proofreading pathways 
and preventing enzyme maturation would rid Salmonella of its competitive edge in the host 
environment. This would be an interesting and highly relevant future topic of research. 
 
6.2.2 Could Tat substrates and chaperones be utilised to the advantage of human 
health? 
The human intestinal microbiota is a highly complex community consisting of bacteria, viruses 
and fungi, thought to have coevolved with the host. The total number of commensal bacterial 
cells living on or in the host is thought to outnumber human cells by ten-fold (Turnbaugh et al., 
2007), with the gut microflora consisting of a large number of anaerobes plus some facultative 
anaerobes mainly residing in the large intestine (Gorbach, 1996). This complex ecosystem is 
extremely important for human health, and is thought to protect us against invading 
pathogens, contribute to normal immune functions within the body and aid energy extraction 
from our diets (Lozupone et al., 2012). The intestinal microflora are important for the 
production of enzymes that enable the breakdown of a number of vitamins, including vitamin 
K, an essential cofactor in production of blood clotting factors such as prothrombin. In 
addition, other enzymes produced aid fermentation of indigestible carbohydrates such as 
pectins, cellulose and hemicellulose from plant material into short-chain fatty acids including 
acetate and butyrate (Gorbach, 1996). The protective abilities of the intestinal microflora 
against pathogen colonisation are also well documented, with these commensals occupying 
similar ecological niches to those required by pathogenic bacteria. It is thought that infections 
are prevented both through direct interactions such as alteration of the environmental 
conditions (such as pH) or the production of bacteriocins, proteinaceous toxins that inhibit 
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members of closely related bacterial species, and indirectly through the stimulation of host 
immunity (Kamada et al., 2013). Disruptions to the intestinal bacterial flora have been 
implicated in many diseases and conditions such as chronic kidney disease (Sabatino et al., 
2014), inflammatory bowel disease (Orel & Trop, 2014), obesity (Moran & Shanahan, 2014) 
and Type 2 diabetes mellitus (Puddu et al., 2014). 
Activities of the human microflora can have influences on host health in many different ways. 
Recent studies into the gut microbiota and cardiovascular disease (CVD) revealed links 
between dietary lipid intake, gut microflora and atherosclerosis (Wang et al., 2011). In this 
pathway, the compound trimethylamine N-oxide (TMAO) is produced as a result of the 
metabolism of the lipid phosphatidylcholine (PC) to choline, trimethylamine (TMA) and betaine 
by the gut microflora. TMA produced during this reaction is then absorbed into the circulation 
and becomes oxidised to TMAO by hepatic FMO3, a human enzyme that has been linked to the 
genetic disorder trimethylaminuria. Trimethyaminuria is a rare autosomal recessive condition 
which results in accumulation of TMA in the body, which is excreted in the sweat and urine 
causing a rotten fish smell (Ulman et al., 2014). It was observed that there was a high 
correlation between systemic levels of TMAO and coronary artery atherosclerosis and cardiac 
risk (Vinjé et al., 2014, Wang et al., 2011). Another published study demonstrated that 
consumption of red meat, high in the nutrient L-carnitine that contains a trimethylamine 
structure similar to that of choline, leads to the production of TMAO through L-carnitine 
metabolism by the gut microflora, and again increases atherosclerosis and CVD risks (Koeth et 
al., 2013, Vinjé et al., 2014). Increased plasma levels of TMAO show a positive association with 
the risk of major adverse cardiovascular events, with this TMAO increase being related to gut 
microbiota through its inhibition upon the application of antibiotics (Tang et al., 2013). The 
increased risk of CVD caused by high TMAO levels is thought to be due to its influence over the 
production of a pro-atherosclerotic phenotype amongst macrophages (Wang et al., 2011). 
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The importance of the gut microbiota for human health is clear. In recent years the idea has 
been touched upon that modulation of the intestinal flora may be a novel therapeutic 
approach for prevention or treatment of serious conditions such as heart disease (Jia et al., 
2008, Vinjé et al., 2014). Pre- and probiotics are already popular ways of attempting to 
influence the proportions of certain bacterial species within the intestine in the interests of 
health. It is possible that through control of the gut microbiota population or through specific 
drug targeting health issues linked to the intestinal microbiome could be prevented or treated.  
In the case of high TMAO levels and the related CVD risks, it could be beneficial to be able to 
reduce the amount of TMAO present in the blood plasma. Certainly, it has been shown that 
certain dietary foods can have an effect on the levels of TMAO in the body (Miller et al., 2014). 
Another potential way to control this is to catalyse the reduction of TMAO produced by the gut 
microbiota back to the compound TMA. E. coli and S. Typhimurium amongst other bacterial 
species are already capable of this reaction under anaerobic conditions, where they utilise 
TMAO as a final electron acceptor during respiration. If it were possible to somehow harness 
this ability and increase levels of the enzyme TMAO reductase in the host it may be possible to 
decrease patient risks of atherosclerosis and CVD. Therefore it is essential to understand the 
entire pathway of enzyme maturation and production in order to investigate future uses of 
TMAO reductase in cardiovascular disease treatment. In addition, there may be new roles to 
be identified for enzymes such as these in other conditions linked to the metabolism activities 
of the gut microbiota. 
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7 Materials and methods 
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 Bacterial strains 7.1
Table 7.1: Bacterial strains used in this study. 
Bacterial Strain Genotype Antibiotic 
Resistance 
Reference 
BL21(DE3) pLysS F- ompT gal dcm lon hsdSB(rB
- mB
-) 
λ(DE3) pLysS(cmR) 
Cml  
DH5α F_ φ80d ∆(lacZ)M15 recA1 endA1 
gyrA96 thi-1 hsdR17  (rk
-mk
+) supE44 
relA1 deoR ∆(lacZYA-argF)U169 
None (Hanahan, 
1983) 
DIG0610 Wild-type S. Typhimurium with 
STM0610 deleted by lambda-red 
leaving 81bp scar  
None (Guymer et al., 
2009) 
DIG1495 Wild-type S. Typhimurium with 
STM1495 (dmsD) deleted by lambda-
red leaving 81bp scar 
None (Guymer et al., 
2009) 
DIG4308 Wild-type S. Typhimurium with 
STM4308 deleted by lambda-red 
leaving 81bp scar 
None (Guymer et al., 
2009) 
DIG100 Wild-type S. Typhimurium with 
tatABC genes deleted by lambda-red 
leaving 81bp scar 
None (Guymer et al., 
2009) 
DIG101 Wild-type S. Typhimurium with 
STM1499 and STM1498 deleted by 
λRED leaving 81bp scar 
None (Guymer et al., 
2009) 
DIG102 S. Typhimurium strain LT2 with the 
gene STM1499 deleted by λRED and 
replaced with an 81bp scar 
None (Guymer et al., 
2009) 
DIG103 Wild-type S. Typhimurium strain LT2 
with the gene STM1498 (ynfF) deleted 
by λRED and replaced with an 81bp 
scar 
None (Guymer et al., 
2009) 
DIG105 S. Typhiumrium strain LT2 with the 
dmsA gene deleted by λRED and 
replaced with an 81bp scar 
None Dr David 
Guymer, 
unpublished 
DIG107 S. Typhimurium DIG104 (ΔtorA) with 
the dmsA gene deleted by λRED and 
replaced with an 81bp scar 
None Dr David 
Guymer, 
unpublished 
FTD100 As MC4100, ΔtorD None (Jack et al., 
2004) 
JARV16 att tatAYFP As B1LK0 (ΔtatB) (Bogsch et al., 1998), 
but with tatA-YFP fusion in the 
lambda site 
Kan  
KM01 As DIG103, with L24Q substitution in 
spYnfE 
None This study 
KM02 As DIG103, with A28Q substitution in 
spYnfE 
None This study 
KM03 As DIG103, with L33Q substitution in 
spYnfE 
None This study 
LT2a Wild-type S. Typhimurium strain. 
Attenuated due to altered rpoS allele. 
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MG1655 Wild-type E. coli strain.  
F-, lambda-, rph-1 
None (Blattner et 
al., 1997) 
MG1655 ΔcyaA::Apra As MG1655, with PCR from 
pMAK705DcyaA::Apra electroporated 
into host using λ red protocol 
Apra  
MC1061 F- Δ(ara-leu)7697 [araD139]B/r Δ(codB-
lacI)3 galK16 galE15 λ- e14- mcrA0 
relA1 rpsL150(strR) spoT1 mcrB1 
hsdR2(r-m+) 
None (Casadaban & 
Cohen, 1980) 
MC4100 F’ lacΔ169 araD139 rpsL150 thi 
flbB5301 deoC7 ptsF25 relA ara+ 
None (Casadaban & 
Cohen, 1980) 
MCBYFP As MC4100, but with tatB C-
terminally tagged with YFP. 
None  
NCTC12023 Wild-type S. Typhimurium strain None  
RJ607-D  As RJ607 (ssTorA::hybO ΔhybA) with 
torD gene replaced by Kan insert 
Kan (Jack et al., 
2004) 
SL1344 Wild-type S. Typhimurium strain None  
 
 Media, additives and growth conditions 7.2
Growth media and supplements used in this work are shown in Table 7.2 and Table 7.3. Strains 
were typically grown at 37 oC unless otherwise stated. Aerobic growth was conducted with 
agitation at 200 rpm, with cultures maintaining at least a 1:4 liquid to air ratio to ensure 
aerobiosis. Anaerobic growth was conducted by filling of containers to the top with medium 
and incubation without agitation. Growth on solid media was also performed at 37 oC unless 
otherwise stated, with anaerobic growth when required being conducted in sealed anaerobic 
jars with an Oxoid AnaeroGen sachet (Thermo Scientific). 
Long term storage of strains was carried out at -80 oC by the addition of a final concentration 
of 25% glycerol to a stationary phase culture, with this being flash frozen with liquid nitrogen. 
 
Table 7.2: Growth media used in this study. 
Media and their components were sterilised by autoclaving unless marked by as asterisk, in which case they were 
filter sterilised and added prior to media use. 
Media Components Concentration 
Luria Bertani (LB) medium Tryptone 
Yeast extract 
NaCl 
1.0% [w/v] 
0.5% [w/v] 
1.0% [w/v] 
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Low salt LB medium Tryptone 
Yeast extract 
NaCl 
1.0% [w/v] 
0.5% [w/v] 
0.5% [w/v] 
LB-agar Tryptone 
Yeast extract 
NaCl 
Agar 
1.0% [w/v] 
0.5% [w/v] 
1.0% [w/v] 
1.5% [w/v] 
M9 medium 
(for Biolog PM growth tests) 
M9 salts (10x) 
1 M MgSO4
* 
1 M CaCl2
* 
20% maltose 
10% [v/v] 
0.2% [v/v] 
2% [v/v] 
0.1-2% [v/v] 
 
Table 7.3: Additives used in this study, with their respective stock and working concentrations. 
Supplement Stock Solution Final Concentration 
Dimethyl sulfoxide (DMSO) 20% 0.4% 
Glucose 20% [w/v] 0.5% 
Glycerol 50% [v/v] 0.5% 
Isopropyl β-D-1-thiogalactopyranoside 1 M 2mM 
Sodium fumarate 16% [w/v] 0.4% 
Sodium selenate (Na2SeO4) 100 mM 10 mM 
Trimethylamine N-oxide (TMAO) 20% [w/v] 0.4% 
 
 
Table 7.4: Antibiotics used in this study, with their stock and working concentrations. 
Antibiotic Stock Concentration Final Concentration 
Ampicillin (Amp) 125 mg ml-1 100 µg ml-1 
Apramycin (Apra) 50 mg ml-1 50 µg ml-1 
Chloramphenicol (Cm) 25 mg ml-1 25 µg ml-1 
Kanamycin (Kan) 50 mg ml-1 50 µg ml-1 
 
 Buffers and solutions 7.3
Table 7.5: General buffers and solutions used in this study. 
Buffer/Solution Components Concentration 
APS Ammonium persulfate 10% [w/v] 
Crosslinking buffer HEPES 
KCl 
50 mM 
150 mM  
DNA loading buffer Bromophenol blue 
Xylene cyanol blue 
Sucrose 
0.25% [w/v] 
0.25% [w/v] 
40% [w/v] 
Laemmli sample buffer (2x) Tris-HCl, pH 6.8 
SDS 
Glycerol  
62.5 mM 
2% [w/v] 
26.3% [w/v] 
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Bromophenol blue 
β-mercaptoethanol 
0.01% [w/v] 
15% [v/v] 
M9 salts (10x stock) 
 
NaCl 
Na2HPO4.7H2O 
KH2PO4 
NH4Cl 
5 g L-1 
64 g L-1 
30 g L-1 
10 g L-1 
ONPG ortho-Nitrophenyl-β-galactoside 4 mg ml-1 
0.1 M Phosphate buffer NaH2PO4-2H2O 
Na2HPO4 
6.59 g L-1 
8.19 g L-1 
Phosphate Buffered Saline (PBS) KH2PO4 
NaCl 
Na2HPO4-7H2O 
1 mM 
155 mM 
3 mM 
Ponceau S solution Ponceau S 
Acetic acid 
0.1% [w/v] 
5% [w/v] 
SDS running buffer Tris-HCl, pH 8.3 
Glycine 
EDTA 
250 mM 
1.92 M 
1.0% [w/v] 
TBS/Tween (TBS-T) Tris-HCl, pH 8.0 
NaCl 
Tween 20 
20 mM 
137 mM 
0.1% [v/v] 
TEV storage buffer Tris-HCl, pH 8 
NaCl 
Glycerol 
EDTA 
Dithiothreitol (DTT) 
50 mM 
25 mM 
10% 
1 mM 
1 mM 
Tris Buffered Saline (TBS) Tris-HCl, pH 7.5 
NaCl 
20 mM 
137 mM 
Tris-Glycine transfer buffer Tris 
Glycine 
Methanol 
25 mM 
192 mM 
10% [v/v] 
Z-buffer Na2HPO4 
NaH2PO4.2H2O 
KCl 
MgSO4.7H2O 
β-mercaptoethanol 
8.52 g L-1 
6.24 g L-1 
0.75 g L-1 
0.25 g L-1 
0.7 ml L-1 
 
 
Table 7.6: Buffers used during the purification of proteins by FPLC. 
Buffer Use Components Concentration 
Buffer A Nickel affinity 
chromatography 
Tris-HCl, pH 7.5 
Imidazole 
NaCl 
25 mM 
25 mM 
250 mM 
Buffer B Nickel affinity 
chromatography 
Tris-HCl, pH 7.5 
Imidazole 
NaCl 
25 mM 
500 mM 
250 mM 
Buffer C Size exclusion 
chromatography 
Tris-HCl, pH 7.5 
NaCl 
25 mM 
250 mM 
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Buffer D TEV purification – nickel 
affinity chromatography 
Tris-HCl, pH 8 
NaCl 
Glycerol 
50 mM 
300 mM 
10% 
Buffer E TEV purification – nickel 
affinity chromatography 
Tris-HCl, pH 8 
NaCl 
Glycerol 
Imidazole 
50 mM 
300 mM 
10% 
500 mM 
Buffer F TEV purification – lysis 
buffer 
Tris-HCl, pH 8 
NaCl 
Glycerol 
Imidazole 
MgCl2 
50 mM 
300 mM 
10% 
25 mM 
2 mM 
 
 
 Genetic manipulations 7.4
7.4.1 Plasmid DNA preparation 
Plasmids were extracted from E. coli and Salmonella strains using the QIAprep Spin Miniprep 
kit (Qiagen). This technique is based on an alkaline lysis method modified by Birnboim & Doly 
(1979). A 5 ml culture inoculated with a single colony was grown overnight prior to 
centrifugation at 10,000 rpm for 10 minutes. Cells were resuspended in an alkaline lysis buffer 
in order to release cell contents, with the lysate being treated with neutralisation buffer and 
cleared of precipitate. Plasmid DNA was then able to be isolated through adsorption onto a 
silica membrane under high-salt conditions. After washing to remove endonucleases and salts, 
plasmid DNA was eluted with dH2O. 
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Table 7.7: Plasmids used throughout this study. 
Plasmid Name Characteristics Resistance Reference 
pBluescript KS+ Cloning vector, with polylinker oriented in the KS orientation. Amp Stratagene 
pFLUOR_mCerN-TorD_YFPN-TorD Production of N-terminal mCer and YFP fusion to individual TorD 
proteins 
Amp Dr Sarah Coulthurst, 
unpublished 
pFLUOR_mCerN-TorD_TorD-YFPC Production of N-terminal mCer and C-terminal YFP fusion to individual 
TorD proteins 
Amp Dr Sarah Coulthurst, 
unpublished 
pFLUOR_TorD-mCerC_ TorD-YFPC Production of C-terminal mCer and YFP fusion to individual TorD 
proteins 
Amp Dr Sarah Coulthurst, 
unpublished 
pFLUOR_TorD-mCerC _YFPN-TorD Production of C-terminal mCer and C-terminal YFP fusion to individual 
TorD proteins 
Amp Dr Sarah Coulthurst, 
unpublished 
pQE70L-stmynfE Over-expression vector with lac operator and T5 promoter, with codons 
expressing hexa-histidine tag at 3’ end after multiple cloning site. Allows 
IPTG-inducible over-expression of YnfE-his protein from S. Typhimurium 
Amp  
pQE80L-Nhis-TEV-DmsD Over-expression vector with lac operator and T5 promoter, with codons 
expressing hexa-histidine tag at 5’ end before multiple cloning site. 
DmsD from S. Typhimurium with N-terminal TEV cleavage site cloned in, 
allowing IPTG-inducible over-expression of his-TEV-DmsD 
Amp This study 
pQE80L-Nhis-TEV-DmsD K61Q As pQE80L-Nhis-TEV-DmsD, with residue K61 substituted for Q Amp This study 
pQE80L-Nhis-TEV-DmsD K200Q As pQE80L-Nhis-TEV-DmsD, with residue K200 substituted for Q Amp This study 
pQE80L-Nhis-TEV-DmsD double As pQE80L-Nhis-TEV-DmsD, with all K residues substituted for Q Amp This study 
pQE80L-HiPIP HiPIP from E. coli  cloned in, allowing IPTG-inducible over-expression of 
HiPIP 
Amp  
pQE80L-SufI SufI from E. coli  cloned in, allowing IPTG-inducible over-expression of 
SufI 
Amp  
pQE80L-TorA TorA from E. coli  cloned in, allowing IPTG-inducible over-expression of 
TorA 
Amp  
pMAK705 Derivative of pMAK700, suicide vector that allows E. coli chromosomal 
mutations 
Cm (Hamilton et al., 1989) 
pMAK-spYnfE pMAK705 containing chromosomal nucleotide sequence 500 bp 
upstream and downstream of S. Typhimurium spYnfE 
Cm This study 
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pMAK-spYnfE L24Q pMAK705 containing nucleotide sequence 500 bp upstream and 
downstream of spYnfE with L24Q substitution 
Cm This study 
pMAK-spYnfE A28Q pMAK705 containing nucleotide sequence 500 bp upstream and 
downstream of spYnfE with A28Q substitution 
Cm This study 
pMAK-spYnfE L33Q pMAK705 containing nucleotide sequence 500 bp upstream and 
downstream of spYnfE with L33Q substitution 
Cm This study 
pT25 Cloning vector for bacterial-two hybrid system. Encodes the T25 
fragment of CyaA (a.a. 1–224) from B. pertussis in frame with a 
multicloning site sequence, under the control of the lac UV5 promoter 
Cm (Karimova et al., 1998) 
pT25-DmsD Encodes DmsD-T25 fusion for bacterial-two hybrid analysis Cm  
pT25-DmsD V16Q As pT25-DmsD, with residue V16 substituted for Q Cm This study 
pT25-DmsD W91Q As pT25-DmsD, with residue W91 of DmsD substituted for Q Cm This study 
pT25-DmsD S96Q As pT25-DmsD, with residue S96 of DmsD substituted for Q Cm This study 
pT25-DmsD G100Q As pT25-DmsD, with residue G100 of DmsD substituted for Q Cm This study 
pT25-DmsD T103Q As pT25-DmsD, with residue T103 of DmsD substituted for Q Cm This study 
pT25-DmsD G171Q As pT25-DmsD, with residue G171 of DmsD substituted for Q Cm This study 
pUNI-PROM pT7.5 with tat promoter cloned EcoRI-BamHI Amp (Jack et al., 2004) 
pUNI-PROM_DmsDst As pUNI-PROM, with dmsD from S. Typhimurium cloned BamHI-PstI Amp  
pUNI-PROM_DmsDst mutant library As pUNI-PROM_DmsDst, subjected to error-prone PCR, giving ~400,000 
clones. 
Amp Dr Holger Knueper, 
unpublished 
pUNI-PROM_DmsDst V16Q As pUNI-PROM_DmsDst, with residue V16 of DmsD substituted for Q Amp This study 
pUNI-PROM_DmsDst W91Q As pUNI-PROM_DmsDst, with residue W91 of DmsD substituted for Q Amp This study 
pUNI-PROM_DmsDst S96Q As pUNI-PROM_DmsDst, with residue S96 of DmsD substituted for Q Amp This study 
pUNI-PROM_DmsDst G100Q As pUNI-PROM_DmsDst, with residue G100 of DmsD substituted for Q Amp This study 
pUNI-PROM_DmsDst T103Q As pUNI-PROM_DmsDst, with residue T103 of DmsD substituted for Q Amp This study 
pUNI-PROM_DmsDst G171Q As pUNI-PROM_DmsDst, with residue G171 of DmsD substituted for Q Amp This study 
pUNI-PROM_TorD As pUNI-PROM, with torD from E. coli Amp  
pUNI-PROM_TorD E23A As pUNI-PROM-TorD, with residue E23 substituted for A Amp  
pUNI-PROM_TorD Q31A As pUNI-PROM-TorD, with residue Q31 substituted for A Amp  
pUNI-PROM_TorD G112A As pUNI-PROM-TorD, with residue G112 substituted for A Amp  
pUNI-PROM_TorD T115A As pUNI-PROM-TorD, with residue T115 substituted for A Amp  
pUNI-PROM_TorD P122A As pUNI-PROM-TorD, with residue P122 substituted for A Amp  
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pUNI-PROM_TorD E142A As pUNI-PROM-TorD, with residue E142 substituted for A Amp  
pUNI-PROM_TorD G112A P122A As pUNI-PROM-TorD, with residues G112 & P122 substituted for A Amp  
pUT18 Derivative of pBluescript II KS (Stratagene) for bacterial-two hybrid 
system. Encodes T18 fragment of CyaA (a.a. 225-399) from B. pertussis 
in frame with a multicloning site sequence from pBluescript II KS.  
Amp  
pUT18-spYnfE Encodes T18-spYnfE (S. Typhimurium) fusion for bacterial-two hybrid 
analysis 
Amp  
pUT18-spYnfE (G3-A42)Q pUT18-spYnfE (S. Typhimurium) vectors with residues G3 to A42 
individually substituted for Q 
Amp This study 
pUT18-YnfEΔsp As pUT18, with YnfE (S. Typhimurium) missing N-terminal signal peptide 
(a.a. 1-42) 
Amp This study 
pUT18-YnfE As pUT18, encoding full length YnfE (a.a 1-813) (S. Typhimurium) Amp This study 
pUT18-YnfG As, pUT18, encoding YnfG (S. Typhimurium), an Fe-S subunit of selenate 
reductase 
Amp This study 
 
 
Table 7.8: Oligonucleotides used throughout this study. 
All oligonucleotides were obtained from Sigma Aldrich. 
Oligonucleotide Name Sequence (5’-3’) Use 
TorD E23A for CAGTTGTTCTCCCGTGCGCTGGACGATGAACAA For TorDec Quikchange 
TorD E23A rev TTGTTCATCGTCCAGCGCACGGGAGAACAACTG For TorDec Quikchange 
TorD Q31Q for GATGAACAACTGACGGCAATCGCCAGTGCGCAG For TorDec Quikchange 
TorD Q31A rev CTGCGCACTGGCGATTGCCGTCAGTTGTTCATC For TorDec Quikchange 
TorD G112A for TTGTTAGTTGAGGCAGCGATGGAAACCAGCGGC For TorDec Quikchange 
TorD G112A rev GCCGCTGGTTTCCATCGCTGCCTCAACTAACAA For TorDec Quikchange 
TorD T115A for GAGGCAGGGATGGAAGCCAGCGGCAATTTCAAC For TorDec Quikchange 
TorD T115A rev GTTGAAATTGCCGCTGGCTTCCATCCCTGCCTC For TorDec Quikchange 
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TorD P122A for GGCAATTTCAACGAAGCGGCAGATCATCTGATC  For TorDec Quikchange 
TorD P122A rev GATCAGATGATCTGCCGCTTCGTTGAAATTGCC For TorDec Quikchange 
TorD E142A for CATTTTTCGCTGGGAGCGGGGACCGTTCCTGCG For TorDec Quikchange 
TorD E142A rev CGCAGGAACGGTCCCCGCTCCCAGCGAAAAATG For TorDec Quikchange 
YnfEst G3Q for GGAGGATCCATGCCCCAAGAAAAGCAACAAACAGGC For spYnfEst Quikchange  
YnfEst G3Q rev GCCTGTTTGTTGCTTTTCTTGGGGCATGGATCCTCC For spYnfEst Quikchange  
YnfEst E4Q for GTGATGCCCGGACAAAAGCAACAAACAGG For spYnfEst Quikchange  
YnfEst E4Q rev CCTGTTTGTTGCTTTTGTCCGGGCATCAC For spYnfEst Quikchange  
YnfEst K5Q for ATGCCCGGAGAAGACCAACAAACAGGCG For spYnfEst Quikchange  
YnfEst K5Q rev CGCCTGTTTGTTGGTCTTCTCCGGGCAT For spYnfEst Quikchange  
YnfEst Q6W for CCCGGAGAAAAGTGGCAAACAGGC For spYnfEst Quikchange  
YnfEst Q6W rev GCCTGTTTGCCACTTTTCTCCGGG For spYnfEst Quikchange  
YnfEst Q7W for CCATGCCCGGAGAAAAGCAATGGACAGGCGTTAGCCGCAGGACG For spYnfEst Quikchange  
YnfEst Q7W rev CGTCCTGCGGCTAACGCCTGTCCATTGCTTTTCTCCGGGCATGG For spYnfEst Quikchange  
YnfEst T8Q for GAAAAGCAACAACAAGGCGTTAGCCGC For spYnfEst Quikchange  
YnfEst T8Q rev GCGGCTAACGCCTTGTTGTTGCTTTTC For spYnfEst Quikchange  
YnfEst G9Q for GCAACAAACACAAGTTAGCCGCAGG For spYnfEst Quikchange  
YnfEst G9Q rev CCTGCGGCTAACTTGTGTTTGTTGC For spYnfEst Quikchange  
YnfEst A19Q for CGTTAGTGAAATCACAGGCGCTTGGCTCACTG For spYnfEst Quikchange  
YnfEst A19Q rev CGTTAGTGAAATCACAGGCGCTTGGCTCACTG For spYnfEst Quikchange  
YnfEst A20Q for GTGAAATCAGCGCAGCTTGGCTCACTGGCG For spYnfEst Quikchange  
YnfEst A20Q rev CGCCAGTGAGCCAAGCTGCGCTGATTTCAC For spYnfEst Quikchange  
YnfEst L21Q for GTGAAATCAGCGGCGCAAGGCTCACTGGCGCTG For spYnfEst Quikchange  
YnfEst L21Q rev CAGCGCCAGTGAGCCTTGCGCCGCTGATTTCAC For spYnfEst Quikchange  
YnfEst G22Q for GTGAAATCAGCGGCGCTTCAATCACTGGCGCTG For spYnfEst Quikchange  
YnfEst G22Q rev CAGCGCCAGTGATTGAAGCGCCGCTGATTTCAC For spYnfEst Quikchange  
YnfEst S23Q for GCGGCGCTTGGCCAACTGGCGCTGGCTGCC For spYnfEst Quikchange  
YnfEst S23Q rev GGCAGCCAGCGCCAGTTGGCCAAGCGCCGC For spYnfEst Quikchange  
YnfEst L24Q for GCGGCGCTTGGCTCACAGGCGCTGGCTGCC For spYnfEst Quikchange  
YnfEst L24Q rev GGCAGCCAGCGCCTGTGAGCCAAGCGCCGC For spYnfEst Quikchange  
YnfEst A25Q for GCGCTTGGCTCACTGCAGCTGGCTGCCGGAGGC For spYnfEst Quikchange  
YnfEst A25Q rev GCCTCCGGCAGCCAGCTGCAGTGAGCCAAGCGC For spYnfEst Quikchange  
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YnfEst L26Q for GCGCTTGGCTCACTGGCGCAGGCTGCCGGAGGC For spYnfEst Quikchange  
YnfEst L26Q rev GCCTCCGGCAGCCTGCGCCAGTGAGCCAAGCGC For spYnfEst Quikchange  
YnfEst A27Q for GGCTCACTGGCGCTGCAGGCCGGAGGCGTATC For spYnfEst Quikchange  
YnfEst A27Q rev GATACGCCTCCGGCCTGCAGCGCCAGTGAGCC For spYnfEst Quikchange  
YnfEst A28Q for CTGGCGCTGGCTCAGGGAGGCGTATCTTTACCG For spYnfEst Quikchange  
YnfEst A28Q rev CGGTAAAGATACGCCTCCCTGAGCCAGCGCCAG For spYnfEst Quikchange  
YnfEst G29Q for CTGGCGCTGGCTGCCCAAGGCGTATCTTTACCG For spYnfEst Quikchange  
YnfEst G29Q rev CGGTAAAGATACGCCTTGGGCAGCCAGCGCCAG For spYnfEst Quikchange  
YnfEst G30Q for GCGCTGGCTGCCGGACAGGTATCTTTACCGTTTGGG For spYnfEst Quikchange  
YnfEst G30Q rev CCCAAACGGTAAAGATACCTGTCCGGCAGCCAGCGC For spYnfEst Quikchange  
YnfEst V31Q for CTGGCTGCCGGAGGCCAATCTTTACCGTTTGGG For spYnfEst Quikchange  
YnfEst V31Q rev CCCAAACGGTAAAGATTGGCCTCCGGCAGCCAG For spYnfEst Quikchange  
YnfEst S32Q for GCTGCCGGAGGCGTACAGTTACCGTTTGGGATG For spYnfEst Quikchange  
YnfEst S32Q rev CATCCCAAACGGTAACTGTACGCCTCCGGCAGC For spYnfEst Quikchange  
YnfEst L33Q for GCCGGAGGCGTATCTCAACCGTTTGGGATGCGTAC For spYnfEst Quikchange  
YnfEst L33Q rev GTACGCATCCCAAACGGTTGAGATACGCCTCCGGC For spYnfEst Quikchange  
YnfEst P34Q for GGAGGCGTATCTTTACAGTTTGGGATGCGTACC For spYnfEst Quikchange  
YnfEst P34Q rev GGTACGCATCCCAAACTGTAAAGATACGCCTCC For spYnfEst Quikchange  
YnfEst F35Q for GGCGTATCTTTACCGCAGGGGATGCGTACCGCG For spYnfEst Quikchange  
YnfEst F35Q rev CGCGGTACGCATCCCCTGCGGTAAAGATACGCC For spYnfEst Quikchange  
YnfEst G36Q for GTATCTTTACCGTTTCAGATGCGTACCGCGGCC For spYnfEst Quikchange  
YnfEst G36Q rev GGCCGCGGTACGCATCTGAAACGGTAAAGATAC For spYnfEst Quikchange  
YnfEst M37Q for CTTTACCGTTTGGGCAGCGTACCGCGGCCGCG For spYnfEst Quikchange  
YnfEst M37Q rev CGCGGCCGCGGTACGCTGCCCAAACGGTAAAG For spYnfEst Quikchange  
YnfEst R38Q for CTTTACCGTTTGGGATGCAGACCGCGGCCGCG For spYnfEst Quikchange  
YnfEst R38Q rev CGCGGCCGCGGTCTGCATCCCAAACGGTAAAG For spYnfEst Quikchange  
YnfEst T39Q for GTTTGGGATGCGTCAGGCGGCCGCGGCGGTG For spYnfEst Quikchange  
YnfEst T39Q rev CACCGCCGCGGCCGCCTGACGCATCCCAAAC For spYnfEst Quikchange  
YnfEst A40Q for CCGTTTGGGATGCGTACCCAGGCCGCGGCGGTGCAG For spYnfEst Quikchange  
YnfEst A40Q rev CTGCACCGCCGCGGCCTGGGTACGCATCCCTTTCGG For spYnfEst Quikchange  
YnfEst A41Q for GGGATGCGTACCGCGCAGGCGGCGGTGCAGCAG For spYnfEst Quikchange  
YnfEst A41Q rev CTGCTGCACCGCCGCCTGCGCGGTACGCATCCC For spYnfEst Quikchange  
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YnfEst A42Q for GATGCGTACCGCGGCCCAGGCGGTGCAGCAGTCG For spYnfEst Quikchange  
YnfEst A42Q rev CGACTGCTGCACCGCCTGGGCCGCGGTACGCATC For spYnfEst Quikchange  
YnfEst sp for GCGCAAGCTTAGAACATCGTCATTATCACAG For cloning of 500 bp upstream of 
spYnfE. Contains HindIII 
restriction site. 
YnfEst sp rev GCGCGGATCCGTTGCCGTCGTTGGAACC For cloning of 500 bp upstream of 
spYnfE. Contains BamHI 
restriction site. 
YnfEst for GCGCACAATGGAGTGAGTGATGCCC For sequencing YnfE clones. 
YnfEst rev GCGCAGCCTGCTGCACCGCCGCGGC For sequencing YnfE clones. 
pQE80 TEV DmsDst for GCGCGGATCCGAAAACCTGTATTTTCAGGGCATGACCACTTTTTTACAACGTGATG For construction of His-TEV-
DmsDst vector 
pQE80 DmsDst rev GCGCAAGCTTTTATTAACGGAATAACGGTTTTACAGCG For construction of His-TEV-
DmsDst vector 
DmsDst V16Q for CAGTAACGGCGCGTCAGCTTGGCGCGTTG For DmsDst Quikchange 
DmsDst V16Q rev CAACGCGCCAAGCTGACGCGCCGTTACTG For DmsDst Quikchange 
DmsDst W91Q for CGTGGGGTTCCGTCCAGCTGGATCGTGAGAGCG For DmsDst Quikchange 
DmsDst W91Q rev CGCTCTCACGATCCAGCTGGACGGAACCCCACG For DmsDst Quikchange 
DmsDst R94Q for CCGTCTGGCTGGATCAGGAGAGCGTATTATTTGGC For DmsDst Quikchange 
DmsDst R94Q rev GCCAAATAATACGCTCTCCTGATCCAGCCAGACGG For DmsDst Quikchange 
DmsDst S96Q for GGCTGGATCGTGAGCAGGTATTATTTGGC For DmsDst Quikchange 
DmsDst S96Q rev GCCAAATAATACCTGCTCACGATCCAGCC For DmsDst Quikchange 
DmsDst G100Q for GAGCGTATTATTTCAGGATTCTACATTGGC For DmsDst Quikchange 
DmsDst G100Q rev GCCAATGTAGAATCCTGAAATAATACGCTC For DmsDst Quikchange 
DmsDst T103Q for GTATTATTTGGCGATTCTCAATTGGCGCTACGTC For DmsDst Quikchange 
DmsDst T103Q rev GACGTAGCGCCAATTGAGAATCGCCAAATAATAC For DmsDst Quikchange 
DmsDst G171Q for CGATCATGCCCAGCATCCGTTTTATC For DmsDst Quikchange 
DmsDst G171Q rev GATAAAACGGATGCTGGGCATGATCG For DmsDst Quikchange 
Full YnfE HindIII for GCGCAAGCTTGTGATGCCCGGAGAAAAGC For construction of vector 
containing full length YnfEst.  
Contains HindIII restriction site. 
Full YnfE EcoRI rev GCGCAATTCTTAGATTTTTTCGATTTCC For construction of vector 
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containing full length YnfEst 
Contains EcoRI restriction site. 
FullYnfG HindIII for GCGCAAGCTTATGACAACCCAGTATGG For construction of vector 
containing full length YnfGst.  
Contains HindIII restriction site. 
FullYnfG EcorRI rev GCGCAATTCTTATACCTCCTTCGGATTGGC For construction of vector 
containing full length YnfGst 
Contains EcoRI restriction site. 
Nosig YnfE EcoRI for GCGCGAATTGCGGTGCAGCAGGCTATGCGC For construction of vector 
containing YnfE lacking the N-
terminal signal peptide (a.a. 1-
42). Contains EcoRI restriction 
site. 
Nosig YnfE HindIII rev GCGCAAGCTTTTAGATTTTTTCGATTTCC For construction of vector 
containing YnfE lacking the N-
terminal signal peptide (a.a. 1-
42). Contains HindIII restriction 
site. 
DmsDst K61Q for CCTGTGGCGGCTATGTTTCAGACCCACAGCGAAGAGTCG For lysine Quikchange with 
pQE80L-Nhis-TEV-DmsDst  
DmsDst K61Q rev CGACTCTTCGCTGTGGGTCTGAAACATAGCCGCCACAGG For lysine Quikchange with 
pQE80L-Nhis-TEV-DmsDst  
DmsDst K200Q for CTCATTATTCCCGTCGCTGTACAACCGTTATTCCGTTAATAAAAGC For lysine Quikchange with 
pQE80L-Nhis-TEV-DmsDst  
DmsDst K200Q rev GCTTTTATTAACGGAATAACGGTTGTACAGCGACGGGAATAATGAG For lysine Quikchange with 
pQE80L-Nhis-TEV-DmsDst  
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7.4.2 Amplification of DNA by Polymerase Chain Reaction (PCR) 
The polymerase chain reaction (PCR) is a popular biochemical technique that allows the 
amplification of specific regions of DNA by several orders of magnitude through the utilisation 
of thermostable DNA polymerase enzymes and oligonucleotides. A typical PCR reaction uses 
oligonucleotide primers designed to be complementary to 5’ and 3’ ends of a thermally 
denatured single stranded DNA template. DNA elongation occurs in a 5’ to 3’ direction, 
enabling the extension of the 5’ and 3’ DNA strands towards one another in order to form a 
complete double strand of DNA. 
PCR consists of three essential steps: denaturation, annealing and elongation. PCR reaction 
step temperatures and timings were modified depending on the size of DNA to be amplified 
and the specific PCR technique being utilised.  
 
7.4.3 Site-directed mutagenesis by QuikchangeTM PCR 
Site-directed mutagenesis was performed based on the QuikchangeTM manual from 
Stratagene. In order to introduce specific amino acid substitutions into a given sequence, 
complementary primers of approximately 30 base pairs in length were designed (Sigma). The 
substituted codon of interest was positioned in the centre of the sequence. DNA with the 
substituted codon was then amplified by PCR, before methylated template DNA present in the 
sample was digested by DpnI (New England Biolabs). DNA was then transformed into 
chemically competent E. coli strain DH5α and extracted by Miniprep. 
 
7.4.4 Agarose gel electrophoresis 
DNA samples were analysed by agarose gel electrophoresis using 1 % w/v agarose gels 
prepared with TAE buffer and containing 0.001 % v/v Gel Red dye (Biotium). Loading dye was 
added to samples to create a visible running front, whilst DNA size markers (Stratagene) were 
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run alongside samples to allow an estimation of band sizes. Gels were run in TAE buffer at 100 
V, with bands beings visualised in a Bio-Rad Gel-Doc imaging system. 
 
7.4.5 DNA digestion and preparation for cloning 
DNA was incubated with 10 units of the restriction enzymes appropriate for sites to be cut, in a 
final reaction volume of 40 or 50 μl, depending on whether the DNA being digested was 
plasmid or PCR product. Also within this reaction volume was the required restriction enzyme 
buffer and DNA, usually either 1 μg of plasmid DNA or 43 μl of PCR product. Samples were 
incubated for at least 2 hours or overnight at 37 oC. 
Digested vectors were dephosphorylated by treatment with alkaline phosphatase, in order to 
prevent self-religation. This involved the incubation of 40 μl digested vector with 5 μl of 10x 
alkaline phosphatase buffer and 5 μl alkaline phosphatase for 30 minutes at 37 oC. Samples 
were then analysed by agarose gel electrophoresis and visualised using UV light. Bands of the 
correct product size were excised and purified using a QIAquick Gel Extraction kit (Qiagen). 
 
7.4.6 DNA ligation 
Digested DNA fragments with compatible ends were joined using T4 DNA ligase (Roche). 
Samples were prepared to a final volume of 10 μl in ligation buffer, containing 1 μl of vector 
and 1 μl or 3 μl of PCR product to be inserted, as well as 1 μl of T4 DNA ligase. Reactions were 
incubated overnight at 18 oC before the entire reaction volume was used in transformations 
with chemically competent cells. 
 
7.4.7 DNA sequencing 
Sequencing of DNA was performed in order to confirm plasmid sequences after cloning or 
QuikchangeTM. DNA sequencing was performed by DNA Sequencing & Services (MRCPPU, 
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College of Life Sciences, University of Dundee, Scotland, www.dnaseq.co.uk) using Applied 
Biosystems Big-Dye Ver 3.1 chemistry on an Applied Biosystems model 3730 automated 
capillary DNA sequencer. Chromatogram files obtained from sequencing reactions were 
analysed using BioEdit Sequence Alignment Editor (Copyright © 1997-2007 Tom Hall). 
 
7.4.8 Preparation of competent cells and transformation with plasmid DNA 
For chemically competent cells, 5 ml liquid LB plus any required antibiotics was inoculated 
1:100 from an overnight culture, and grown aerobically at 37 oC with shaking at 200 rpm until 
an OD600 pf 0.5 was achieved. Cells were then harvested by centrifugation at 3020x g for 10 
minutes. Cells were resuspended in TSB medium and kept on ice for at least 15 minutes before 
use or freezing in liquid nitrogen and stored at -80 oC. Transformation was performed by 
incubating 100 μl of competent cells with 1 μl of plasmid for 15 minutes on ice. Cells were then 
heat-shocked at 42 oC for 90 seconds followed by a further 2 minute incubation on ice. 1 ml of 
LB was then added and cells were grown at 37 oC for 1 hour, before cells were isolated by 
centrifugation at 16060x g for 1 minute. Cells were plated onto LB agar plates containing any 
required antibiotics and grown overnight at 37 oC. 
For transformation with Salmonella, electrocompetent cells were prepared. 25 ml low salt LB 
plus required antibiotics was inoculated 1:100 with overnight culture. Cells were grown 
aerobically at 30 oC to OD600 0.5. After cooling on ice for 40 minutes, cells were isolated by 10 
minutes centrifugation at 4500 rpm, and then resuspended in 10 ml ice cold sterile 10 % 
glycerol. Cells were washed with 10 ml ice cold 10 % glycerol another two times before being 
resuspended in 0.5 ml ice cold 10 % glycerol. 50 μl aliquots were then taken and either used 
immediately or frozen in liquid nitrogen and stored at -80 oC. To transform, 1 μl plasmid was 
added to a 50 μl aliquot and incubated on ice for 10 minutes. Cells were placed into an ice-cold 
Gene Pulser cuvette (Bio-Rad) and an electric pulse was passed through. 1 ml LB was mixed 
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with the sample and cells were recovered at 37 oC for 1 hour prior to spreading on LB agar 
plates with appropriate antibiotics overnight. 
 
7.4.9 In-frame chromosomal integration using pMAK705 vector 
Gene replacement on the chromosome of Salmonella was achieved through the use of the 
suicide vector pMAK705 for homologous recombination (Hamilton et al., 1989). The gene 
region including 500 base pairs up and downstream of the region of interest was cloned into 
pMAK705 using DNA amplification, digestion and ligation techniques as described above, using 
pBluescript KS+ as a cloning intermediate. For integration of YnfE signal peptide sequence 
variants, pBluescript KS+ containing the appropriate gene region was subjected to 
QuikchangeTM PCR prior to subcloning into pMAK705. Plasmids were transformed into a recA+ 
host strain using slightly different transformation conditions of 5 minutes heat shock at 37 oC 
and cell recovery at 30 oC for 1.5 hours. Cells were then grown on LB + chloramphenicol (Cm) 
plates overnight at 30 oC. All following steps were performed using selective LB containing 
chloramphenicol unless otherwise stated. 
Overnight liquid cultures of transformed strains were grown aerobically at 30 oC. Serial 
dilutions at 1 x 10-7 (control), 1 x 10-5, 1 x 10-4 and 1 x 10-3 were plated onto LB + Cm, with the 
control plate then incubated at 30 oC and others at 44 oC overnight. Cells are only able to grow 
at 44 oC if plasmid integration has occurred. 10 ml liquid media was inoculated with four cell 
colonies per culture, and grown for 24 hours at 30 oC. A loopful of culture was used to 
inoculate fresh media before a further 24 hour incubation at 30 oC, with this step then being 
repeated once more. From this final culture plates were streaked to obtain single colonies. This 
process should lead to resolution of the co-integrated plasmid. To cure cells of the plasmid, a 
number of 10 ml LB culture without Cm were inoculated with one colony each before being 
grown at 44 oC for at least 16 hours. These cultures were streaked onto LB only plates and 
incubated at 44 oC overnight. Resulting individual colonies could then be patched onto both LB 
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only and LB + Cm plates to test sensitivity. Those that appeared Cm sensitive were analysed for 
desired chromosomal mutations by PCR and DNA sequencing. 
 
 Protein methods 7.5
7.5.1 Overproduction of proteins 
Proteins were overexpressed using pQE vector pQE80, encoding for an N-terminally His-tagged 
protein. Plasmids were transformed into the E. coli strains BL21 (DE3) pLysS or MC4100, before 
a single colony was used to inoculate a 5 ml overnight starter culture in LB plus appropriate 
antibiotics. 500 ml cultures were then inoculated using these starter cultures, at 1:1000 
dilution. Cultures were grown aerobically in 2 L baffled flasks at 37 oC with 170 rpm shaking 
until they had reached OD600 0.6. Induction of recombinant protein expression was then 
initiated by addition of 2 mM isopropyl β-D thiogalatopyranoside (IPTG, Sigma). Cultures were 
then grown overnight at 18 oC before cells were harvested the next day by centrifugation. 
 
7.5.2 Purification of hexa-histidine tagged proteins using immobilised metal ion 
affinity chromatography 
Cell pellets after induction of protein overexpression were resuspended in buffer A by 
homogenisation, in a volume to cell weight ratio of 10ml/g cells. In addition, protease inhibitor 
(either EDTA-free complete protease inhibitor cocktail – Roche, or protease inhibitor cocktail 
set III, EDTA-Free - Calbiochem), lysozyme and DNase were added to the cell suspension. Cells 
were then lysed by three times passage at 15 000 psi through an Emulsiflex C3 high pressure 
homogenizer. Cell debris was then removed from the supernatant by centrifugation at 27143x 
g for 30 min at 4 oC. His-tagged proteins could then be isolated from the supernatant by 
immobilized metal ion affinity chromatography (IMAC) on an ÄKTATM FPLC system (GE 
Healthcare).  
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Supernatant of lysed cells was filtered through a 0.45 µM membrane filter, before being 
loaded onto a 5 ml HisTrapTM HP column (GE Healthcare) pre-equilibrated with Buffer A. The 
column was then further washed with Buffer A to remove all unbound and non-specifically 
bound protein, usually approximately 5 column volumes. Bound protein was then eluted using 
an imidazole gradient of 25 mM to 500 mM (0 – 100 % Buffer B) over 5 column volumes and 
collected in 5 ml collection tubes. Fractions containing the protein of interest were identified 
by SDS-PAGE and were pooled and concentrated if required. 
 
7.5.3 Purification of tobacco etch virus protease 
Tobacco etch virus (TEV) protease is a 27 kDa enzyme commonly used for the cleavage of 
affinity tags from recombinant proteins after purification. TEV protease recognises the general 
epitope E-X-X-Y-X-Q-G/S, where cleavage occurs between the Q and the G or S (Carrington & 
Dougherty, 1988). Cell cultures expressing pET24b TEVhis were grown and overexpression 
induced as previously described. Cells were then resuspended in Buffer F plus EDTA-free 
complete protease inhibitor cocktail (Roche), lysozyme and DNase to a volume 5 times that of 
cell pellet mass. Lysis was performed,  as before, by three times passage at 15 000 psi through 
an Emulsiflex C3 high pressure homogenizer followed by centrifugation at 27143x g for 30 min 
at 4 oC to remove cell debris. The supernatant was then filtered through a 0.45 µM membrane 
filter. 
A 5 ml HisTrapTM HP column (GE Healthcare) was pre-equilibrated with Buffer D and 6 % Buffer 
E prior to sample loading. The column was then washed with a further 5 column volumes 
before elution of protein using a Buffer E gradient of 0-60 % over 5 column volumes. Fractions 
were collected in 5 ml collection tubes, with EDTA being immediately added to a final 
concentration of 1 mM. SDS-PAGE was used to identify fractions containing TEV protease, with 
those fractions being pooled and dialysed overnight into Buffer G at 4 oC using 6.45 ml/cm 
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volume, 8 kDa molecular weight cut-off dialysis tubing (BioDesign). Protein concentration was 
then adjusted to 0.5 mg/ml prior to flash freezing and storage at -80 oC. 
 
7.5.4 TEV cleavage of hexa-histidine tags 
For removal of the hexa-histidine tag, protein purified by IMAC as described above was mixed 
with TEVhis protease in a mg/ml ratio of approximately 1:10. This was then subjected to 
overnight dialysis at 4 oC using 6.45 ml/cm volume, 8 kDa molecular weight cut-off dialysis 
tubing (BioDesign) into Buffer A containing 1 mM DTT in order to remove unwanted imidazole 
from the sample. Cleaved DmsD protein was isolated from TEVhis protease and any uncleaved 
protein by reverse nickel chromatography with a 5 ml HisTrapTM HP column. The flow-through 
containing cleaved DmsD in Buffer A was collected in 5 ml collection tubes before the column 
was washed with Buffer B to remove any bound TEVhis and cleaved hexa-histidine tag. 
Fractions were checked for the presence of the protein of interest by SDS-PAGE before being 
pooled and concentrated. 
 
7.5.5 Purification of proteins using size-exclusion chromatography 
For further purification after IMAC, proteins can be separated according to size by size-
exclusion chromatography (SEC). Samples were concentrated to 500 µl in a Vivaspin® 20 spin 
concentrator (Vivaproducts) with an appropriate molecular weight cut-off. SEC was performed 
using a Superdex 75 10/300 GL prepacked column with an ÄKTATM FPLC system (both GE 
Healthcare). The column was first equilibrated with 1 ½ column volumes of degassed miliQ 
water, then 1 ½ column volumes of buffer C, prior to loading of the protein sample via a 500 µl 
loop. The column was then washed with a further 1 ½ column volumes of buffer C, in order to 
allow isocratic elution of proteins into 5 ml collection tubes. Fractions were analysed using 
SDS-PAGE before being pooled and concentrated. 
 
219 
 
7.5.6 Protein concentration determination 
Concentrations of purified protein samples were determined through measurement of 
absorbance at 280 nm (A280) with an ND-1000 Nanodrop spectrophotometer (Thermo 
Scientific). Whilst the relationship of absorbance to protein concentration is linear, in reality 
the degree of absorbance of a protein can be greatly affected by specific amino acid 
composition, particularly due to the presence of aromatic amino acids. Therefore, this method 
is only suitable for proteins of high purity with a known amino acid composition. A correction 
factor based on the molar extinction coefficient is used to calculate relative absorbance and 
therefore accurately predict protein concentration. Correction factors were calculated using 
the ExPASy ProtParam server (http://web.expasy.org/protparam/). 
 
7.5.7 Purified protein crystallisation trials 
Crystallisation trials were carried out at room temperature by the sitting-drop vapour-diffusion 
method in 96-well plates. Plates were set up using a Phoenix liquid handling system with 
purified DmsD protein (14 mg/ml) (Rigaku, Art Robbins Instruments) and the commercially 
available screens: PEG (Qiagen), The Classics suite (Qiagen), Hampton crystal screen (Hampton 
Research), and Wizard (Emerald Biosystems). In addition conditions from Qiu et al. (2008) (20% 
PEG400, 1 M ammonium sulfate, 10% glycerol, imidazole, pH 8.0) were tested. Drops were 
checked under microscope every day for the first week, then around once every week after 
this.  
 
7.5.8 Polyclonal antibody production 
Purified proteins were concentrated and flash frozen before being sent to Eurogentec S.A. 
(Belgium) for antibody to be produced, raised using the 28-day Speedy protocol with rabbits. 
Antiserum received was aliquoted and stored at -80 oC prior to use. 
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7.5.9 Affinity purification of polyclonal antiserum 
Purified protein against which the antiserum was raised was ran on an SDS-PAGE gel and 
transferred onto nitrocellulose membrane by Western blot. The nitrocellulose membrane was 
incubated with ponceau stain for 1 min to reveal protein, which was marked prior to 
destaining of membrane with distilled water. The region of nitrocellulose membrane 
containing the protein was cut out and blocked in 1x PBS containing 5% milk for 1 hour, and 
subsequently was washed three times with 1x PBS. 200 µl antiserum and 800 µl 1x PBS was 
then used to incubate the membrane overnight at 4 oC with gentle shaking. The supernatant 
was then removed and the membrane was washed three times with 1x PBS, before 1 ml 100 
mM glycine, pH 2.5, was added for 5 min with gentle shaking to elute the purified antibody 
bound to the membrane. This liquid was recovered and 100 µl 1 M Tris-HCl, pH 7.5 added to 
neutralise the pH and prevent antibody damage. The elution step was repeated for a second 
time, with first and second elutes then able to be tested in Western blots for antibody purity. 
Purified antibody was used at a dilution of 1:200.  
 
7.5.10 SDS-PAGE 
SDS polyacrylamide gel electrophoresis is used to separate proteins according to molecular 
weight under denaturing conditions. Tris-glycine gels were prepared with varying 
concentrations of polyacrylamide, according to experimental requirements, with a 0.75 mm 
thickness for use with the Mini-PROTEAN II system (Bio-Rad). Samples were prepared for PAGE 
by mixing 1:1 with Laemmli buffer. Tris-glycine gels were placed into a Bio-Rad gel 
electrophoresis tank before being submerged in SDS running buffer. Samples were loaded 
alongside Precision Plus ProteinTM All Blue standards (Bio-Rad) for allow approximation of 
protein molecular weights. The gel was run at 100 V until the dye front had passed through the 
stacking gel layer, before the voltage was increased to 200 V until the dye front or the 
appropriate marker had reached the end of the resolving gel. Gels could then be incubated in 
Coomassie based InstantBlue stain (Expedon) for visualisation of proteins, or used further in 
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semi-dry western blotting. Stained gels were washed with water to destain prior to drying at 
80 oC for 75 minutes in a Gel Dryer Model 583 (Bio-Rad). 
 
7.5.11 Semi-dry western immunoblot 
For analysis by western immunoblot, samples were separated by SDS-PAGE as described 
above. Gels were soaked in Tris glycine transfer buffer before being placed on top of 
nitrocellulose membrane (Amersham Hybond-ECL, GE Healthcare), also pre-soaked in Tris 
glycine transfer buffer. These were stacked with 2 pieces of pre-soaked 3MM Whatmann 
paper on either side, and placed inside a TransBlot SD SemiDry Transfer Cell (Bio-Rad) for 
protein transfer. Transfer was performed for 30 minutes at a constant voltage of 10 V. 
Nitrocellulose membrane was then blocked in 5 % skimmed milk TBS at room temperature for 
at least 1 hour, or at 4 oC overnight, with shaking. 
The membrane was washed with TBS-T prior to a 1 hour incubation with primary antibody 
diluted in 20 ml TBS-T. A further 3 10 minute washes with TBS-T were then performed before 
the membrane was incubated for a further 1 hour with the secondary antibody, again diluted 
in 20 ml TBS-T. Working concentrations of antibody are listed below.  Bands were visualised 
using enhanced chemiluminescent detection. This involved the use of horseradish peroxidase-
conjugated secondary antibodies, where the conjugated horseradish peroxidase is able to 
oxidise luminol in the presence of peroxide, resulting in the emission of light proportional to 
protein quantities as the luminol decays. Bands were pictured using Konica Minolta medical 
film after the membrane was incubated with ImmobilonTM Western Chemiluminescent HRP 
Substrate (Milipore), and developed using a SRX-101A medical film processor. 
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Table 7.9: Antibodies used in this work. 
General working concentrations used are shown. 
Antibody 
- Primary 
Working 
concentration 
Raised in Reference 
Monoclonal penta-His 1:2,000 Mouse QIAGEN (Cat.# 34660) 
Polyclonal DmsD antiserum 1:20,000 Rabbit  
Polyclonal TorD antiserum 1:20,000 Rabbit  
Polyclonal mCherry antiserum 1:20,000 Rabbit This study 
Polyclonal TatA antiserum 1:500 Rabbit  
Polyclonal YnfEst antiserum 1:20,000 Rabbit This study 
Anti-MBP monoclonal  1:20,000 Mouse New England Biolabs 
(Cat.# E8032S) 
- Secondary    
Anti-mouse IgG HRP conjugate 1:10.000 Goat Bio-Rad 
Anti-rabbit IgG HRP conjugate 1:10,000 Goat Bio-Rad 
DyLight 594 anti-rabbit 1:200 Goat  
 
7.5.12 Chemical crosslinking of proteins 
For evaluation of interactions between DmsD and spYnfEst, purified DmsD prepared as 
described in sections 7.5.2, 7.5.4 and 7.5.5 was used in experiments involving chemical 
crosslinking. The process of crosslinking involves the chemical joining of two or more 
molecules through the addition of a covalent bond by a crosslinking reagent. Crosslinking 
reagents are molecules that consist of two or more reactive ends, usually on either end of a 
spacer arm of varying length, which can chemically attach to the proteins of interest via 
specific functional groups such as primary amines. In these experiments the crosslinkers 
disuccinimidyl suberate (DSS), formaldehyde and 1-Ethyl-3-[3-dimethylaminopropyl] 
carbodiimide hydrochloride (EDC) were used.  
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DSS is a non-cleavable, homobifunctional crosslinker that reacts with primary amines. The 
structure of DSS contains two N-hydroxysuccinimide (NHS) esters on either side of an 8 carbon 
spacer arm that is 11.4 Å in length (Figure 7.1). NHS esters are highly reactive specifically 
towards primary amines (-NH2) such as those found on lysine residues as well as the N-
terminus of proteins. Providing there are no other primary amines in solution, specific 
crosslinking of the target molecules can occur between lysine residues within 11.4 Å of each 
other.  
EDC, an amine-to-carboxyl crosslinker, is a zero-length crosslinker, meaning that it can cause 
direct conjugation of primary amines and carboxylates (-COOH) but does not become part of 
the final crosslink between molecules (Figure 7.1). Instead it causes the formation of an amine-
reactive O-acylisourea intermediate through interactions with a carboxyl group. This 
intermediate can go on to interact with an amine and form an amine bond, with the release of 
an isourea by-product. 
Formaldehyde is a chemical widely used for crosslinking and chemical fixation of proteins and 
cells (Figure 7.1).  
 
Figure 7.1: Chemical structures of crosslinkers DSS, EDC and formaldehyde. 
 
DmsD and synthetic peptide were co-incubated in HEPES crosslinking buffer in a reaction 
volume of 100 µl, on ice for 1 hour, prior to the addition of the chemical crosslinker of choice. 
DSS was added to the reaction to a final concentration of 1 mM, EDC to 2 mM and 
formaldehyde to 1 % before subsequent 30 minute incubation on ice. Reactions were stopped 
by the addition of 10 mM Tris before being mixed in a 1:1 ratio with Laemli buffer. Samples 
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were then analysed through the use of SDS-PAGE (17 % acrylamide gels) and Western blot with 
DmsD antiserum. The occurrence of crosslinks between DmsD and synthetic peptides could be 
observed by the appearance of a bandshift on gels. 
 
 Protein assays 7.6
7.6.1 BV-linked oxidoreductase assays 
Oxidation or reduction of substrates by oxidoreductase enzymes can be coupled to the in vitro 
reduction or oxidation of an artificial electron acceptor such as benzyl viologen (BV). BV 
changes from colourless when oxidised (BVOx) to blue-purple when reduced (BVRed), and 
therefore the level of oxidation or reduction can be quantified through measuring A600 using a 
Lambda UV/Vis spectrophotometer (Perkin Elmer). Reactions can be initiated by addition of 
substrate or sample dependent upon the assay, and the conversion between BVOx and BVRed is 
then monitored. Oxidoreductase activity was calculated using the following equation: 
 
BVOx [µmol min-1 mg-1] = ∆𝐴600�𝑚𝑚𝑚
−1�× 𝑉𝑐𝑐𝑐𝑐𝑐𝑐𝑐[𝑙] ×1000
2 × 𝜀600[𝑚𝑚−1𝑐𝑚−1] × 𝑚𝑝𝑝𝑝𝑐𝑐𝑝𝑝 [𝑚𝑚]×1[𝑐𝑚]
 
ΔA600 = absorption change at 600 nm per minute 
Vcuvette = volume of cuvette (0.0018 l) 
ε600 = extinction coefficient of oxidised BV at 600 nm (7.4 mM-1 cm-1) 
mprotein = mass of protein in periplasmic fraction 
 
The extinction coefficient ε600 is multiplied by a factor of 2 due to the transfer of two electrons 
to or from BV for each substrate molecule. 
 TMAO reductase activity assay 7.6.1.1
TMAO reductase activity was tested using the artificial electron donor BV. TMAO reductase 
can be reduced by BV, leading to a colour change from blue-purple to colourless. 
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Bacterial cells were grown overnight anaerobically in LB supplemented with 0.5% glycerol, 
0.4% TMAO and appropriate antibiotics. Cells were isolated by centrifugation at 3000 x g for 
10 minutes before washing in 10 ml 50 mM Tris-HCl, pH 7.5. Cells were again subjected to 
centrifugation at 3000 x g for 10 minutes and resuspended in 1 ml 50 mM Tris-HCl, 40% 
sucrose, pH 7.5. Periplasmic samples were isolated from cells, through removal of the outer 
membranes and peptidoglycan by 30 min incubation with 5 mM EDTA and 0.6 mg/ml lysozyme 
at 37 oC. Periplasmic protein concentration was determined through the use of the Lowry 
method (Lowry et al., 1951) with a DCTM protein assay kit (BioRad). A standard curve was 
generated using bovine serum albumin (BSA) for sample comparison. 10-100 µl periplasmic 
sample was used for determination depending upon protein concentration. 
10 µl of 200 mM BV was added to a glass cuvette along with 10 µl of periplasmic sample. The 
cuvette was then filled to the top with 0.1 M phosphate buffer that had been deoxygenated 
using N2 before the cuvette was sealed with a perforated stopper. The cuvette was inverted 
gently to mix the sample after this step and every subsequent addition. Using a Hamilton 
syringe approximately 10 µl 1% dithionate (dissolved in 1 mM NaOH) was added to reduce the 
BV and an intense purple colour was achieved. To initiate the reaction 10 µl 20% TMAO was 
added, with the colorimetric output being measured at A600. The specific periplasmic TMAO 
reductase activity was determined using the earlier described equation (Section 7.6.1). TMAO 
reductase activity is quantified as µmol of oxidised benzyl viologen min-1 mg-1 protein.  
 Hydrogenase-2 (Tat proofreading) activity assay 7.6.1.2
Under anaerobic conditions, the E. coli hydrogenase-2 complex is able to catalyse the oxidation 
of molecular hydrogen. In this assay this oxidation reaction was coupled with the reduction of 
BV, enabling activity to be calculated based on the colour change as BV was increasingly 
reduced. Strains were grown anaerobically overnight in LB supplemented with 0.5% glycerol, 
0.4% TMAO and appropriate antibiotics, with cells then being isolated by centrifugation at at 
3000 x g for 10 minutes. Whole cell samples were washed in 10 ml 50 mM Tris-HCl, pH7.5 per 
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gram of cell pellet, and taken for use in the activity assay. 100 µl 250 mM BV was added to a 
glass cuvette before it being filled to the top with 50 mM Tris-HCl, pH7.5, that had been 
deoxygenated with H2. The cuvette was stoppered and inverted to mix, before approximately 
10 µl 1% dithionate was added. Once the mixture UV absorbance was steady, 10 µl cell sample 
was added. The colorimetric output was measured at A600 in order to detect BV reduction. 
Cellular hydrogenase activity could then be determined using the earlier described equation 
(Section 7.6.1), and is quantified as µmol of oxidised benzyl viologen min-1 g-1 cells. 
 
7.6.2 Bacterial two-hybrid system and β-galactosidase assay 
The bacterial two-hybrid system is based on the reconstitution of an adenylate cyclase signal 
transduction pathway in E. coli, where the two complementary fragments, namely T18 and 
T25, of adenylate cyclase from Bordetella pertussis are fused to two potentially interacting 
proteins (Karimova et al., 1998). If protein interactions occur, the two fragments are brought 
into close proximity and cAMP is produced, inducing downstream activation of catabolic 
genes. Chemically competent MG1655 ΔcyaA::Apra cells were transformed with vectors 
encoding T18 and T25 fusions to proteins of interest before plating onto MacConkey agar 
plates containing 1 % maltose as the carbon source. Plates were incubated for 2 days at 30 oC 
to allow time for colonies to grow. MacConkey contains the dye phenol red, and acts as an 
indicator for sugar fermentation through a colour change. MG1655 ΔcyaA::Apra cells are 
unable to ferment lactose or maltose under normal conditions, except in the case of an 
interaction between the two proteins of interest where expression of genes such as the lac or 
mal operons is enabled. A positive interaction can be then interpreted on MacConkey by the 
appearance of red colonies, while pink colonies indicate no interaction is occurring. 
For quantification of interactions, a β-galactosidase assay was used. Colonies from MacConkey 
agar plates were used to inoculate 5 ml LB plus antibiotic cultures and grown at 30 oC 
overnight, 200 rpm shaking. These cultures were sub cultured and grown under the same 
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conditions until an approximate OD600 of 0.5 was reached. OD600 was recorded and 1 ml 
samples were taken for assay. 50 ml toluene was added to cell suspensions followed by 30 
seconds of vortexing and incubation on ice for 15 minutes. 0.5 ml of the sample was then 
removed from below the toluene layer and transferred to a fresh tube, with 50 µl then added to 
450 µl Z buffer. Following equilibration in a 28 oC waterbath for 10 minutes, 100 µl ONPG (4 mg/ml in Z 
buffer) was added and ‘start’ time noted. Samples were incubated at 28 oC until development of a 
yellow colour, with the reaction then being stopped by addition of 250 µl 1 M Na2CO3 and ‘stop’ time 
noted. A420 of samples was recorded. The specific β-galactosidase could then be calculated 
using the following formula: 
 
β-galactosidase activity (Miller units)= 𝐴420 × 10
3
𝑡×𝑉×𝑂𝑂600
 
𝑡 = time of reaction (min) 
𝑉 = volume of cells (ml) 
 
 Cellular fractionation 7.7
7.7.1 Preparation of cytoplasmic/membrane/periplasmic fractions 
Cells were grown overnight in 500 ml volumes, before being subjected to centrifugation at 
5,000 x g for 30 min at 4 oC. Cell pellets were washed with 10 ml 50 mM Tris-HCl, pH 7.5, and 
again isolated by centrifugation at 18,860 x g for 12 min at 4 oC. The pellet was resuspended in 
10 ml g-1 wet weight of cells with 50 mM Tris-HCl pH 7.5 containing 40% sucrose. At this point 
a 100 µl sample was removed and mixed with 100 µl Laemmli sample buffer and then frozen 
with liquid nitrogen, for the whole cell sample. EDTA and lysozyme were added to the 
resuspended cells to a final concentration of 5 mM and 0.6 mg/ml respectively, before the 
cells being incubated at 37 oC for 30 min. Samples were then centrifuged for 20 min at 25,000 x 
g at 4 oC. A 100 µl sample of the upper level of the resultant supernatant was taken and flash 
frozen with Laemmli sample buffer as the periplasmic fraction. The rest of the supernatant was 
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discarded, and the pellet gently resuspended in 50 mM Tris-HCl in the same volume as the last 
step. Again a 100 µl sample was mixed with Laemmli buffer and frozen for the sphaeroplast 
fraction.  A few flakes of DNase I (Sigma-Aldrich) were added to the cells before lysis by 
sonication. Cell debris could then be removed by centrifugation twice at 18,860 x g for 12 min 
at 4 oC. A small amount of the supernatant was then decanted. This encompassed the crude 
extract fraction, and an aliquot could be taken here and flash frozen with Laemmli buffer. A 1 
ml sample was subjected to ultracentrifugation at 278,000 for 30 min at 4 oC. Immediately, 100 
µl was removed from the top of the supernatant to give the cytoplasmic fraction; this was flash 
frozen as previously described. The remainder of the cytoplasm was removed and discarded by 
pipetting, with the membrane pellet then being resuspended in 800 µl 50 mM Tris-HCl pH7.5. 
A 100 µl aliquot of this membrane suspension was also mixed with Laemmli sample buffer and 
flash frozen. 
 
 Growth curves 7.8
7.8.1 Set-up of 96-well plates 
Growth curves were performed to further analyse results of Biolog Phenotype Microarray 
screen. S. Typhimurium strains were grown overnight in minimal media or LB. Subcultures 
were then grown until they reached OD600 of approximately 0.6. 2 µl was then inoculated into 
100 µl defined minimal media containing the required carbon source in 96-well plates. Plates 
were incubated for 24 or 48 hours at 37 oC with gentle agitation, and A600 readings were taken 
every 20 minutes. Readings could then be plotted in excel to give growth curves. 
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 Microscopy methods 7.9
7.9.1 Confocal microscopy 
 Slide preparation 7.9.1.1
Coverslips for imaging were first prepared with Cell-TakTM (BD Biosciences) in order to allow 
bacterial cell immobilisation. 1.5 µl Cell-Tak per coverslip was mixed with 25 µl per coverslip of 
fresh 0.1 M NaHCO3 solution. Immediately, 25 µl of the mixture was spotted onto coverslips 
and incubated for at least 30 min at room temperature prior to use. Excess liquid was removed 
from the coverslip surface immediately prior to immobilisation of cells. 
Bacterial cells for confocal microscopy were grown aerobically at 37 oC in LB and appropriate 
antibiotics, before being subcultured and grown until reaching OD600 0.3. Cells were then 
washed in 1x PBS prior to spotting of 25 µl onto surface of coverslip, over the adsorbed Cell-
Tak spot. Coverslips were covered with foil to protect from the light and incubated at room 
temperature for at least 30 min, with unbound cells being washed off with 1x PBS. For live cell 
imaging, coverslips were placed onto slides with a drop of 1x PBS between the two surfaces to 
hold them together by surface tension. 
 Imaging 7.9.1.2
Cells were imaged using a Leica SP5 SMD (Single molecule detection) confocal laser scanning 
microscope at Heriot-Watt University, under the supervision of Professor Rory Duncan and Dr 
Colin Rickman. Image reconstruction and generation of residual maps showing colocalisation 
was performed using ImageJ software. 
 
7.9.2 OMX microscopy 
 Slide preparation 7.9.2.1
Cell cultures were grown aerobically overnight at 37 oC in LB plus appropriate antibiotics. Cells 
were subcultured and grown to mid-logarithmic phase. Those cells in which Tat substrate 
expression was to be induced were grown for 2 ½ hours before IPTG was added to a final 
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concentration of 2 mM. Cultures were then allowed to grow for a further 2 ½ hours prior to 
slide preparation. Bacterial cells were washed and resuspended in mili-Q ultrapure water, 
before being diluted to OD600 0.3. 
Number 1.5 coverslips were used for imaging with the OMX. Cells were mounted using poly-
lysine. This required spotting of 5 µl poly-lysine onto the coverslip before allowing it to air dry. 
Washed cells were then spotted onto the poly-lysine and also allowed to air dry. Fixation was 
performed using ice-cold 100% methanol, which was spotted onto the coverslip for 5 min 
before rehydration with three washes with TBS/Tween. Cells were permeabilised by 
incubation with 10 µl of lysozyme (10µg/ml) for 10 min, followed by washing with 1x PBS. A 1 
hour incubation with GFP-booster (1:200 in PBS + 2% bovine serum albumin) (Chromotek) was 
performed to enhance fluorescence. Coverslips were washed thoroughly with 1x PBS, before 
being mounted onto glass slides using 10 µl Pro-Long Gold (Life Technologies). After overnight 
curing at room temperature, slides were sealed using clear nail varnish. 
 Imaging 7.9.2.2
Cells were imaged using 3D structured illumination microscopy (3D SIM) with the OMX 
microscope in the College of Life Sciences at the University of Dundee, with the assistance of 
OMX Scientific Officer Dr Markus Posch. Images were reconstructed and analysed using 
SoftWorx software. 
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8 Appendix 
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 Biolog plates 8.1
Maps of respiratory sources in individual Biolog plates. Information obtained from 
http://www.biolog.com/products/?product=Phenotype%20MicroArrays%20for%20Microbial%
20Cells&view=Product%20Literature. 
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